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Summary 
Cutting-edge structural studies by crystallography are presently aimed at very complex 
targets including membrane, multi-domain and secreted proteins of human origin. Such 
proteins can often only be expressed in higher eukaryotic systems, such as insect or 
mammalian cell lines due to the requirement of the complex eukaryotic protein expression 
and post-translational modification machinery. For NMR studies, the need of isotope labeling 
poses extreme challenges in such eukaryotic hosts, since the growth media need to contain 
isotope-labeled amino acids. The costs of commercially available isotope-labeled amino acids 
are very high and so far even prohibitive in the case of deuteration. 
This thesis describes the development of an economic approach to isotope labeling in 
higher eukaryotes, where the necessary labeled amino acids are provided to the growth media 
from autolyzed yeast grown on inexpensive 13C glucose, 15N ammonium salt and 2H2O. The 
method was used in the baculovirus-infected insect cell system to produce isotope-labeled 
proteins relevant to human health and their study by NMR. 
Chapter 1 provides an introduction to recombinant expression in insect cell lines and the 
use of the baculovirus expression vector system. Furthermore, the amino acid metabolism in 
insect cells and its relevance for isotope labeling is discussed. Frequently used approaches to 
isotope labeling and their applications are outlined.  
Chapter 2 describes in detail the production of isotope-labeled yeast extracts and their 
supplementation to insect cell growth media for labeled protein expression. Parts of this 
chapter have been published (Opitz et al., An economic approach to efficient isotope labeling 
in insect cells using homemade 15N-, 13C- and 2H-labeled yeast extracts. J. Biomol. NMR, 
2015). The method achieves uniform protein 15N and 13C labeling of up to 90 % and 
deuteration levels of >60 %, which are the highest reported incorporation levels based on 
cellular extracts so far. 
Chapter 3 describes the design of a thermostabilized mutant of the turkey β1-adrenergic 
receptor (TS-β1AR) for NMR solution studies. This mutant was expressed with selective 15N-
valine labeling in insect cells and used for an extensive NMR characterization of ligand 
interactions. It was possible to follow ligand-induced backbone motions at many key residues 
in the receptor. The latter results have been published (Isogai, Deupi, Opitz et al., Backbone 
NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor. Nature, 
2016). The final section of the chapter shows the expression of uniformly 2H-15N labeled TS-
β1AR, which has been used to record high-quality 15N-edited NOESY spectra and obtain a 
number of further backbone resonance assignments. 
Chapter 4 describes the expression of the human lipopolysaccharide-binding protein 
(hLBP) for NMR studies in baculovirus-infected insect cells by secretion of the protein to the 
culture medium. A labeling scheme was explored based on the combination of isotope-
labeled autolyzed yeast and commercial extracts of algal cells. The combined approach made 
it possible to produce milligram quantities of uniformly 15N-labeled hLBP and to acquire 
two-dimensional 1H-15N-TROSY spectra. 
Chapter 5 describes the enzymatic synthesis of 15N2-L-glutamine from inexpensive 2-
oxoglutaric acid and 15N ammonium salt. Since supplementation of L-glutamine is required 
for efficient expression, the method further reduces the costs of the labeling approach based 
on autolyzed yeast and enables economic production of selectively deuterated L-glutamine. 
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For additional cost reduction, also the recombinant expression of glutamate-ammonia ligase 
was established. 
Chapter 6 describes the use of autolyzed yeast as an economical source of labeled amino 
acids in the cell-free expression system. An initial protocol for high-yield expression was 
established and its optimization is discussed. Isotope labeling by 15N and 2H is demonstrated 
for the green fluorescent protein GFP produced in the cell-free expression system based on 
isotope-labeled yeast.  
Chapter 7 describes a proteomics approach to study short-term adaptation of E. coli to 
growth on 2H7-glucose and 2H2O. Characterization of the cellular adaptation process has 
implications for the production of deuterated proteins. The results show that deuterated media 
induce differential expression of proteins involved in the response to osmotic and 
temperature-induced stress. The data further indicate downregulation of proteins involved in 
ribosome biogenesis and differential activation of chaperones targeting nucleic acids as well 
as proteins. Simultaneously, an alteration of the energy metabolism was observed in the 
perdeuterated environment, in particular upregulation of anaplerotic reactions in the 
TCA cycle. 
Chapter 8 explores the use of isotope-labeled yeast as an economic source of amino acids 
for labeling in mammalian cells. The initial results indicate that, similar to the protocol 
applied in insect cells, inexpensive dropout media supplemented by labeled yeast extracts 
enable good expression of the uniformly labeled angiotensin II receptor type 1a for NMR 
studies.  
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1.1 Scope of this thesis 
Production of isotope-labeled proteins for nuclear magnetic resonance studies 
Ambitious contemporary structural and functional studies by nuclear magnetic resonance 
(NMR) are aimed at complex targets including membrane, multi-domain and secreted 
proteins of human origin. The production of these proteins in functional isotope-labeled form 
is a major bottleneck. Escherichia coli (E. coli) remains the most widely used expression 
system offering a number of advantages, namely inexpensive culture media, rapid growth, 
ease of cloning, and most importantly, a wide variety of isotope labeling schemes. These 
labeling schemes have been developed based on synthetically defined minimal media, which 
are often inexpensive and enable very high incorporation levels. Key to this development is 
the metabolic flexibility of E. coli. In fact, growth and expression can be established on 
simple carbon and nitrogen sources such as 13C-glucose and 15N-ammonium salts. Further, 
E. coli is amenable to growth in a perdeuterated environment and provides efficient 
deuteration (>90 %) (1, 2) to improve the spectral properties of larger proteins (>20 kDa). 
However, correct folding and activity of human proteins often requires various post-
translational modifications, which are highly limited or even absent in E. coli. Especially, 
erroneous formation of disulfide bonds poses a major challenge and frequently results in 
aggregation and the loss of biological function (3). Furthermore, efficient routing of 
transmembrane and secretion of glycoproteins is often not possible. Great effort has been 
made to improve folding and expression of eukaryotic proteins in E. coli including alteration 
of the cellular redox environment (4), the use of chaperones (5), and glycol-engineering (3, 
6). Although these approaches yield impressive results for some targets (7), they are not 
applicable to all proteins. 
In contrast, insect cell lines (ICL) have been widely used for the recombinant expression 
of several thousands challenging higher eukaryotic proteins for crystallographic studies (8). 
Key to this success is the cellular environment of the insect cell, which comprises a 
comprehensive folding machinery and provides post-translational modifications such as 
homogenous protein glycosylation patterns. Most notably, baculovirus-infected insect cells 
have played a pivotal role in crystallographic studies of G protein coupled receptors (GPCRs) 
(9) and have been applied for the determination of 84 GPCR structures out of 115 known to 
date (10). Using the baculovirus expression vector system (BEVS), high amounts of protein 
can be obtained by using strong viral promoters that encode for proteins, which are not 
essential for proliferation of the baculovirus and thus can drive recombinant expression of 
heterologous genes. Moreover, suspension cultures of ICL display excellent scalability and 
compare well to flask-based expression in E. coli. Large-scale production of recombinant 
proteins is commonly achieved by cultivation in disposable conventional bioreactors (11) or 
the efficient WAVE Bioreactor™ System (12). 
However, production of isotope-labeled proteins for NMR studies poses a major challenge 
in insect cells and in fact, in all higher eukaryotic expression systems. The limited metabolic 
capabilities of insect cells do not allow uniform isotope labeling from growth on simple 
carbon and nitrogen sources, which are successfully used for low-cost recombinant 
expression in E. coli and lower eukaryotes such as yeast. Consequently, the concept of a 
defined minimal medium is not available for insect cell cultures and uniform labeling has so 
far been exclusively relying on very expensive commercial media (13-15). 
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Most importantly, perdeuteration of non-exchangeable proton sites is key to NMR studies 
of complex proteins (1, 2). This requires growth of insect cells on culture media 
supplemented with deuterated amino acids. However, as such media contain several hundred 
milligrams of individual amino acids, the costs are prohibitively high. Indeed, a commercial 
medium for uniform deuteration in insect cells is currently not available.  
 
Aims of this work 
Although commercial media for 15N and 13C, 15N labeling in insect cells have been 
available for nearly a decade, routine use has not yet become widespread. This is in part due 
to the very high costs associated with this approach and more importantly, the lack of 
deuteration, which is an essential tool to study complex proteins by NMR. An alternative 
approach has gained increased momentum (16), which is based on the use of isotope-labeled 
yeast extracts and substantially more economic than the commercial media. However, the 
method has so far only been applied for 15N labeling (17) and its applicability for advanced 
NMR experiments and the analysis of challenging proteins has not been demonstrated. 
 
This thesis has been aimed at the development of an economic approach to uniform 
isotope labeling in higher eukaryotes based on the supplementation of isotope-labeled cellular 
extracts as the source of amino acids in amino acid-depleted dropout media. In particular, the 
research work should  
(i) establish a method for robust expression and high levels of isotope incorporation in 
insect cells 
(ii) establish a step-by-step protocol for implementation in a standard laboratory 
environment to facilitate widespread use  
(iii) provide a proof of successful application to advanced NMR experiments  
(iv) establish a method for efficient deuteration in insect cells. 
 
Organization of the following sections 
The next section of this introduction (Chapter 1.2) gives an overview of isotope labeling 
approaches in insect cells, their development and applications. This is followed (Chapter 1.3) 
by a detailed description of the insect cell system, its use for recombinant protein production, 
and the baculovirus expression vector system. The concluding section (Chapter 1.4) discusses 
important aspects of the acid metabolism in insect cells and their implications for isotope 
labeling.  
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1.2 Isotope labeling in insect cells 
Amino acid type selective labeling in insect cells 
Amino acid type selective (AATS) labeling is well-established in insect cells and often the 
method of choice for NMR studies due to moderate costs and a minimum effort in 
preparation of the labeled growth medium (18, 19). Furthermore, reduced metabolic 
scrambling in ICL is considered advantageous for AATS labeling (20), as dilution of the 
isotope label is significantly lowered compared to E. coli. So far, two approaches to AATS 
labeling have been established based on supplementation of the labeled amino acid to a 
dropout medium deficient in this amino acid or addition of the labeled amino in large excess 
to the full medium (excess labeling). 
Excess labeling has been reported to yield incorporation of up to 84 % when 15N-leucine 
was directly added to an otherwise unlabeled commercial medium (19). However, 
incorporation levels strongly depend on the amino acid content of the commercial medium, 
which is not disclosed and hence requires a laborious optimization of the supplementation 
scheme. A major drawback of excess labeling is the high amount of labeled amino acid, 
which is required for efficient isotope incorporation. Based on the desired labeling strategy, 
the costs of the used amino acids may become prohibitive. Therefore, excess labeling is often 
not feasible and replacement of individual unlabeled amino acids by labeled ones using a 
dropout medium is advantageous. 
Initially, dropout media for AATS labeling have been prepared from several components 
according to established formulations (21). Today, commercial suppliers offer customized 
media at affordable prices, which remove the need for a time-consuming preparation step. 
Replacement of a single or several amino acids by the desired isotope-labeled amino acid(s) 
has been shown to yield very high incorporation rates (up to 94 %) (18, 19). Typically, 
essential amino acids (F, I, K, L, M, T, V, and W) are preferred for this approach due to the 
absence of metabolic scrambling. Moreover, culture media contain considerable sources of 
unlabeled amino acids in the form of yeast extract and fetal bovine serum. Therefore, AATS 
labeling is commonly used in insect cells adapted to growth in serum-free media containing 
the minimal amount of yeast extract required to promote proliferation and expression. 
One of the first proteins to be selectively isotope labeled in the BEVS for NMR studies 
was the eponymous bovine rhodopsin of the rhodopsin-like G protein coupled receptor 
family A. Great effort was made to prepare a selectively labeled rhodopsin sample using 
[α,ε-15N2]-lysine (22). This approach was successfully applied to investigate the Schiff-base 
linkage between retinal and the lysine residue 296 by solid state NMR. Shortly after, the first 
comprehensive study of AATS labeling in insect cells established incorporation of seven 15N-
labeled amino acids into glutathione-S-transferase (GST) (23). Additional insights into the 
amino acid metabolism in ICL were gained and used to derive a preliminary metabolic 
network describing scrambling of 15N. NMR analysis of selectively 15N-labeled GST revealed 
significant scrambling of amino acids related to the TCA cycle such as glutamine, glutamic 
acid, aspartic acid and asparagine as well as alanine. Expression media were supplemented 
with unlabeled yeast extracts, which are a major source of unlabeled amino acids but 
otherwise were required to obtain high protein yield. Consequently, additional quantities of 
15N-labeled amino acids were used to limit label dilution. However, a thorough analysis of the 
isotope incorporation was not reported.  
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Almost simultaneously, Strauss and coworkers reported AATS labeling of the human 
Abelson tyrosine kinase domain (cAbl) by 15N-labeled glycine, tyrosine, phenylalanine and 
valine (Figure 1.1) (18). Remarkably, very high levels of 15N incorporation (≥90 %) were 
achieved for the three essential amino acids, whereas significant dilution of the label was 
observed for glycine. High expression levels in the presence of the kinase-specific inhibitor 
imatinib (24) and the available assignment of the protein backbone (25) render cAbl an ideal 
model for optimization of labeling protocols in insect cells. Indeed, AATS labeling in the 
BEVS was significantly improved by modification of the previous labeling procedures (18, 
23) and applied to cAbl (19). Key to this improvement was supplementation of defined 
amounts of yeast extracts.  
 
 
Figure 1.1 Amino acid type selective labeling of the Abelson kinase domain (cAbl) in insect cells. 
Supplementation of 15N-labeled FGMY was according to the protocol established by Strauss and coworkers 
(18). 1H,15N-HSQC spectra were recorded on selectively-labeled cAbl in complex with imatinib (blue) and 
dasatinib (green). Interestingly, 15N-serine resonances were observed in these spectra (orange circles) due to 
significant metabolic scrambling of glycine. The figure is adapted from (26). 
 
Side chain labeling of methyl groups in methionine residues has been established as a 
valuable alternative to selective labeling of the protein backbone (27). Methyl groups exhibit 
a C3 rotational symmetry and display very rapid rotational motion, which results in beneficial 
relaxation properties for NMR studies of large proteins (1). Due to their conformational 
freedom, methionine side chains are often part of ligand binding surfaces (28). Selective 
labeling by [methyl-13C]-methionine was first reported for the β2‑adrenergic receptor to 
investigate conformational changes upon agonist binding (29). NMR revealed changes in the 
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equilibrium populations for the methionine residue 82 located in the transmembrane helix 5, 
which may correspond to modulations of the signal transduction level in different ligand-
receptor complexes. 
In general, AATS labeling of essential amino acids in ICL results in high incorporation 
and negligible isotope scrambling due to significantly constrained amino acid metabolism 
(20, 23). Conversely, non-essential amino acids such as glutamate and alanine are important 
for the cellular nitrogen metabolism (30) and display substantial scrambling. Furthermore, 
selective labeling only provides limited spectral information and often requires laborious site-
directed mutagenesis to enable NMR resonance assignment (29). Combinatorial labeling by 
13C and 15N has enabled backbone assignment (27) in selectively labeled samples and 
provides an alternative to the laborious mutagenesis approach. 
 
Uniform isotope labeling in insect cells 
The BEVS is not amenable to the use of inexpensive minimal media, which have been 
applied very successfully to uniform isotope labeling in E. coli. Due to the limited amino acid 
metabolism in ICL, growth is not possible on a single carbon source and ammonium alone. 
Therefore, supplementation of all canonical amino acids is required and is a key challenge to 
establish uniform labeling in insect cells and other higher eukaryotic expression systems such 
as avian and mammalian cells. Moreover, growth in media containing high fractions of heavy 
water (D2O) is essential to produce uniformly deuterated proteins in E. coli but has not yet 
been established in ICL. In principle, uniform labeling can be achieved by preparation of 
customized media comprising isotope-labeled amino acids and their precursors, namely 
carbohydrates. However, as growth media for insect cells contain gram quantities of amino 
acids (21), this approach is very expensive . 
An important advance for application of the BEVS in NMR has been the development of 
commercial media formulations providing uniform isotope labeling (BioExpress-2000, 
Cambridge Isotope Laboratories). Still, the use of these media is very costly, e.g. 15000 EUR 
per liter of 13C, 15N-labeled culture. Application of BioExpress-2000 was pioneered for cAbl 
expressed in Sf9 cells (13) and successfully used to assign the protein backbone to near-
completeness (96 %) (25). This was followed by a detailed study based on residual dipolar 
couplings of the solution conformations of the kinase domain in complex with several 
inhibitors (26). However, more elaborate triple-resonance backbone correlation experiments 
on cAbl were not possible due to the large size of the protein (34 kDa) and the lack of 
deuteration. 
Additional complications for efficient isotope labeling in the BEVS arise from the 
associated handling procedures. First, recombinant baculovirus stocks are commonly 
produced in full growth medium, which present a source of unlabeled amino acids. High-titer 
virus stocks are therefore essential to decrease the required volume of the viral inoculum, 
thereby reducing the carry-over of this unlabeled medium (19). Moreover, insect cells need to 
be adapted to growth in serum-free medium as fetal bovine sera are a source of free amino 
acids. High incorporation of isotopes necessitates complete removal of the unlabeled growth 
medium prior to expression of the recombinant protein (18). Medium exchange is typically 
achieved by centrifugation and subsequent resuspension of the cells in freshly prepared 
labeling medium. This is a crucial step and great care has to be taken to minimize cell 
damage, which will eventually lower the expression yield.  
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In-cell NMR studies on baculovirus-infected insect cells 
In-cell NMR has gained increased momentum over recent years. Studies in living cells can 
provide new insights into biological function and the role of the cellular environment. In situ 
NMR studies in baculovirus-infected Sf9 cells were pioneered by Hamatsu and coworkers 
(31). Uniform isotope labeling by 15N and 13C was based on the commercially available 
expression medium BioExpress-2000 (Cambridge Isotope Laboratories). The unique property 
of the BEVS to suppress host cell gene synthesis and simultaneously produce high amounts 
of the recombinant protein under control of strong promoters in the very late phase of 
infection was highly advantageous. Efficient isotope incorporation (~98 %) was possible by 
transfer of infected Sf9 cells into the labeling medium 24 hours post infection and continued 
expression for another 24 hours. The utility of this approach was demonstrated for different 
model proteins of variable size comprising up to 148 residues. Triple-resonance backbone 
correlation (HNCA, HN(CO)CA, and HNCO) and 15N-edited NOESY experiments were 
recorded on the 57 amino acid Streptococcus protein G B1 domain (GB1). However, non-
uniform sampling and maximum entropy reconstruction of the obtained spectra were required 
as stability of the recombinant proteins was limiting the effective measurement time due to a 
decrease in the viability of the cells in the NMR tube. 
 
Economic approaches to uniform isotope labeling in insect cells 
In recent years, the development of alternative labeling methods based on cellular extracts 
of yeast has gained increased momentum (16, 17). Commonly, these extracts are 
supplemented to a commercial dropout medium devoid of all amino acid sources. 
Remarkably, the underlying concept was reported for mammalian cell lines about two 
decades ago (32), but has not been followed up until recently. This approach is significantly 
more economic as compared to the commercial labeling media and enables uniform labeling 
by 15N and 13C, albeit not demonstrated in the original protocol (16). Moreover, 
supplementation of yeast extracts is well-known to promote growth and expression in insect 
cells (33).  
Growth of yeast is well established in minimal media consisting of the simplest precursors 
for biosynthesis of all amino acids such as glycerol, methanol or glucose and ammonium 
salts. Preparation of yeast cell extracts requires degradation of the initial cellular biomass or 
the isolated protein fraction of these cells to obtain free amino acids. Two main procedures to 
achieve such degradation have been used to different extent, namely acidic hydrolysis at 
elevated temperatures (34) and autolytic cell digestion (autolysis) by endogenous enzymes 
(16).  
The highest amount of free amino acids is generally obtained based on hydrolysis in 
methanesulfonic acid at 115 °C for several hours, which is used to degrade the purified 
protein fraction (34). However, a major disadvantage of this approach is the loss of amino 
acids by chemical degradation caused by these harsh conditions (32, 34). In particular, 
oxidation of tryptophan and cysteine occurs, while at the same time glutamine and asparagine 
are converted to glutamic acid and aspartic acid, respectively. Deficiency in the non-essential 
amino acids cysteine, glutamine and asparagine is largely compensated for by the metabolic 
capabilities of the insect cell (35-37). Conversely, tryptophan cannot be synthesized and 
represents an essential amino acid (38). 
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Autolysates of yeast cells can be prepared in a laboratory environment using a bioreactor 
setup (16). Commonly, autolysis is performed under slightly acidic conditions (pH 6) and 
temperatures of 50 °C for several hours up to days, which enables recovery of practically all 
amino acids required for growth of insect cells. Consequently, autolysis is preferred over acid 
hydrolysis for the preparation of yeast extracts. However, for some amino acids (20) 
concentrations are very low and may become a limiting factor during expression. Preparation 
of homemade yeast extracts and their use for uniform isotope labeling was demonstrated 
earlier by expression of the human histamine receptor H1R in insect cells (16, 17). However, 
efficient incorporation of 15N (~80 %) required repeated passaging in the labeled growth 
medium. Furthermore, additional amino acids had to be supplemented to the medium at 
concentrations of up to 20 % typically used in the IPL-41 formulation (21) to obtain high-
level expression. Most importantly, a proof of applicability has not been provided for 
canonical NMR experiments. 
 
Current developments in economic isotope labeling protocols 
While the work on this thesis was ongoing, further approaches to uniform labeling in ICL 
have been published based on cellular extracts of algae and yeast (39, 40). These methods 
have been addressed to some extent the shortcomings of the originally reported protocol (16) 
and progress has been made towards more robust protocols for uniform labeling.  
Commercial extracts of isotope-labeled yeast (CortecNet) were used for production of 15N-
labeled proteins in Sf9 and S2 insect cell lines (40). Interestingly, the protocol employs an 
ammonium salt to replace glutamine in the culture medium, thereby further reducing the 
costs. So far, this approach resulted in 15N incorporation levels of up to 66 %. However, the 
authors suggested that starvation further increases incorporation to 80 % based on 
preliminary trials. Whereas, uniform labeling by 13C has been proposed on the basis of this 
protocol, the use of deuterated yeast extracts has not been explored. 
Algal extracts as a source of labeled amino acids have been pioneered in higher eukaryotic 
expression systems over two decades ago. Hansen and coworkers used cellular extracts of 
algae obtained by acidic hydrolysis to establish uniform isotope labeling in mammalian cell 
lines (32). Nowadays, amino acid mixtures prepared from algal extracts are available from 
different commercial sources (Cambridge Isotope Laboratories and Sigma-Aldrich) providing 
all commonly applied labeling schemes at minimal costs, which may enable widespread 
application of these products. Whereas yeast cells still require organic carbon sources such as 
glycerol, methanol or glucose, algal cells assimilate CO2 to form complex carbohydrates. 
Therefore, the use of algal extracts is particularly cost-effective for uniform 13C labeling.  
The first protocol for uniform labeling by 15N, 13C and 2H based on commercial algal 
extracts (39) has been established shortly after the initial application of commercial yeast 
extracts (40). This approach involves supplementation of 5 mM ammonium salt to 
compensate for deficiencies of glutamine and asparagine in the algal extract similar to the 
labeling protocol based on commercial yeast extracts (40). Supplementation of the essential 
amino acid 15N-labeled tryptophan has been required but at significantly reduced 
concentrations as compared to commercial media formulations. In general, incorporation 
levels of 80 % and 75 % were achieved for uniform 15N and 13C labeling, respectively. 
Moreover, partial deuteration with overall incorporation levels of up to 76 % was reported for 
labeling by 2H,15N and 2H,13C,15N. However, incorporation of deuterium was only estimated 
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from the total isotope shift in combination with 15N or 13C, 15N labeling by mass spectrometric 
analysis, but a direct analysis of the deuteration level was not carried out. 
Earlier, the use of commercial algal extracts in ICL has been reported in combination with 
AATS labeling of the β2-adrenergic receptor (β2AR) by [αβγ-2H, methyl-13C]-methionine 
(41). This tailor-made labeling scheme has been utilized to provide fractional background 
deuteration based on highly deuterated algal amino acid mixtures, thereby increasing the 
sensitivity of the investigated methionine side chain resonances. Incorporation of 2H into 
non-exchangeable backbone and side chain protons as high as 90 % has been obtained for 
fourteen labeled amino acids using a meticulous protocol for addition of individual amino 
acids. Remarkably, a lowered overall deuteration has been found for non-essential amino 
acids, which is caused by metabolic scrambling in insect cells. The protocol enabled to study 
dynamics of β2AR in lipid bilayers, which displayed significant differences to the detergent-
solubilized receptor (29). However, broader application of this protocol is hindered by the 
laborious labeling procedure, which requires the costly supplementation of several deuterated 
amino acids at defined time points during expression.  
 
Considerations of the medium osmolarity 
A common limiting factor of the labeling approaches is the maximum osmolarity tolerated 
by insect cells. Commercial media are typically adjusted to an osmolarity range of 320 to 380 
mOsm/kg resembling the physiological conditions in the insect hemolymph, which are 
optimal for growth and protein expression (42). The commercial media typically contain 
about 4 g/L yeast extract (43) corresponding to 50‑70 mOsm/kg. For isotope labeling dropout 
media depleted in all amino acid sources are used with an osmolarity of about 220 mOsm/kg. 
Supplementation of such a dropout medium with 4 g/L yeast extract increases the osmolarity 
to 270‑290 mOsm/kg and provides amino acids at an overall concentration of about 1.5-2 g/L 
(20). This amino acid concentration is however not sufficient to promote growth and 
expression in insect cells. As the optimal osmolarity is not yet reached, additional amounts of 
labeled extracts may be supplemented to increase the amino acid content. Indeed, high 
expression levels have been obtained by supplementation of yeast and algal extracts at 
concentrations of 10 g/L (39, 40). 
 
  
 11 
1.3 Recombinant expression in insect cells 
Stable transfection of insect cells 
Several commercial systems are available for stable transfection, which enables long-term 
integration of heterologous genes into the ICL and constitutive expression of the recombinant 
protein. Stably transfected cells will efficiently propagate these genes to their progeny.  
Stable transfection is most widely used in the lepidopteran cell line Sf9 (44) and 
Schneider 2 (S2) cells derived from late embryonic stages of D. melanogaster (45). 
Recombinant expression in stably-transfected S2 cells is commonly based on the actin and 
the metallothionein promoters of D. melanogaster (46, 47). A commercial Drosophila 
Expression System (DES) was established based on the metallothionein promoter, which 
offers tight gene regulation and efficient selection by an accessory vector mediating antibiotic 
resistance (48). Several proteins have been expressed in milligram quantitates using the 
commercial DES (49). 
In lepidopteran cell lines, such as Sf9 cells, stable transfection is based on the use of 
immediate early promoters found in different baculoviruses (50, 51). This approach was 
commercialized in the InsectSelect™ and InsectDirect® system. Selection of a suitable clone 
for constitutive expression is similar to the DES, but may further be accomplished by 
incorporation of the resistance gene cassette into a single expression vector. Moreover, 
milligram amounts of secreted and functional active protein were obtained per liter of stably 
transfected cell culture (52). 
Unfortunately, stably transfected insect cell lines often display significant differences in 
the expression level related to the copy number of the gene and unspecific integration. 
Therefore, clonal selection of single cells is used to determine the optimal clone for protein 
production. However, this step is laborious due to the involved screening effort and the 
lengthy scale-up process starting from a single cell. Site-specific integration of heterologous 
genes was established to facilitate optimization of recombinant expression following stable 
transfection. Based on random integration of gene cassettes comprising a reporter and 
resistance gene, the screening process is greatly accelerated. These gene cassettes are flanked 
by recombinase recognition sites, which enable integration of the heterologous gene by 
recombinase-mediated cassette exchange following co-transfection with plasmids containing 
the recombinase gene and the gene of interest (53). This approach has been pioneered in 
Chinese Hamster Ovarian (CHO) cells (54) and was recently expanded to Sf9 cells (55).  
A key limitation of stably transfected ICL is the requirement for an extensive selection 
process, which also involves several weeks of scale-up procedure. Furthermore, the overall 
yield of recombinant protein is typically lowered compared to the baculovirus expression 
vector system. 
 
The baculovirus-infected insect cell system 
Pioneering work that laid the foundation of the baculovirus expression vector system 
(BEVS) reaches back to the 1980s (56), when the viral polyhedrin protein was shown to be 
non-essential for propagation of the baculovirus in cell cultures. The potential for 
recombinant expression of heterologous proteins was immediately realized and used to obtain 
high amounts of the human interferon beta (57). Since then the baculovirus/insect cell system 
has seen major improvements including elaborated tools for genetic manipulation of the 
baculovirus as well as the ease of culturing (58) and eventually emerged as the predominantly 
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used eukaryotic expression system (3). Very strong viral promoters in the BEVS enable high 
yields of recombinant proteins, which often surpass the productivity obtained by stably 
transfected insect cells. Consequently, due to increased expression levels and the reduced 
timespan of the process the use of the BEVS is often favored over stable transfection of ICL. 
Recombinant expression based on the BEVS is well-established in the lepidopteran cell 
lines Sf9 and Sf21 originating from the IPLB-SF-21 cell line, which was isolated from 
ovarian tissue of Spodoptera frugiperda pupae (44). Sf9 cells were established as a clonal 
isolate of the Sf21 cell line. Moreover, the use of the BEVS in High-Five™ cells originally 
derived from BTI-TN-5B1-4 ovarian cells of the cabbage looper Trichoplusia ni (59) has 
seen wide application, especially for highly efficient secretion of glycoproteins. All of these 
cell lines support growth in serum-free medium as suspension or adherent cultures and 
propagation of the recombinant baculovirus. The highest productivity of the BEVS has been 
obtained in High-Five™ cells (60, 61), but a significant decrease in expression levels was 
reported at higher cell densities (62). In addition, maintenance of this cell line in suspension 
is challenging, which is related to an increased propensity to form cell aggregates. Therefore, 
efficient generation of recombinant baculovirus is preferentially performed in Sf9 and Sf21 
cell lines (7, 20).  
Recent approaches have established intact silkworm pupae and larvae as expression hosts 
to obtain milligram quantities of purified proteins using the BEVS (63). Furthermore, 
expression of uniformly 15N-labeled immunoglobulin G for NMR studies was reported for 
larvae reared on a diet containing isotope-labeled yeast extracts (64). 
 
The baculovirus life cycle and heterologous gene expression 
The baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) was 
originally isolated from the alfalfa looper Autographa californica (65). Two structurally 
distinct states of AcMNPV were described, namely the highly infectious budded virus (BV) 
and the polyhedral-shaped occlusion-derived virus (OV) (66, 67). Infection of insect cells by 
parental baculovirus (Figure 1.2) involves a regulatory cascade consisting of four gene 
classes related to expression of viral proteins: early, delayed early, late and very late genes. 
The class of very late genes is characteristic to baculoviruses and of great importance for 
recombinant expression in insect cells based on the BEVS. Initial attachment to the host cell 
occurs during the early phase of the infection cycle and is followed by the release of the viral 
DNA into the host cell, effectively suppressing cellular gene expression (68). Viral entry is 
accomplished by clathrin-mediated endocytosis in less than an hour. Within the first 10 to 
20 hours post infection (hpi) viral DNA is replicated in the nucleus of the infected host cell 
and further enveloped by the cellular plasma membrane to form new BV. This is referred to 
as the late phase of infection and involves exponential generation of these virions, which are 
consequently released to propagate baculovirus infection throughout the host known as a 
secondary wave of infection (69). A characteristic decrease in the protein synthesis of the 
host cell is observed about 18 hpi and associated with very high viral titers (70). During the 
very late phase (24-48 hpi) of the infection cycle occlusion bodies are formed containing 
large numbers of enveloped virions, which are further embedded in a protein matrix 
comprised of polyhedrin. This protein is expressed under the control of the very strong polh 
promoter and was shown to require the host factor polyhedrin promoter binding protein 
acting in trans (71). Moreover, fibrillary structures are observed in the cytoplasm and the 
nucleus of the host cells formed by the p10 protein. Expression of the p10 gene is driven by 
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the second very late promotor p10 (72, 73) and is crucial for efficient release of occlusion 
bodies (74). Concurrent production of both proteins in very high amounts is specific to the 
very late phase. However, propagation of the baculovirus coupled to the generation of 
progeny virions is limited to the late phase of the infection. Therefore, both viral genes are 
amenable to substitution by heterologous genes to provide high-level expression of 
recombinant proteins in the very late phase. Remarkably, polh and p10 promoters can drive 
heterologous gene expression at different loci in the viral genome and allow for multiple 
copies to increase the yield of recombinant protein. 
  
 
Figure 1.2 Principle of the baculovirus expression vector system (BEVS) in insect cells. Entry of the budded 
virus into the host cell is accomplished via clathrin-mediated endocytosis (1) and immediately followed by the 
release of the virion nucleocapsid (2). Uncoating of the viral DNA occurs in the nucleus of the cell to initiate 
replication in the late phase of the infection (3). Subsequently, release of newly formed budded virus is triggered 
(4), which results in a secondary infection wave infecting adjacent insect cells. In the very-late phase of 
infection host cell gene synthesis is shut down. Simultaneously, very-late and strong viral promoters drive 
expression of the recombinant protein. Glycoproteins are routed via the secretion pathway of the host cell and 
efficiently secreted to the medium (5). 
 
An important step towards the development of the BEVS was the observation that 
transfection with viral DNA alone could cause baculovirus infection (75). Today, 
recombinant baculovirus DNA (bacmid) is commonly generated by in vivo transposition in 
E. coli (76) or recombination in insect cells (77). This bacmid is used for transient 
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(co‑)transfection of insect cell lines to obtain recombinant baculovirus in adherent and 
suspension cultures, followed by up to three amplification steps to yield high titer virus 
stocks. 
 
Limitations of the baculovirus expression vector system 
The metabolic capabilities of insect cell cultures are significantly reduced as compared to 
E. coli or lower eukaryotes such as yeast and algae. Consequently, complex media providing 
several essential components are required to promote growth. However, a wide array of 
commercial medium formulations including serum-free and protein-free media is available at 
minimal cost. ICL are commonly maintained as permanent cultures for several passages, 
which requires sub-culturing routines in the order of days. Recombinant expression in insect 
cells usually varies from two to four days and thus compares less favorably with the faster 
bacterial or lower eukaryotic expression systems.  
A crucial step in the overall process of the BEVS and unique to baculovirus-infected 
insect cells is the requirement to generate and amplify recombinant baculovirus. Major 
progress was made to simplify the construction of recombinant viral DNA. Artificial 
baculovirus genomes (bacmid) were established, which are constitutively present in E. coli 
(76). In vivo transposition based on Tn7-recombinase in the engineered E. coli DH10Bac™ 
strain is used to introduce the recombinant gene into a parental bacmid. Following clonal 
selection, the recombinant bacmid can be isolated and enables transient transfection of ICL. 
To date, several commercial solutions are available, which combine the original bacmid 
technology with novel cloning approaches such as the GATEWAY system (Life 
Technologies). Recently, expression of protein complexes comprising multiple subunits was 
established in the BEVS by the MultiBac system (78). Homologous recombination is used to 
generate a single baculovirus expression vector, which may provide the correct stoichiometry 
of the subunits for these protein complexes. Moreover, multilocus vectors are available for 
expression of several large proteins by a single recombinant virus (79). Irrespective of this 
technological development, generation of recombinant baculovirus remains a highly time-
consuming step in the BEVS. 
Following successful transfection of insect cells with recombinant bacmid DNA, high 
amounts of budded baculovirus are released to the culture supernatant in the late phase of 
infection. High titer stocks for expression cultures are obtained in consecutive amplification 
rounds by infection of insect cells with this supernatant. These stocks are typically stable for 
several months and enable repetitive protein production. The additional amplification of the 
recombinant baculovirus stock can effectively be avoided by the use of baculovirus-infected 
insect cells (BIICs), which allow for titer-independent and reproducible infection at large-
scale (80). 
The BEVS utilizes strong viral promoters to obtain remarkably high expression levels for 
cytosolic proteins that often exceed the capacity of mammalian cell lines such as HEK293 or 
CHO cells. However, production of secreted glycoproteins and transmembrane proteins is 
often significantly lower compared to cytosolic proteins (81). This is not only related to 
routing or post-translational processing of these proteins, but further due to the progressing 
infection of the recombinant baculovirus (81). At the very late phase of the infection cycle, 
the viral chitinase (chiA) is expressed in high amounts, which is required to degrade the chitin 
skeleton for the release of occlusion bodies (82). Accumulation of this enzyme in the 
endoplasmic reticulum (ER) (83) may interfere with the secretion of the recombinant 
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glycoprotein (84). Moreover, high levels of the viral cysteine protease cathepsin are observed 
towards the end of the infection, which also predominantly localizes in the ER (85). 
Cathepsin accumulation is likely to impede secretion and may further result in degradation of 
the glycoprotein. Baculovirus expression vectors deficient in the genes encoding for the viral 
chitinase and cathepsin have been described to increase the yield of secreted proteins (86). 
Interestingly, expression of chiA is essential to obtain functional cathepsin (87), hence 
deletion of this gene is sufficient to suppress viral proteolytic activity. As a consequence, 
commercial BEVS have been established comprising a deletion in the chiA gene to enhance 
recombinant expression of glycoproteins. 
Whereas glycosylation is present in ICL, it is limited to simple oligo-mannose sugar 
chains. Mammalian cell lines exhibit complex glycosylation patterns, which involve terminal 
sialylation (53, 88). Simple glycosylation patterns are well suited to provide homogenous 
samples of diffracting quality for X-ray crystallography. Conversely, alterations in the 
glycosylation pattern may impede folding and compromise biological activity of mammalian 
proteins (89, 90). Several stably transfected ICL have been established to overcome this 
limitation. In particular, stable transfection has been used to include sialylation and 
galactosylation by heterologous genes encoding a specific sialyltransferase and the 
β-1,4 galactosyl transferase of mammalian origin (91, 92). Although these transformed cell 
lines have been shown to produce sialylated glycosylation patterns, the actual benefit for the 
BEVS is limited, as the use of immediate early viral promoters eventually shuts down the 
expression of these transferases in the very late phase of the progressing infection. Moreover, 
protein inhomogeneity may increase as described for recombinant expression in mammalian 
cells, which often hampers the crystallization process of these proteins. 
In contrast to other widely used expression systems including mammalian cell lines, 
screening of constructs prior to large-scale expression is laborious in the BEVS. One way 
around this limitation is the transient transfection of insect cells. However, the expression 
levels obtained by transiently transfected cells may not necessarily correlate with the 
productivity of infected cells based on the BEVS. Another approach to enable high-
throughput expression using the BEVS relies on the conventional bacmid generation and a 
further in vivo recombination step. Successful recombination rescues a non-viable gene 
deletion, thereby selecting for the recombinant baculovirus (93). The method allows for 
integration into a robotic setup and rapid isolation of parental baculovirus. Commonly used 
commercial systems based on this technology are referred to as BacMagic (Merck) and 
flashBAC (Oxford Expression Technologies). The latter system is often utilized to generate 
recombinant baculovirus as an alternative to in vivo transposition in E. coli. 
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1.4 Aspects of the amino acid metabolism in insect cells pertinent 
to isotope labeling 
Essential amino acids and the nitrogen metabolism 
Insect cells lack the ability to synthesize isoleucine, leucine, lysine, methionine, 
phenylalanine, threonine, tryptophan and valine (94). Hence, these amino acids are not 
subjected to metabolic scrambling. This is highly advantageous for selective labeling 
approaches, which are less affected by label dilution as compared to E. coli. Conversely, 
insect cells can synthesize all remaining canonical amino acids mainly through activity of 
different amino transferases and utilization of the carbon scaffold of glucose, which is 
metabolized via glycolysis and the TCA cycle. Moreover, important methyl transfer reactions 
are involved in metabolic scrambling of glycine and biosynthesis of cysteine. These 
metabolic pathways are highly relevant to isotope labeling (Figure 1.3). 
The nitrogen metabolism in insect cell lines (ICL) has been extensively studied revealing a 
strong interrelation between the carbon and the nitrogen metabolism (35, 37, 95). In general, 
several metabolic pathways are identical to the ones described for mammalian cell cultures. 
However, insect cells display a remarkable difference in the assimilation of nitrogen 
depending on the available nutrients.  
 
The central role of glutamate, aspartate and alanine 
Glutamate is commonly formed from α-ketoglutarate in a reversible reaction catalyzed by 
glutamate dehydrogenase. However, a second metabolic pathway for biosynthesis of 
glutamate in insect cells has been reported and involves reductive amination of α-
ketoglutarate by action of the NADH-dependent glutamine synthetase/glutamate synthase 
(GOGAT) (35, 95). Apparently, this is the preferred pathway for nitrogen assimilation in 
ICL. Regulation of these pathways is dependent on the extracellular concentrations of 
glutamine and glucose (35). Most notably, glutamate plays a key role in several 
transamination reactions, namely biosynthesis of alanine, aspartate and serine and is the 
direct precursor for the synthesis of glutamine. Formation of alanine and aspartate is achieved 
via a reversible transamination reaction step from the α-keto acids pyruvate and oxaloacetate, 
respectively (30). Alanine is a generic metabolic product in insect cells and predominantly 
formed under glucose excess. Conversely, limitation of glucose results in secretion of 
ammonium into medium, which hints on increased gluconeogenesis and anaplerotic flux of 
glutamine into the TCA via the α-ketoglutarate node by consecutive activity of glutaminase 
and glutamate dehydrogenase (35). Hence, a decrease is observed in the transamination rate 
of glutamate to synthesize alanine from pyruvate.  
 
Biosynthesis of asparagine, glutamine and proline 
Remarkably, synthesis of asparagine and glutamine from their respective precursor 
aspartate and glutamate involves two distinct pathways. Glutamine is formed by direct 
condensation of ammonium with glutamate by the activity of glutamate-ammonia ligase 
(GAL), whereas biosynthesis of asparagine by aspartate-ammonia ligase synthetase (AAL) 
requires the transfer of the amide group of glutamine to aspartate (32). 
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Figure 1.3 Metabolic scrambling of amino acids in insect cell lines. Pathways involving more than one reaction 
step are simplified (dashed arrows). Enzymatic reactions are as follows: 1, transamination of D-3-
phosphoglycerate by phosphoserine aminotransferase (PSAT); 2, conversion of serine to glycine by activity of 
serine hydroxymethyltransferase (SHMT); 3, reverse transsulfuration pathway to form cysteine by consecutive 
activity of cystathione beta synthase (CBS) and cystathione gamme-lyase (CGL); 4, transamination of pyruvate 
by alanine amino transferase (AlaAT); 5, transamination of oxaloacetate by aspartate amino transferase 
(AspAT); 6, formation of asparagine by aspartate-ammonia ligase (AAL); 7, incorporation of glutamine amide 
and amino nitrogen into glutamate by activity of NADH-dependent glutamine synthetase/glutamate synthase 
(GOGAT); 8, reversible deamination of glutamate by glutamate dehydrogenase (GDH): 9, conversion of 
glutamine to glutamate by glutaminase and 10, condensation of ammonium with glutamate by glutamate-
ammonia ligase (GAL). Transamination (1, 2, 4, and 5) and reactions of GDH and GOGAT are generally 
reversible (double arrows). Glycolytic scrambling of the glucose carbon scaffold is indicated in red. The unique 
transfer of amino and amide nitrogen catalyzed by GOGAT to form two molecules of glutamate is color-coded 
in purple and green, respectively.  
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Further, biosynthesis of proline is based on spontaneous cyclization of glutamate-5-
semialdehyde, which is formed from glutamate by two consecutive reactions via activity of 
glutamate-5 kinase and glutamate-5-semialdehyde dehydrogenase (38). This cyclization will 
result in exchange of the Hδ positions and may decrease incorporation of deuterium. 
Moreover, unlabeled glucose is scrambled into synthesized proline in form of the carbon 
backbone of glutamate, which exits the TCA at the α-ketoglutarate node. 
 
Metabolism of serine, glycine and cysteine 
Biosynthesis of serine, cysteine and glycine is strongly interrelated in all animal cell lines 
(38) and is responsible for substantial metabolic scrambling of these amino acids. Serine is 
derived from 3-phosphoglycerate, an intermediate of the glycolytic degradation of glucose. 
Hence, the carbon scaffold of glucose is transferred to serine. This pathway involves a 
notable transamination step catalyzed by phosphoserine transaminase, which again utilizes 
glutamate as the amino group donor (38).  
Serine serves as a methyl donor for covalent methylation of tetrahydrofolate to generate 
N5, N10-methylen tetrahydrofolate (N5, N10-THF) by serine hydroxymethyl transferase, which 
will result in the formation of glycine (38). N5, N10-THF is a versatile donor of C1 carbon 
units in several metabolic reactions such as thymidine biosynthesis. Moreover, condensation 
of N5, N10-THF with CO2 and ammonium by glycine synthase represents an alternative 
pathway for synthesis of glycine in animal cells (38). Both pathways will eventually 
incorporate solvent protons into Hα position of glycine and substantially lower the level of 
deuterium labeling. 
Whereas methionine is considered an essential amino acid, cysteine can by synthesized de 
novo by condensation of homocysteine and serine. Homocysteine is an intermediate of the 
S-adenosylmethionine (SAM) cycle, which involves continuous demethylation and 
regeneration of methionine to provide an important methyl donor for various metabolic 
reactions such as synthesis of nucleic acids and lipids (38). However, homocysteine can be 
removed from this cyclic pathway by action of cystathionine-β-synthase to form cystathionin, 
followed by a final deamination and cleavage step to yield cysteine and α-ketobutyrate. 
Consequently, this enables biosynthesis of cysteine by transsulfuration of methionine in 
insect cells. As a result, cysteine comprises the carbon scaffold of the precursor serine. 
 
Changes in the amino acid metabolism during baculovirus infection  
Interestingly, baculovirus infection was shown to reduce overall influx of most of the 
amino acids into Sf9 cells (96). This decrease in amino acid incorporation may hint on a 
significant cellular pool of amino acids, which is utilized during growth arrest in infected 
cells. Consequently, dilution of the isotope label may be expected due to residual unlabeled 
biomass and reduced uptake of labeled amino acids from the growth medium. In contrast, 
production of alanine was remarkably increased during viral infection. Simultaneously, 
higher glucose consumption is observed and results in increased formation of pyruvate. 
Moreover, baculovirus-infected insect cells displayed increased activity of the GOGAT, 
which transfers the amide-nitrogen of glutamine to α-ketoglutarate yielding two molecules of 
glutamate (95). Glutamate is channeled into the TCA cycle via the α-ketoglutarate node, 
thereby liberating considerable amounts of ammonium. ICL employ substantial fractions of 
pyruvate to generate alanine through activity of alanine aminotransferase (AlaAT) for 
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ammonium detoxification. This is an important source of label dilution as pyruvate is formed 
by glycolytic degradation of unlabeled glucose. Indeed, significant label dilution was 
observed for 13C-alanine in the commercial medium (13) and media based on algal extracts 
(39). Clearly, this metabolic pathway will further result in protonation of alanine. Hence, 
supplementation of 13C-labeled and potentially deuterated glucose may be required to achieve 
high levels of isotope incorporation. Conversely, the use of L-cycloserine, as specific 
inhibitor of AlaAT (97), was sufficient to improve incorporation of labeled alanine into the 
expressed protein (39) and allowed to supply unlabeled glucose in the labeling medium. 
 
Implications for isotope labeling  
An important consequence of this strong interrelation between the carbon and the nitrogen 
metabolism is that high incorporation of 13C further requires supplementation of 13C-labeled 
glucose in addition to labeled amino acids. Moreover, all transamination reactions and the 
demethylation of serine to glycine integrate solvent protons into the Hα positions of the 
resulting amino acids, which impedes efficient incorporation of deuterium. Finally, 15NH4+ is 
incorporated into glutamine and alanine under glucose excess, whereas glucose limitation 
increases the metabolic flux of glutamine into the TCA cycle via the α-ketoglutarate node. 
All these pathways contribute significantly to scrambling of 15N and involve glutamic acid as 
a central molecule, which simultaneously functions as an amine acceptor and a donor for 
transamination reactions. Therefore, supplementation of glutamine is not strictly required, 
when ammonium is added to the prepared labeling media (37) but will result in increased 
incorporation of glucose-derived carbon scaffolds into several amino acids via the TCA 
cycle. 
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2 Development and application of an economic 
approach to uniform isotope labeling in insect 
cells 
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Organization of the chapter 
The first section (Chapter 2.1) is a reprint of the original publication Opitz, Isogai and 
Grzesiek (98), which describes the use of isotope-labeled yeast extract to obtain uniformly 
labeled proteins in baculovirus-infected insect cells. Economic implementation of the 
labeling procedure is presented in a step-by-step protocol. The approach is successfully 
applied to complex targets of human origin using advanced NMR experiments. 
The following section (Chapter 2.2) reports a mass spectrometric approach to analyze the 
isotope incorporation in the uniformly labeled Abelson kinase (cAbl) and the green 
fluorescent protein (GFP) expressed in insect cells, which were grown on 2H,15N-labeled 
yeast and perdeuterated algal extracts, respectively. The method allows simultaneous analysis 
of different isotopes resolved for individual amino acids.  
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2.1 An economic approach to efficient isotope labeling in insect 
cells using homemade 15N-, 13C- and 2H-labeled yeast extracts 
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Abstract Heterologous expression of proteins in insect
cells is frequently used for crystallographic structural
studies due to the high yields even for challenging proteins
requiring the eukaryotic protein processing capabilities of
the host. However for NMR studies, the need for isotope
labeling poses extreme challenges in eukaryotic hosts.
Here, we describe a robust method to achieve uniform
protein 15N and 13C labeling of up to 90 % in baculovirus-
infected insect cells. The approach is based on the pro-
duction of labeled yeast extract, which is subsequently
supplemented to insect cell growth media. The method also
allows deuteration at levels of[60 % without decrease in
expression yield. The economic implementation of the
labeling procedures into a standard structural biology lab-
oratory environment is described in a step-by-step protocol.
Applications are demonstrated for a variety of NMR
experiments using the Abelson kinase domain, GFP, and
the beta-1 adrenergic receptor as examples. Deuterated
expression of the latter provides spectra of very high
quality of a eukaryotic G-protein coupled receptor.
Keywords Abelson kinase  GPCR  GFP  Beta-1
adrenergic receptor  Baculovirus  Heteronuclear NMR
Introduction
Labeling by the stable isotopes 15N, 13C and often also
2H is a prerequisite for the majority of contemporary
biomolecular NMR experiments. It is well established for
protein expression in the heterologous host Escherichia
coli where minimal media provide an inexpensive,
straightforward manner of isotope incorporation. However,
high-quality functional expression of proteins from higher
organisms such as humans often requires a higher
eukaryotic host system. This seems related to the avail-
ability of a proper protein folding, post-translational
modification, and membrane insertion machinery, which is
less developed or absent in E. coli.
The baculovirus/insect cell (Spodoptera frugiperda)
system is a well-established, highly successful eukaryotic
expression system capable of many post-translational
modifications, which has been used in numerous crystal-
lographic studies of soluble and membrane proteins.
However, the restricted amino acid metabolism of insect
cells presents an extreme challenge for isotope labeling.
Typical insect cell growth media are complex (O’Reilly
et al. 1994) and require the addition of all amino acids in
isotope-labeled form. Based on a commercial medium
containing labeled amino acids, the uniform 15N and 13C
labeling and high-yield expression of the human Abelson
kinase domain (c-Abl) has been demonstrated in this sys-
tem (Strauss et al. 2005). In combination with selective
labeling of individual amino acids (Strauss et al. 2003),
almost complete backbone assignments and high resolution
structural information could be obtained for the 32 kDa
c-Abl using this uniformly 15N/13C-labeled material (Vaj-
pai et al. 2008a, b). Although this procedure of uniform 15N
and 13C labeling is clearly feasible, it is extremely
expensive. Furthermore, for the majority of larger
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expression targets, labeling by 2H would be required for
optimal sensitivity and resolution. However, the costs of
deuterated 15N- and/or 13C-labeled amino acids are pro-
hibitive, and only addition of deuterated, but otherwise
unlabeled amino acids has been reported (Kofuku et al.
2014).
As alternative to the addition of labeled amino acids to
the insect cell medium the addition of labeled yeast
autolysates (yeastolates) has been proposed (Egorova-
Zachernyuk et al. 2009). Incorporation of 15N by supple-
mentation of such extracts as the sole amino acid source to
an inexpensive dropout medium was demonstrated for the
human histamine receptor H1R (Egorova-Zachernyuk et al.
2010). However, the method was not further developed for
high-efficiency isotope labeling including 13C and 2H as
well as applications to multi-dimensional NMR. A recent
refinement of the yeastolate-based approach (Meola et al.
2014) achieved protein expression yields of 6–11 mg/L and
15N incorporation levels between 65 and 80 % by supple-
mentation with a labeled yeast extract from a commercial
source of undisclosed composition.
Here we have developed a robust method for the pro-
duction of 15N- and 13C-labeled yeast extract and its use as
supplement in insect cell growth media for protein
expression. The method achieves uniform protein 15N and
13C labeling of up to 90 % at typical expression yields of
40 mg/L for soluble proteins. By growing yeast in
deuterated media, the procedure can also yield protein
deuteration levels of[60 % without decrease in insect cell
expression yield. The methods are applied to c-Abl, GFP,
and the beta-1 adrenergic receptor. For the latter, 2H,15N
labeling provides spectra of so far unprecedented quality
for a eukaryotic G-protein coupled receptor. The labeling
procedures are described in a step-by-step protocol for
economic implementation in a standard structural biology
laboratory environment.
Results and discussion
Production and characterization of optimized Pichia
pastoris yeastolate
Detailed protocols for the yeast fermentation and the pro-
duction of yeastolate are given in Table 1. In brief, Pichia
pastoris was grown in a fermenter under fed-batch condi-
tions with typical volumes of 0.5–5 L. Growth on a glu-
cose- and ammonium-based yeast minimal medium (YM)
yielded up to 64 g cell wet weight (CWW) of yeast bio-
mass per liter of cell culture medium in 15N- or 15N/13C-
labeled form. Deuteration could be achieved by adapting
the yeast cells first on a 70 % D2O-YM medium, which
was followed by a switch to 100 % D2O-YM. Under these
conditions, still 48 g/L CWW were produced, corre-
sponding to a reduction by 25 % relative to the H2O
conditions.
An optimized protocol for Pichia pastoris autolysis
was developed, which maximizes the amino acid content
in the yeast extract. Among others, the protocol contains
a zymolyase incubation step to process the yeast cell
wall prior to autolysis and papain treatment during the
high-temperature incubation phase. The protocol yields
on average 6.6 ± 0.7 g lyophilized yeastolate per liter of
cell culture, containing 38 ± 4 % (w/w) of free amino
acids.
The isotope incorporation levels of the free amino acids
in the yeastolates were determined by LC/MS analysis
(Supplementary Table S1). Using 15NH4Cl as the sole
nitrogen source for yeast growth, an average 15N incor-
poration of 96 % was observed. Likewise, 13C6-glucose as
the sole carbon source yielded an average 13C incorpora-
tion of 97 %. Growth on 100 % D2O-YM, but not using
any other deuterated ingredients, resulted in an average 2H
incorporation of 75 %. This is in good agreement with
previously reported deuteration levels in E. coli for growth
on D2O and otherwise protonated medium components
(Rosen et al. 1996).
Optimization of yeast extract supplement to insect
cell medium
To establish the amount of amino acids required as sup-
plement to an amino acid-depleted, yeast extract-free insect
cell medium (DSF4, Bioconcept), cell proliferation after
baculovirus infection as well as the expression of c-Abl
were assayed for Sf9 insect cells grown on this medium
supplemented by varying amounts of amino acids. Starting
with amino acid concentrations according to the estab-
lished IPL-41 medium (Weiss et al. 1981), the supple-
mentation was step-wise reduced. Reduction to 20 % of the
IPL-41 amino acid level did not affect cell viability and
protein expression, while any further reduction led to a
significant decrease of both parameters.
In a next step, the content of single amino acids in a
commercial (Bacto Yeast Extract, Difco) and the Pichia
yeastolate was quantified by mass spectrometric
phenylthiohydantoin amino acid analysis (PTH-AAA).
Cysteine was not detectable by PTH-AAA, but an earlier
study indicates a low content [\1 % (w/w)] in various
yeasts (Martini et al. 1979). Figure 1 shows the determined
amino acid concentrations for 8 g/L commercial and
Pichia yeastolates in comparison to the 20 % IPL-41
J Biomol NMR
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Table 1 Fermentation of Pichia pastoris and preparation of yeastolate
Preparation of yeast medium (YM)
Unlabeled YM 1. Prepare unlabeled minimal medium based on glucose and yeast nitrogen base (YNB) in ultrapure water
(Milli-Q) as 100 mM potassium phosphate, 2.5 g/L glucose, 2 mg/L biotin, and 6.7 g/L YNB without amino
acids (e.g. BD Difco)
2. Adjust medium to pH 6
3. Filter-sterilize and store at 4 C
15N-YM Follow recipe for unlabeled YM, but use YNB without amino acids and without ammonium (e.g. BD Difco).
Add 4.3 g/L 15NH4Cl as nitrogen source
13C,15N-YM Follow recipe for 15N-YM and replace unlabeled glucose by 2.5 g/L of 13C6-glucose
2H,15N-YM
and 2H,15N,13C-YM
Prepare 15N-YM or 15N,13C-YM in 99.8 % D2O. Possibly higher levels of deuteration may be achieved using
2H7-glucose or
2H7,
13C6-glucose respectively. Supply all components as powders to avoid dilution of
deuterium
Feeding solution for fed-
batch phase
1. Prepare 100 mL of feeding solution per 1 L of fermentation volume based on YM without amino acids and
without ammonium, but replace 2.5 g/L by 25 g/L glucose. Use isotope-labeled water and glucose according
to your labeling strategy
2. Adjust solution to pH 6
3. Filter-sterilize and store at 4 C
Fermentation of Pichia pastoris
Fermentation in H2O 1. Grow wild-type Pichia pastoris strain (X-33) on fresh LB agar plate at 30 C
2. Inoculate unlabeled YM preculture (e.g. 10 mL), grow at 30 C and 200 rpm (shaking flask) over night to
OD600 2
3. Use preculture to inoculate unlabeled YM scale-up culture (e.g. 100 mL) at OD600 0.2
4. Grow scale-up culture (shaking flask, 30 C, 200 rpm) to OD600 2. Harvest cells by centrifugation at
5000g for 15 min
5. Resuspend pelleted cells in labeled YM. Inoculate fermenter to yield a starting OD600 of 0.2 in fermentation
volume (e.g. 1 L)
6. Run fermenter-controlled batch-phase at 30 C, agitation speed 500 rpm, 0.5 L/min airflow, pH 6.0 (adjusted
by addition of 4 M NaOH). Maintain dissolved oxygen (DO) level above 35 % by controlled stirring
7. When initial glucose is fully depleted as judged by increase in DO, start fed-batch phase at a feeding rate to
counteract the DO increase
8. Stop fermentation when fed glucose is depleted. Harvest cells by centrifugation at 5000g for 30 min
Fermentation in D2O 1. Replace unlabeled YM in the scale-up culture with 70 % D2O-YM for D2O adaptation
2. Grow scale-up culture to OD600 of 2. Harvest cells by centrifugation at 5000g for 15 min
3. Resuspend cell pellet in 100 % D2O, labeled YM. Inoculate fermenter to yield a starting OD600 of 0.2 in
fermentation volume (e.g. 1 L)
4. Follow H2O fermentation steps 6–8, but use D2O feeding and pH control solutions
5. For recycling of D2O, supernatants can be sterile-filtered, charcoal-treated, and distilled
Yeastolate preparation
1. Wash yeast cell pellet with ultrapure water and centrifuge (5000g, 30 min)
2. Prepare a 30 % (w/v) yeast slurry in sterile-filtered water and adjust pH to 7.5 using NaOH
3. Add 0.5 % (w/w) Zymolyase 20T (Amsbio) and incubate slurry at 35 C in water bath for 6 h maintaining pH at 7.5
4. Heat inactivate Zymolyase 20T at 65 C for 20 min
5. Adjust to pH 6 and add 0.5 % (w/w) papain powder (Carl Roth)
6. Incubate slurry under continuous shaking for 5 days at 50 C
7. Mechanically homogenize lysate (e.g. using tissue grinder)
8. Spin down cell debris at 20,000g for 30 min and collect supernatant
9. Filter supernatant through 10 kDa MWCO using a stirred filtration cell (Millipore). Collect flow-through
10. Lyophilize flow-through to yield a powder of yeastolate. Store at 4 C
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medium. Interestingly, the overall content of amino acids
was comparable in both yeastolates, but differed for indi-
vidual amino acids. In most cases, the yeastolate amino
acid concentrations exceeded those of the 20 % IPL-41
medium. However, glutamine and methionine concentra-
tions were significantly lower in the yeastolates.
The performance of the yeastolate-based insect cell
growth media was then assessed by the expression of
c-Abl protein in Sf9 cells. Expression in a commercial
full medium (Insect Xpress, Lonza) was taken as refer-
ence and resulted in yields of 62 mg/L of purified c-Abl
(Fig. 2). Following the results of the amino acid analysis,
the DSF4 medium was initially supplemented by 8 g/L of
either commercial or Pichia yeastolate without further
addition of the low-abundance amino acids glutamine,
methionine and cysteine. Under these conditions,
expression levels dropped to only 2.4 mg/L purified
c-Abl. Hence, the DSF4 was further supplemented by
1.0 g/L glutamine and 1.0 g/L methionine (20 % IPL-
41). This dramatically increased the yield to 45 mg/L of
purified c-Abl, recovering 73 % of the full medium
expression. A subsequent test showed that the additional
supplementation of methionine was not required, since its
omission did not alter the expression level (Fig. 2). Also
no further increase was observed upon supplementation
of 0.23 g/L cysteine (20 % IPL-41), indicating that
addition of cysteine was not necessary. This observation
may be explained by previous findings that Sf9 cells can
synthesize cysteine from methionine (Doverskog et al.
1998). It has been reported that Sf9 cells are able to
synthesize glutamine from ammonium (Drews et al.
2000) and thus glutamine may be substituted by
m
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Fig. 1 Amino acid content of different yeast extracts and IPL-41.
The free amino acid content of the commercial (Bacto Yeast Extract,
Difco, white) and Pichia yeast extract (gray) was quantified by HPLC
analysis following pre-column derivatization with phenyl isothio-
cyanate. Levels of cysteine were not determined by this method. The
amino acid content of the yeast extracts is compared to 20 %
concentrations of amino acids in the IPL-41 medium (black), which
was found to be sufficient to promote protein expression in Sf9 insect
cells
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Fig. 2 Expression yield of c-Abl in Sf9 insect cells under various
conditions. A reference yield was obtained in the commercial Insect
Xpress medium (Lonza). Different supplements to SF4 medium
depleted in amino acids and yeastolate (DSF4) were tested: 8 g/L of
Pichia yeastolate (YE), 8 g/L YE ? 1 g/L methionine ? 1 g/L
glutamine (YE ? M, Q), and 8 g/l YE ? 1 g/L glutamine
(YE ? Q). Cell cultures in supplemented DSF4 were starved for
2 h prior to final medium exchange. All yields were quantified by UV
absorption of purified protein at 280 nm
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ammonium in Sf9 expression cultures (Meola et al.
2014). However, the substitution by up to 10 mM
ammonium resulted in expression levels that were below
10 % of the glutamine-supplemented cultures. Therefore,
DSF4 supplemented by 8.0 g/L YE and 1.0 g/L glu-
tamine was taken as the optimal medium for all further
experiments.
Expression of 15N-labeled c-Abl and trGFPuv
Based on this optimized medium 15N-labeled c-Abl was
produced for NMR analysis. Initially, insect cells were
grown in unlabeled medium and then changed to the
medium containing 15N-yeastolate and 15N2-glutamine
immediately prior to virus infection. This resulted in yields
of 40 mg/L purified protein and an average 15N incorpo-
ration of 77 % as determined by mass spectrometry. Since
spillover from the initial unlabeled medium was suspected
as the source of the low labeling, a starvation step in DSF4
without yeastolate and glutamine supplement was intro-
duced 2 h prior to the exchange to DSF4 medium with
labeled yeastolate and glutamine. The starvation step
increased the 15N incorporation to 89 % without reduction
of the expression level (Table 3). A similarly high 15N
incorporation of 90 % (Table 3) was obtained for the
expression of a truncated (Met1-Ile229), optimized form of
green fluorescent protein (trGFPuv) (Khan et al. 2003) with
a yield of 40 mg/L. Hence, all subsequent expressions were
performed with the 2 h starvation step included in the
labeling protocol (Table 2).
Figure 3 shows an 1H-15N HSQC spectrum recorded on
the 15N-labeled c-Abl protein expressed in insect cells
grown on the 15N-yeastolate. The resonances are identical
to previously published spectra of c-Abl (Vajpai et al.
2008b). The HSQC resonance intensities were compared
quantitatively to an HSQC recorded under identical con-
ditions on a 15N-labeled c-Abl sample prepared from insect
cells grown on the commercial, uniformly 15N-labeled
BioExpress-2000 (CIL #CGM-2000-N) medium (Strauss
et al. 2005; Vajpai et al. 2008b). For the latter, an average
15N labeling efficiency of 91.4 % based on mass spec-
trometry has been reported. After correction for the
respective concentrations, the resonance intensities agreed
within *10 % for all amino acid types (data not shown).
This corroborates the very similar 15N incorporation
obtained by mass spectrometry and indicates that there is
no obvious specific 15N incorporation for certain amino
acids.
Table 2 Expression of labeled proteins in insect cells based on yeastolate
Preparation of labeling medium
Prepare stock solution of yeastolate (e.g. 200 g/L) in sterile ultrapure water. Filter-sterilize and store aliquots at -20 C
15N labeling Supplement dropout medium depleted of amino acids and yeast extract (e.g. DSF4, BioConcept) with 8 g/L
15N-yeastolate and 1 g/L 15N2-glutamine
15N,13C labeling Supplement dropout medium depleted of amino acids, yeast extract and all carbon sources (e.g. DSF4, BioConcept)
with 8 g/L 15N,13C-yeastolate, 5 g/L 13C6-glucose and 1 g/L
15N2-glutamine
2H,15N,13C labeling As 15N,13C labeling but use 8 g/L 2H,15N,13C-yeastolate
Adjust pH to 6.2 (±0.2)
Filter-sterilize medium and store at 4 C
Labeled expression in insect cells
1. Adapt Sf9 or Sf21 cells to growth in serum-free medium (e.g. Insect Xpress, SF4) and optimize expression conditions at 27 C, shaken at
80 rpm in Erlenmeyer flasks
2. Scale up cells in mid-log phase of growth to desired expression volume (typically 1.5 9 106 - 2 9 106 cells/mL)
3. When the required cell density is reached, harvest cells by centrifugation at 200g for 4 min (20 C)
4. Resuspend cells in dropout medium of same volume (depleted of amino acids and yeast extract) and starve cells for 2 h (27 C, 80 rpm)
5. Determine cell density and viability. Spin down amount of cells required for expression (300g, 4 min)
6. Resuspend cells in labeling medium with half the volume of the final culture
7. Infect with baculovirus according to optimized conditions (MOI, functional titer). Avoid label dilution by using high-titer stocks
8. Adjust to final culture volume after 6 h
9. Grow baculovirus-infected cells for 48–72 h in labeled medium (27 C, 80 rpm)
10. Harvest cells at 1000g for 10 min and purify recombinant protein
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Expression of 15N,13C-labeled trGFPuv and triple
resonance NMR
To test its usefulness for canonical triple resonance protein
NMR experiments, an 1H,15N,13C-labeled sample of
trGFPuv was expressed according to the protocol given in
Table 2 using 15N,13C-yeastolate and resulting in a yield of
39 mg/L. The labeling procedure is similar as for the 15N
labeling. However, to achieve optimal 13C labeling, the
DSF4 medium was further depleted of glucose, maltose and
sucrose, and 5 g/L of 13C6-glucose were supplemented as
the only sugar source. Glutamine was only supplemented in
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Fig. 3 1H-15N HSQC spectrum of 15N-labeled c-Abl expressed in Sf9 insect cells. The protein was expressed in Sf9 cells grown on
15N-yeastolate and 15N2-glutamine as described in the text. The spectrum was recorded in 2 h on a 200 lM
15N-labeled c-Abl sample
Table 3 Isotope incorporation of proteins expressed using different yeastolate labeling schemes
Protein Label Observed mass (Da) Observed shift (Da)a Expected shift (Da)b Incorporation ratioc
c-Abl Unlabeled 34,892.6d – – –
15N 35,249.2 356.6 402 0.89
15N,13C 36,558.7 1666.1 1934 0.85e
2H,15N 36,337.4 1444.8 2236 0.61f
trGFPuv Unlabeled 25,585.3 – – –
15N 25,859.6 274.3 305 0.90
15N,13C 26,778.0 1192.7 1409 0.84g
a Calculated as the difference between observed mass and unlabeled reference
b Theoretical mass shift based on total number of atoms to be labeled
c Ratio of the observed by the expected mass shift
d The N-terminus of c-Abl kinase domain starts with S*YYHHHHHHDYDIPTTENLYFQGAMDP-c-Abl(S229–S500), * N-acetylation of serine
(Strauss et al. 2003)
e 13C incorporation assuming 1532 labeled carbon atoms and 0.89 15N incorporation (356.6 Da)
f 2H incorporation assuming 1789 non-exchangable protons and 0.89 15N incorporation (356.6 Da)
g 13C incorporation assuming 1099 labeled carbon atoms and 0.90 15N incorporation (274.3 Da)
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15N-labeled form, since addition of the considerably more
expensive 15N, 13C-glutamine did not result in a significant
increase of 13C labeling as judged by mass spectrometric
analysis. An overall 13C incorporation of 84 % was esti-
mated by mass spectrometry, subtracting the previously
determined 90 % 15N incorporation from the total mass
(Table 3).
The efficiency of 13C incorporation into specific atom
positions was further analyzed by NMR spectroscopy.
Using modulation by the one-bond 1JNC’ scalar coupling in
the 15N evolution period of a constant-time 1H-15N HSQC
(Supplementary Figure S1), the 13C enrichment of the
carbonyl nucleus of the amino acid preceding the 1H-15N
amide could be determined. Figure 4 shows averages and
standard deviations of this enrichment according to the
different observed amino acid types. The average 13C
incorporation determined by this experiment amounts to
81 %, which is slightly lower than the 84 % determined by
mass spectrometry. This reduction may be explained by
systematic errors in the NMR determination due the
imperfection of the 13C’ coupling pulse and the faster
relaxation of the 15N-{13C’} antiphase term, which
diminishes the apparent size of the 13C signal (Grzesiek
et al. 1993). The amino acid-specific analysis reveals that
most amino acids have higher than 80 % (uncorrected
NMR value) 13C incorporation at the carbonyl position.
However, incorporation is reduced for glutamate (62.4 %),
aspartate (71 %), and cysteine (72 %). This is consistent
with the reported metabolic conversion of (12C-)glutamine
into the latter amino acids in insect cells (Drews et al.
2000).
The 81 % 13C incorporation determined from the one-
bond 1JNC’ scalar coupling corresponds to the probability
for finding a 13C’ nucleus in the amino acid preceding an
15N-labeled amide. However, within a single labeled
amino acid the probability for a next neighbor 13C
carbon should be higher due to the overall 96 % 13C
content of the amino acids coming from the yeastolate
(Supplementary Table S1). This was tested by measuring
the incorporation of 13Ca nuclei next to 13C’ nuclei in a
modified HNCO, which was modulated by the one-bond
1JC’Ca coupling in a constant-time
13C’ evolution period
(Supplementary Figure S2). These intraresidue next
neighbor 13C incorporation ratios are also presented in
Fig. 4 according to the different amino acid types. No
pronounced variations are observed. The average of the
intraresidue next neighbor 13C incorporation within a
labeled amino acid amounts to 93 % and is clearly
considerably higher than the sequential incorporation.
Again, the 13C incorporation derived by the NMR
experiment presents a lower estimate due to imperfec-
tions of the 13Ca coupling pulse and the faster relaxation
of the 13C’-{13Ca} antiphase term. The high level of
intraresidue next neighbor 13C incorporation agrees with
the expected low metabolic conversion of amino acids
and has the practical advantage that NMR experiments,
which rely on intraresidue heteronuclear connectivities,
do not suffer from potentiated losses in sensitivity due to
low next neighbor labeling.
The capability to achieve sequential assignments was
demonstrated by recording HNCO and HNCA spectra on
the 15N,13C-labeled trGFPuv. Figure 5 shows sequential
strip plots from the 3D experiments. Overall, 97 % (89 %)
of all expected crosspeaks were observed for the HNCO
(HNCA) using an experimental time of 17 h (69 h) on a
230 lM sample of this 26 kDa protein.
Expression of 2H,15N-labeled c-Abl
To test deuterium labeling, 2H,15N-labeled c-Abl was
expressed in insect cells grown on DSF4 medium supple-
mented by 1 g/L 15N2-glutamine and 8 g/L
2H,15N-labeled
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Fig. 4 Specific 13C incorporation in 15N,13C-GFP analyzed by NMR
spectroscopy. 15N,13C-GFP was expressed in Sf9 cells grown on
15N,13C-yeastolate and 15N2-glutamine.
13C enrichments of the
carbonyl nucleus preceding a 15N amide determined via the 1JNC’
scalar coupling (white) and of a Ca nucleus next to a 13C’ carbonyl
determined via the 1JC’Ca scalar coupling (gray) are shown as
averages and standard errors for the different amino acid types that
could be detected. Details are given in Supplementary Figures S1 and
S2
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yeastolate, which had been obtained from a D2O/
15NH4Cl
yeast culture with otherwise protonated medium com-
pounds (Table 1). A yield of 43 mg/L purified 2H,15N-c-
Abl was achieved, which is identical to the 15N-labeled or
15N,13C-labeled expression. Mass spectroscopic analysis
indicated an average 2H incorporation of 61 % (Table 3),
which corresponds to a 19 % drop from the 75 % initial
deuteration level of the yeastolate amino acids (Supple-
mentary Table S1).
The benefits of the deuterium labeling were evident in
an initial NMR analysis of average amide proton T2 values,
which increased from 10.8 ms in 1H,15N-labeled to
16.2 ms in 2H,15N-labeled c-Abl. An example for the
improvement in the spectral sensitivity is given in Fig. 6
for the case of NOESY experiments. Figure 6 shows the
amide regions of 1H,1H-NOESY spectra recorded under
identical conditions with a mixing time of 230 ms on
protonated (Fig. 6a) and deuterated (Fig. 6b) c-Abl.
Clearly many more cross peaks become visible for the
deuterated case. Furthermore, 15N-edited 3D NOESY
spectra were recorded with optimized mixing times of 100
and 230 ms, corresponding to the decay times of the
diagonal peaks (selective T1), for the protonated and
deuterated c-Abl, respectively. Obviously, the sensitivity is
tremendously increased for the deuterated c-Abl sample
(Fig. 6d) and many i, i ? 1 and i, i ? 2 connectivities are
detected, which are not present for protonated c-Abl
(Fig. 6c).
Expression of 2H,15N-labeled beta-1 adrenergic
receptor
To apply the yeastolate labeling procedure to a highly
challenging protein, 2H, 15N-labeled thermostabilized beta-
1 adrenergic receptor (b1AR) (Warne et al. 2008) was
expressed in Sf9 cells as described before. A yield of
0.8 mg/L purified, detergent-solubilized protein was
achieved, which was comparable to yields from the com-
mercial Insect Xpress (Lonza) medium. The fractional
deuteration increased the amide proton T2 from 3.9 ms
observed for the protonated receptor to 5.9 ms for the
2H,15N-labeled receptor. Likewise, the 15N TROSY T2
increased from 21 to 29 ms upon deuteration. Figure 7
shows the well-resolved TROSY-HSQC recorded for 13 h
on the 85 lM 2H,15N-labeled receptor dissolved in a decyl-
maltoside detergent micelle (total molecular weight
*100 kDa). About 240 of the 304 expected backbone
amide resonances are observable.
Cost analysis
An estimate of the total cost of various isotope labeling
schemes in insect cells based on the described YE is pro-
vided in Table 4 using current market prices for labeled
ingredients and insect cell media. The estimated cost of 1 L
insect cell medium for pure 15N labeling amounts to 970 €,
which is slightly higher than the estimate of 800 € given
for a commercial source of YE-based medium (Meola et al.
2014). However, it should be noted that by the present
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Fig. 5 Triple resonance backbone correlation experiments recorded
on 15N,13C-GFP. Strip plots from the 3D data sets of HNCO (a) and
HNCA (b) experiments are displayed for a consecutive stretch of
amino acids. 15N,13C-GFP was expressed in Sf9 cells grown on
15N,13C-yeastolate and 15N2-glutamine
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method about 4 times higher yields (40 mg/L protein) and
90 % labeling have been achieved without additional costs
from a purge phase of insect cell growth on labeled med-
ium. The high expression yield translates into a cost of only
63 € for a typical NMR sample of 0.3 mM Abl kinase
domain (MWT 32 kDa) in a 270 lL volume. Furthermore,
the largest part of the 15N-labeled medium costs stems
from the addition of 1 g/L of 15N-labeled glutamine
(800 €). This expense may be reduced to negligible levels
by enzymatic synthesis of 15N2-glutamine via
15N-gluta-
mate, which can be produced by glutamate dehydrogenase
from 15N-labeled ammonium and 2-oxoglutaric acid (Kragl
et al. 1993) and subsequently be converted to 15N2-glu-
tamine by glutamine synthetase under the addition of 15N-
labeled ammonium (Hansen et al. 1992).
Table 4 indicates that compared to 15N labeling, the
additional cost for partial deuteration ([60 %) is rela-
tively small (1398 € for 1 L 2H,15N insect cell medium).
Since the costs arise from the D2O used for yeast
growth, they may again be reduced considerably by
recycling D2O via distillation. Due to the high amount of
glucose required for the yeast growth (27.5 g/L), costs
for YE-based insect cell medium increase significantly
for 13C labeling and amount to 4424 € for 1 L of
15N,13C insect cell medium. Again the additional cost for
the fractional deuteration is relatively minor (4848 € for
1 L 2H,15N,13C insect cell medium). The estimated costs
for one sample of triple-labeled Abl kinase domain are
still only 314 € under these conditions.
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Fig. 6 NOE sensitivity
enhancement by deuteration.
Top: 2D 1H-1H-NOESY spectra
recorded under identical
conditions on 200 lM samples
of 15N-c-Abl (a) and 2H,15N-c-
Abl (b) expressed in Sf9 insect
cells (NOE mixing time of
230 ms). Bottom: strip plots for
a consecutive stretch of amino
acids from 3D 15N-edited
NOESYs recorded on the same
15N-c-Abl (c) and 2H,15N-c-Abl
(d) samples under identical
conditions with the exception of
optimized NOE mixing times of
100 ms (15N-c-Abl) and 230 ms
(2H,15N-c-Abl)
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Fig. 7 1H,15N-TROSY spectrum of 2H,15N-labeled beta-1 adrenergic
receptor. 2H,15N-labeled b1AR was expressed in Sf9 cells grown on
2H,15N-yeastolate and 15N2-glutamine as described in the text. The
TROSY was recorded in 13 h on 85 lM 2H,15N-labeled b1AR
solubilized in n-decyl-b-D-maltopyranoside
J Biomol NMR
123
Conclusion
We have developed a robust protocol for stable isotope
labeling of proteins in insect cells based on labeled yeast-
olate. Our approach overcomes low incorporation rates and
low yields described in previous yeastolate-based labeling
approaches. This was achieved by a quantitative analysis of
the yeastolate amino acid content, supplementation of
lacking glutamine, site-specific quantification of isotope
incorporation and subsequent optimization. In particular,
significant dilution of the isotope labels was prevented by
introducing an initial starvation step. In addition to 15N
labeling, also efficient 15N,13C and partial ([60 %) 2H
labeling is demonstrated. Higher 2H incorporation may be
achievable by growing yeast on deuterated glucose in
addition to D2O. The described uniform deuteration via the
yeastolate may also be combined with the supplementation
of specifically labeled amino acids for further gains in
resolution and sensitivity (Kofuku et al. 2014).
The preparation of the labeled yeastolate can be readily
implemented in a standard, academic structural biology
laboratory and does not rely on commercial media of
undisclosed content. The costs are moderate for 15N and
fractional 2H labeling and may be reduced further by
synthesis of labeled glutamine. Labeling by 13C increases
the costs, but due to the high yields, still allows production
of protonated or partially deuterated 15N,13C-samples of
‘difficult’ eukaryotic proteins such as c-Abl at moderate
costs of several hundred Euros.
It is hoped that the proposed method will enable detailed
studies of eukaryotic proteins such as G-protein-coupled
receptors that so far have been inaccessible to NMR due to
their requirement of expression in a eukaryotic host. As
initial example we provide a well-resolved spectrum of the
2H,15N-labeled beta-1 adrenergic receptor. Besides their
application for insect cells, the described homemade yeast
extracts may also serve as a basis for isotope labeling in
other higher eukaryotic expression systems such as Chinese
hamster ovary and human embryonic kidney cells (Egor-
ova-Zachernyuk et al. 2009).
Materials and methods
Yeast growth and preparation of yeast extract
Detailed protocols are presented in Table 1.
Quantitative amino acid analysis by LC/MS
Crude yeast extract was purified by solid phase extraction
using a strong cation-exchange matrix (DSC-SCX SPE,
Sigma). Briefly, lyophilized powder was dissolved in
30 mM phosphoric acid solution (pH 2.7) and applied to
the conditioned SCX column. The packed column was
washed two times with 30 mM phosphoric acid solution.
Samples were eluted with 2.5 M NH4OH containing 10 %
acetonitrile and dried in a centrifugal evaporator.
Purified powder was dissolved in 50 % methanol to
yield a 10 lg/lL solution for pre-column derivatization
with phenyl isothiocyanate (PITC). Two volumes of a
freshly prepared coupling solution containing methanol/
triethylamine/PITC (7:2:1) were added and the solution
was derivatized for 30 min at room temperature protected
from light. After derivatization, the mixture was dried
under vacuum. Unlabeled standards for each amino acid
were prepared accordingly.
The derivatized phenylthiohydantoin (PTH) amino acids
were taken up in 20 % acetonitrile for LC/MS analysis.
Optimal separation was achieved by HPLC (Agilent) on an
Eclipse XDB-C18 reverse phase column (Agilent) at a flow
rate of 2.1 mL/min and 50 C using a gradient elution of
50 mM ammonium acetate at pH 7.2 (Eluent A) against
46:44:10 100 mM ammonium acetate (pH 7.2)/acetonitrile/
methanol (Eluent B) (Supplementary Table S2). The PTH
Table 4 Cost estimates for yeastolate-based isotope labeling in
insect cellsa
1 L yeast medium
Labeling 15NH4Cl
b 13C6-glucose
c D2O
d Total
15N 86 – – 86
15N,2H 86 – 350 436
15N,13C 86 2475 – 2561
15N,13C,2H 86 2475 350 2911
1 L insect cell medium
Labeling Yeastolatee Glucosef Totalg c-Abl sample costsh
15N 104 – 974 63
15N,2H 528 – 1398 91
15N,13C 3104 450 4424 287
15N,13C,2H 3528 450 4848 314
a All costs are given in Euro using conservative estimates of market
prices for labeled ingredients and growth media
b 4.3 g/L 15NH4Cl
c 27.5 g/L 13C6-glucose
d 1 L D2O
e Costs for 8 g isotope-labeled yeastolate based on a yield of 6.6 g
per 1 L yeast culture
f Addition of 5 g/L 13C6-glucose for
13C labeling
g Total costs of yeastolate, glucose and 1 g 15N2-glutamine (800
EUR) supplements to 1 L of insect cell culture dropout medium (70
EUR, SF4, Bioconcept)
h Costs for a 270-lL, 300-lM c-Abl (32 kDa) sample based on an
expression yield of 40 mg/L
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amino acids were detected by optical absorption at 254 and
280 nm, and subsequently identified and quantified for
their isotope content on a Bruker microTOF electrospray
ionization mass spectrometer. The amount of individual
amino acids was determined from the integration of the
absorbance peak area and referencing to the unlabeled
standard.
Determination of isotope incorporation of expressed
proteins by MS
Purified protein samples were desalted by solid phase
extraction on C4 reverse phase micro spin columns
according to the supplier’s protocol (The Nest Group).
Isotope incorporation was determined by ESI-TOF mass
spectrometry (Bruker microTOF) applying direct infusion
of the prepared proteins. Mass spectra were analyzed by
maximum entropy deconvolution.
Cell culture and preparation of recombinant
baculovirus
In general, handling and maintenance of Sf9 cell culture
was based on established protocols (O’Reilly et al.
1994). Permanent cultures were subcultured in mid-log
phase and kept in full SF4 medium (Bioconcept) and
Insect Xpress medium (Lonza) at 27 C and shaken at
80 rpm. Recombinant bacmid DNA was generated in
DH10Bac E. coli cells using the commercial pFastBac
vector according to the supplier’s procedure (Life
Technologies). Baculovirus was generated in adherent
cultures as reported by O’Reilly et al. (O’Reilly et al.
1994). Subsequently, high-titer virus stocks for expres-
sion were produced by two additional amplification
rounds in suspension cultures. In the first amplification
round, 50 mL of Sf9 cell culture containing 1 9 106 -
cells/mL in serum-free medium were infected with
recombinant virus and cultured until cell viability
decreased to B90 %. The supernatant (P1) was collected
by centrifugation at 1000g and 4 C for 15 min. For the
second amplification round, 100 mL of serum-free Sf9
cell culture containing 1 9 106 cells/mL was infected
with P1 and processed accordingly to yield a P2 virus
stock.
Functional titration of the P2 virus stock was applied to
determine the optimal amount for expression. Briefly,
small-scale cultures of Sf9 cells were infected in full SF4
medium at a cell density of 1.5 9 106 cells/mL with P2
virus stock corresponding to functional titers of 1–10 mL
per 1 L of cell culture. The yield of purified protein was
then quantified for different expression times.
Expression and purification of Abelson kinase
domain in insect cells
Samples of Abelson kinase domain (c-Abl) in complex
with imatinib were prepared according to the previously
published protocol leaving out the TEV cleavage step of
the N-terminal polyhistidine tag (Vajpai et al. 2008a).
NMR samples were prepared in 20 mM BIS–TRIS (pH
6.5), 150 mM NaCl, 2.5 mM TCEP, 5 % D2O and 0.02 %
NaN3.
Cloning and purification of truncated trGFPuv
A synthesized gene sequence of the truncated GFP cycle
3 mutant (trGFPuv) based on the previously published
construct (Huang et al. 2007) was purchased from a
commercial supplier (Genewiz). The sequence was
codon-optimized for expression in insect cells. Recom-
binant baculovirus was prepared by insertion of the
trGPFuv gene into the pFastBac vector (Life Technolo-
gies). Bacmid DNA was produced in DH10Bac E. coli
cells according to the standard protocol provided by the
supplier.
Functional virus titer and the optimal expression time
were determined in small-scale expression tests. trGFPuv
was subsequently expressed in SF4-adapted Sf9 insect cells
until the cell viability decreased to 90 %. Cells were har-
vested at 1000g for 10 min and lysed by sonication. The
protein was purified following the established protocol in
E. coli (Huang et al. 2007). NMR samples were prepared in
20 mM sodium phosphate (pH 7.4), 5 % D2O and 0.02 %
NaN3.
Expression and purification of turkey beta-1
adrenergic receptor
Purification of the thermostabilized, turkey beta-1 adren-
ergic receptor [mutant JM3 (Miller and Tate 2011)] was
adapted from the established protocol (Warne et al. 2008).
Since the receptor was prepared for solution NMR, solu-
bilization and subsequent purification steps were carried
out in n-decyl-b-D-maltopyranoside (DM). NMR samples
were prepared in 20 mM TRIS/HCl (pH 7.5), 100 mM
NaCl, 1 mM alprenolol hydrochloride (racemic), 5 % D2O,
0.1 % DM and 0.02 % NaN3.
NMR spectroscopy
NMR experiments were recorded on a Bruker Avance III
900 MHz spectrometer equipped with a triple-resonance
cryoprobe. Amide proton T2 values were determined from
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a jump-return spin-echo experiment (Sklenar and Bax
1987). Amide 15N T2 values were determined from the
decay of a 15N spin echo in a TROSY experiment.
All experiments on c-Abl were acquired at a temper-
ature of 25 C. 1H-15N HSQC experiments on 15N-c-Abl
were recorded with 75 (15N) 9 1024 (1H) complex
points and acquisition times of 30 ms (15N) and 40 ms
(1H). 2D 1H,1H-NOESY experiments on 15N-c-Abl and
2H,15N-c-Abl were recorded with 388 (1H) 9 2048 (1H)
complex points, acquisition times of 18.6 ms (1H) 9 80
(1H) ms, and a total experimental time of 6.5 h. The 3D
15N-NOESY-HSQC experiments were recorded with 268
(1H) 9 130 (15N) 9 2048 (1H) complex points, acquisi-
tion times of 16 ms (1H) 9 30 ms (15N) 9 80 (1H) ms,
and a total experimental time of 77 h.
All experiments on trGFPuv were acquired at a tem-
perature of 37 C. The 3D HNCO experiment on 15N,13C-
trGFPuv was recorded with 104 (15N) 9 100 (13C) 9 2048
(1H) complex points, acquisition times of 27 ms
(15N) 9 20 ms (13C) 9 80 (1H) ms, and a total experi-
mental time of 17 h. The 3D HNCA experiment on
15N,13C-trGFPuv was recorded with 86 (15N) 9 82
(13C) 9 2048 (1H) complex points, acquisition times of
22 ms (15N) 9 9 ms (13C) 9 80 (1H) ms, and a total
experimental time of 69 h.
The 2D 1H,15N-TROSY experiment on 2H,15N-b1AR
was recorded at 30 C with 150 (15N) 9 1024 (1H) com-
plex points, acquisition times of 30 ms (15N) 9 43 (1H)
ms, and a total experimental time of 13 h.
Data processing and analysis
All NMR data were processed with the NMRPipe software
package (Delaglio et al. 1995). Protein assignments and
analysis of peak intensities were carried out using the
programs Sparky (Goddard and Kneller 2008) and PIPP
(Garrett et al. 1991).
Quantification of 13C incorporation by NMR
Details of the constant-time 1H-15N HSQC and HNCO
used for the quantitative assessment of 13C incorporation at
the carbonyl and Ca position are given in Supplementary
Figures S1 and S2.
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Table S1: Label incorporationa of free amino acids in different yeastolates determined 
by LC/MS  
 Atom number 15N yeastolate 13C yeastolate 2H yeastolate 
 C H
 b N Shift (Da) Incorporation 
Shift 
(Da) Incorporation 
Shift 
(Da) Incorporation 
Ala 3 4 1 0.97 0.97 2.69 0.91 2.54 0.63 
Arg 6 7 4 3.68 0.92 5.84 0.98 6.43 0.92 
Asn 4 3 2 1.92 0.96 3.82 0.96 2.66 0.89 
Asp 4 3 1 0.97 0.97 3.88 0.98 2.44 0.81 
Gln 5 5 1 0.91 0.91 4.73 0.95 4.49 0.90 
Glu 5 5 2 1.94 0.97 4.76 0.96 4.09 0.82 
Gly 2 2 1 0.97 0.97 1.79 0.90 1.65 0.82 
His 6 5 3 2.86 0.95 5.91 0.99 3.96 0.79 
Ile 6 10 1 0.97 0.97 5.80 0.98 7.40 0.74 
Leu 6 10 1 0.97 0.97 5.73 0.96 8.76 0.88 
Lys 6 9 2 1.94 0.97 5.55 0.94 7.40 0.82 
Met 5 8 1 0.96 0.96 4.80 0.97 5.17 0.65 
Phe 9 8 1 0.97 0.97 8.60 0.96 4.71 0.59 
Pro 5 7 1 0.97 0.97 4.70 0.95 5.43 0.78 
Ser 3 3 1 0.96 0.96 2.82 0.95 1.82 0.61 
Thr 4 5 1 0.97 0.97 3.81 0.96 3.21 0.64 
Trp 11 8 2 1.89 0.94 10.77 0.99 4.34 0.54 
Tyr 9 7 1 0.97 0.97 8.82 0.99 4.19 0.60 
Val 5 8 1 0.97 0.97 4.86 0.98 6.62 0.83 
 Average    0.96  0.96  0.75  
a Free amino acids were derivatized with phenyl isothiocyanate, separated on a C18 reverse-phase column by 
HPLC and detected by an ESI-TOF mass spectrometer. Shifts were computed using weighted average values of 
the observed masses relative to the unlabeled amino acid species. The incorporation was determined as the ratio 
of the calculated mass shift over the theoretical contribution of the respective atom type. 
b Non-exchangeable protons. 
 
Table S2: Gradient elution protocol used for amino acid analysis by LC/MSa  
Step Time  (min) 
Eluent Ab 
(%) 
Eluent Bc 
(%) 
1 0 100 0 
2 6 99 1 
3 14 91 9 
4 17 65 35 
5 20 65 35 
6 24 55 45 
7 26 0 100 
8 29 0 100 
 
a The gradient was applied on an Eclipse XDB-C18 column (Agilent) at a flow rate of 2.1 ml/min, with a column 
length of 150 mm and an inner diameter of 4.6 mm. 
b 50 mM ammonium acetate at pH 7.2. 
c 46:44:10 100 mM ammonium acetate (pH 7.2)/acetonitrile/methanol.  
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Figure S1: Quantitative NMR analysis of 13C enrichment of the carbonyl nucleus using the 
modulation by the one-bond 1JNC’ scalar coupling in the 15N evolution period of a constant-
time 1H-15N HSQC. 
A) Pulse scheme of the constant-time 1JNC’-modulated 1H-15N HSQC. Narrow and wide pulses 
have flip angles of 90° and 180°, respectively and are applied with phase x unless specified 
otherwise. The 1H, 15N, 13C’, and 13C! carriers are set to 4.7 (H2O), 116.5, 177, and 56 ppm, 
respectively. 1H pulses have an RF field strength of 28 kHz with the exception of the water-
selective, low-power, rectangular ~1 ms 90° pulses and the ~2 ms sinc water-selective 90° 
pulse applied before the reverse 15N-1H INEPT transfer. The 15N pulses have an RF field 
strength of 6.25 kHz. 15N WALTZ-16 decoupling during acquisition is applied at an RF field 
strength of 1.5 kHz. The 13C’, 13C! 180° decoupling pulses have an RF field strength of 7.0 
and 15.7 kHz, respectively. Delay durations are " = 2.25 ms, # = 5.4 ms, and TN = 38 ms. To 
obtain modulation of crosspeak intensities by the one-bond 1JNC’ scalar coupling, the delay !"
is incremented in interleaved experiments. For the present experiment, five increments with !"#" 0, 9.45, 18.9, 28.35, and 37.8 ms were used. Gradient durations (z-direction, sine bell 
shaped, 30 G/cm at center): G1,2 = 1.0, 0.4 ms. Phases: !1 = x, -x and !rec = x, -x. Quadrature 
detection in the 15N dimension is obtained by altering !1 in the usual States-TPPI manner. 
Data matrices were recorded as 2048 (1HN) x 464 (15N) complex points with acquisition times 
of 80 and 65 ms, respectively. The total experimental times using 16 scans was 15.5 h. Peak 
amplitudes were obtained by fitting the resonances with the NLINLS program of NMRPipe. 
The amplitudes were then fitted to the equation A1 cos(2$ 1JNC’ !) + A2 by MATLAB 
(MathWorks) and the relative 13C enrichment of the carbonyl nucleus R was calculated as R = 
A1/(A1 + A2). 
B) Representative fit of the cosine-modulated amplitude for glycine-10 of trGFPuv. 
 
o oo o
Gz
!" !"y
g TN - 
G1 G2 G2
Dipsi-x
t1
2
t1
2 Waltz16
 t2
y -yy -x!"
¡ ¡
q#
15N
1H
13C'
13C_
g TN - 
0 20 40
ï
0
2
4
g [ms]
In
te
ns
ity
 [A
U]
A1 + A2 = 4.35
A2 = 0.85
A B
-4- 
  
Figure S2: Pulse scheme of the 1JC’C!-modulated HNCO used to quantify the 13C enrichment 
of the C! nucleus. Narrow and wide pulses have flip angles of 90° and 180°, respectively and 
are applied with phase x unless specified otherwise. The 1H, 15N, 13C’, and 13C! carriers are set 
to 4.7 (H2O), 116, 177, and 56 ppm, respectively. 1H pulses have an RF field strength of 28 
kHz with the exception of the water-selective, low-power, rectangular ~1 ms 90° pulses and 
the ~2 ms sinc water-selective 90° pulse applied before the reverse 15N-1H INEPT transfer. 
The 15N pulses have an RF field strength of 6.25 kHz. 15N WALTZ-16 decoupling during 
acquisition is applied at an RF field strength of 1.5 kHz. The 13C’, 13C! 180° decoupling 
pulses have an RF field strength of 7.0 and 15.7 kHz, respectively. Delay durations are " = 
2.25 ms, # = 5.4 ms, TN = 13.6 ms, and TC = 11.2 ms. To obtain modulation of crosspeak 
intensities by the 1JC!C’ scalar coupling, the delay !"is incremented in interleaved experiments. 
For the present experiment, five increments with !"= 0, 2.2, 4.4, 6.6 and 8.8 ms were used. 
Gradient durations (z-direction, sine bell shaped, 30 G/cm at center): G1,2,3,4 = 1.0, 1.5, 1.0 
and 0.4 ms. Phases: !1 = x, x, -x, -x; !2 = x, -x and !rec = x, -x, -x, x. Quadrature detection in 
the 15N and 13C dimensions is obtained by altering !1 and !2, respectively, in the usual States-
TPPI manner. For the present experiment the 15N dimension was not recorded, and data 
matrices consisted of 2048 (1HN) x 202 (13C) complex points with acquisition times of 80 and 
22 ms, respectively. The total experimental time using 104 scans was 40.5 h. Peak amplitudes 
were obtained by fitting the resonances with the NLINLS program of NMRPipe. The 
amplitudes were then fitted to the equation A1 cos(2$ 1JC!C’ !) + A2 by MATLAB 
(MathWorks) and the selective, intraresidue 13C enrichment of the C! coupled to the carbonyl 
nucleus R was calculated as R = A1/(A1 + A2). 
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2.2 Mass spectrometric analysis of isotope-labeled proteins 
expressed in insect cells  
  
Introduction 
Metabolic scrambling and dilution of the isotope label are key challenges for expression of 
highly deuterated proteins in insect cells. High levels of deuteration can only be obtained by 
providing the majority of the amino acid sources in the growth medium in their deuterated 
form. However, so far the highest reported level of deuteration was only ~76 % based on the 
use of perdeuterated algal extracts (39). A thorough understanding of the metabolic pathways 
causing the scrambling of the deuterium label may help to improve deuteration in insect cells. 
Whereas incorporation of deuterium has been studied extensively in E. coli (99) and in the 
associated cell-free expression system (100, 101), it remains poorly characterized in insect 
cells and in fact all higher eukaryotic expression systems. A very recent investigation of 
deuterium incorporation in insect cells has been carried out for the partially deuterated 
β2-adrenergic receptor studied by NMR (41), which was grown on deuterated algal extracts 
and deuterated amino acids supplemented at specific time points during expression and 
analyzed by NMR. The observed deuteration levels were not uniform and varied between not 
significant and 90 %. A strategy to achieve higher levels of deuteration remains unclear. 
This section describes a mass spectrometric approach to study the isotope incorporation of 
uniformly labeled proteins expressed in insect cells. The method allows rapid and 
simultaneous analysis of 2H and 15N incorporation resolved for individual amino acids on 
sub-microgram sample quantities at any time point during expression. An overall dilution of 
the isotope label was observed for all analyzed amino acids, which was more pronounced in 
the case of deuteration. It is very likely that a significant cellular pool of unlabeled amino 
acids causes this dilution. The analysis further indicated that deuteration was significantly 
lower for several non-essential amino acids, such as alanine, glutamate, glycine, and 
aspartate. Finally, possible optimizations of deuterium labeling in insect cells are discussed.  
 
Remark on author contribution 
The work of this section was carried out together with Jethro Hemmann (temporarily 
member of the lab of Professor Stephan Grzesiek fulfilling compulsory paid community 
service, now University of Zurich) who performed expression, purification, and mass 
spectrometric analysis of 2H-labeled GFP. 
 
Results and Discussion 
Amino acid-resolved isotope incorporation of 2H,15N-labeled Abelson kinase  
Mass spectrometric analysis of single amino acids was established using 2H,15N-labeled 
Abelson kinase (cAbl) expressed in Sf9 insect cells grown on 8 g/L 2H,15N-labeled yeast 
extract (YE), prepared by fermentation of yeast in D2O using protonated glucose, and 1 g/L 
15N2-glutamine. 2H,15N-labeled cAbl was chosen as a reference based on the previous analysis 
of isotope incorporation on the whole protein level by mass spectrometry and NMR (see 
Chapter 2.1). The purified protein was hydrolyzed in 6 M hydrochloric acid to obtain free 
amino acids, which were further modified by a pre-column derivatization step to facilitate 
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LC/MS analysis (see Materials and Methods). Analysis of the isotope incorporation was not 
possible for cysteine and tryptophan, as acid hydrolysis results in oxidation of the two amino 
acids and impedes their recovery (34).  
Furthermore, glutamine and asparagine are converted to glutamate and aspartate, 
respectively (32, 34). The isomeric amino acids leucine and isoleucine cannot be 
distinguished based on their atomic mass. Consequently, isotope incorporation of D, E, and I 
reflects a pairwise weighted average with N, Q, and L corresponding to their individual 
abundance in cAbl. 
The average incorporation of 15N was computed as the combined weighted average of the 
single amino acids obtained by hydrolysis of 2H,15N-labeled cAbl (Figure 2.1A, red bars) 
yielding an average incorporation of 89.4 %. This agrees very well with an incorporation 
level of 89 %, which has been determined on the whole protein using mass spectrometry 
(Chapter 2.1). Remarkably, the 15N incorporation was homogenous for most of the amino 
acids. However, methionine displayed a significantly lower incorporation level (75.6 %). 
Yeast extracts have low abundance in methionine, which is not synthesized de novo in insect 
cells (38). As supplementation of methionine was not required for high-level expression in 
the yeast extract-based growth medium (see Chapter 2.1), this hints at a significant 
intracellular amount of methionine. Consequently, unlabeled methionine may be incorporated 
into the protein and may reduce the overall 15N incorporation. 
In contrast, incorporation of 2H was strongly dependent on the amino acid type 
(Figure 2.1A, grey bars). The average level of deuteration based on the combined weighted 
average of the single amino acids was only 49.3 %. In the case of alanine, aspartate, and 
glutamate 2H incorporation was significantly reduced to 4 %, 14 %, and 3.5 %, respectively. 
These non-essential amino acids were essentially protonated, which is likely the result of 
metabolic scrambling and may thus be rationalized by the amino acid metabolism of insect 
cells (Chapter 1.3). Based on the amino acid composition of cAbl (see Chapter 2.1), an 
average 2H incorporation of 55 % is expected using the weighted average 2H incorporation of 
individual amino acids (Figure 2.1A, grey bars). This corresponds to a decrease in the 
deuteration level by 20 % in insects cells with respect to the original 75 % of the nutrient 
yeast extract (Chapter 2.1, Table S1). The previous analysis of the isotope incorporation on 
the whole protein had indicated a slightly higher average 2H incorporation of ~60 % for 
2H,15N-labeled cAbl (see Chapter 2.1), which may be due to the oversimplifying assumption 
that the 15N incorporation was identical for different preparations of isotope-labeled cAbl.  
To further understand the apparent difference in the isotope incorporation related to 
analytical approach, the distribution of 2H and 15N isotopologues was analyzed on a single 
amino acid level. The 15N incorporation was similar for most of the amino acids with the 
exception of methionine (Figure 2.1B, red bars). In contrast, analysis of the 2H incorporation 
(Figure 2.1B, grey bars) revealed significant fractions of completely protonated 
isotopologues for all detected amino acids. As only 15N-labeled sources of amino and amide 
nitrogen including 15N2-glutamine have been supplemented to the growth medium, this 
observation strongly suggests biosynthesis of non-essential amino acids from fully protonated 
precursors and 15N-labeled amino acids (Chapter 1.3). Whereas the sources of unlabeled 
nitrogen are limited in the growth medium, back-protonation may be caused by several 
components such as the solvent, α-keto acids, and carbohydrates. 
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Figure 2.1 Amino acid-resolved isotope incorporation of 2H,15N-labeled cAbl analyzed by mass spectrometry. 
A Weighted average incorporation of 15N (red) and 2H (grey) was determined for single amino acids obtained by 
acid hydrolysis of 2H,15N-labeled cAbl expressed in Sf9 insect cells grown on 2H,15N-labeled yeast extract (see 
Materials and Methods). B Isotopologue distributions of individual amino acids. The isotope shift indicates the 
number of labeled nitrogen atoms (red) or aliphatic deuterons (grey) in the amino acid including the fully 
unlabeled species (isotope shift of 0).  
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Compared to the 2H,15N-labeled yeast extract (Chapters 2.1, Table S1), an average 
reduction of deuteration level by ~9 % was apparent for the essential amino acids F, I, K, L, 
M, T, and V (Figure 2.1B, grey bars). As metabolic scrambling is limited to non-essential 
amino acids (Chapter 1.3), such a reduction in the overall deuteration level was likely caused 
by a completely unlabeled fraction of essential amino acids. In the case of 15N labeling, the 
overall incorporation was reduced to 90 % (Figure 2.1A, red bars). In the absence of further 
metabolic scrambling, a similar decrease would be expected for the deuteration. However, the 
observed 55 % deuteration is significantly lower than this value. To further investigate this 
effect, a mass spectrometric analysis of the initial level of deuteration in the deuterated yeast 
extracts has to be performed in further experiments. 
 
Analysis of 2H incorporation for growth of insect cells on perdeuterated algal extracts  
The 2H incorporation depends on the initial level of deuteration in the labeled extract, 
which was so far prepared by autolysis of yeast grown on D2O but not using any other 
deuterated ingredients (see Chapter 2.1). As a result, an average 2H incorporation of 75 % 
was obtained for such an extract. Thus, it may be possible to increase the deuteration in insect 
cells using perdeuterated yeast extracts, which requires growth of yeast in fully deuterated 
growth media.  
Alternatively, commercial perdeuterated algal extracts (D-ISOGRO, Sigma-Aldrich) can 
be employed as a source of highly deuterated amino acids in insect cells (39). To test whether 
deuteration in insect cells may be further increased using perdeuterated algal extracts, isotope 
incorporation was first analyzed on the free amino acids in 2H-labeled algal extracts using 
mass spectrometry. The overall deuteration in these extracts was computed using the 
weighted average for all detected amino acids (Figure 2.2A, blue bars) and amounts to 
94.7 %. This is slightly lower compared to the expected deuteration level of 98.5 % 
according to the supplier’s information. In most of the cases, the average deuteration of the 
single amino acids exceeded 90 %. However, deuterium labeling of histidine and tyrosine 
was significantly lower, amounting to only 83.6 % and 73.7 %, respectively. 
The analysis of isotopologue pattern for each amino acid in the perdeuterated algal extract 
(Figure 2.2B, blue bars) indicated very high levels of deuterium incorporation corresponding 
to the expected shift based on the non-exchangeable aliphatic sites of the individual amino 
acid. Compared to the isotopologue patterns observed for only partially deuterated amino 
acids obtained by hydrolysis of 2H,15N-labeled cAbl, low levels of residual protonation were 
observed, which are caused by growth of algal cells on D2O with a typical deuteration level 
of 99.8 %. This slightly increases the residual protonation of amino acids with long aliphatic 
or complex side chains such as isoleucine, arginine or phenylalanine according to a binomial 
distribution. Furthermore, only partial deuteration of histidine (Figure 2.2B, H) and tyrosine 
(Figure 2.2B, Y) was observed in the perdeuterated algal extracts. It is very unlikely that only 
two amino acids are partially deuterated in an otherwise perdeuterated algal extract prepared 
by growth of algal cells in D2O for several generations. Therefore, back-protonation of 
histidine and tyrosine has possibly occurred during acid hydrolysis of the protein or during 
the subsequent derivatization step. To test whether this effect is caused by hydrolysis of the 
protein, direct analysis can be performed on 2H5-histidine and 2H7-tyrosine, which are 
available from commercial suppliers. It is expected that the same effect was present in the 
analysis of H and Y obtained by acid hydrolysis of 2H,15N-labeled cAbl. 
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In the next step, incorporation of deuterium was investigated using the green fluorescent 
protein (GFP) expressed in Sf9 insect cells using 8 g/L 2H-labeled algal extract and 1 g/L 
1H-glutamine (see Chapter 4). Again, the purified protein was subjected to acid hydrolysis 
and pre-column derivatization prior to LC/MS analysis. Consequently, similar considerations 
apply for the recovery and analysis of certain amino acids (C, D, E, I, L, and W) as described 
above. Most notably, the overall deuteration level was significantly reduced to 53.4 %, which 
is only slightly higher than the level obtained for 2H,15N-labeled cAbl (49.3 %). The weighted 
average incorporation of individual amino acids also indicated differential back-protonation 
(Figure 2.2A, green bars) and the overall deuteration pattern of the amino acids obtained by 
hydrolysis of 2H-labeled GFP resembles the one observed for 2H,15N-labeled cAbl 
(Figure 2.1A, grey bars). This hints at metabolic scrambling irrespective of the expressed 
protein. Again, differential incorporation of deuterium was observed based on the amino acid 
type. In particular, a substantial reduction in the deuteration level to 4 %, 0.4 %, and 1.5 %, 
was observed for the non-essential amino acids alanine, aspartate, and glutamate, respectively 
(Figure 2.2A, green bars). For expression of 2H-labeled GFP, cultures were grown on dropout 
media containing 5 g/L glucose and 1 g/L glutamine, which provide protonated carbon 
scaffolds for biosynthesis of A, D, and E (Chapter 1.3). Therefore, metabolic scrambling may 
explain the significant reduction of the 2H incorporation for these amino acids. In the original 
protocol (Chapter 2.1), the use of deuterated glucose has been explored, but no improvement 
was obtained. This suggests that glutamine is the major source of the protonated carbon 
scaffold and deuteration of glutamine is likely to increase deuteration in insect cells.  
The distribution of the 2H isotopologues was analyzed for each amino acid obtained by 
hydrolysis of 2H-labeled GFP (Figure 2.2B, green bars) indicating that in all amino acids one 
fraction was completely protonated. Although back-protonation of single aliphatic sites was 
observed, its contribution to the dilution of isotope label was insignificant. Whereas in most 
cases only the fully protonated isotopologue was detected, significant changes were observed 
for A, D, E, G, and S (Figure 2.2B, green bars). As discussed above, these non-essential 
amino acids are subjected to significant metabolic scrambling involving important 
anaplerotic and housekeeping reactions in insect cells (Chapter 1.3). 
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Figure 2.2 Amino acid-resolved incorporation of deuterium analyzed by mass spectrometry. A Weighted 
average deuteration of single amino acids determined by direct analysis of the free amino acids in 2H-labeled 
algal extract (blue) and by acid hydrolysis of 2H-labeled GFP (green) expressed in Sf9 insect cells grown on 2H-
labeled algal extract (see Materials and Methods). B Isotopologue distribution for individual amino acids in 2H-
labeled algal extract (blue) and amino acids obtained by acid hydrolysis of 2H-labeled GFP (green). The isotope 
shift indicates the number of aliphatic deuterons in the amino acid including the fully protonated species 
(isotope shift of 0). 
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Remarkably, the results obtained for perdeuterated algal extracts strongly correlate with 
the mass spectrometric analysis of the amino acids obtained by hydrolysis of 2H,15N-labeled 
cAbl. Moreover, the average incorporation of 2H was comparable for perdeuterated algal and 
partially deuterated yeast extracts. At first, this is counterintuitive, as the initial deuteration 
level is significantly higher in the perdeuterated algal extract (~95 %). However, analysis of 
the isotopologue distribution indicated that a major fraction of fully protonated amino acids 
was incorporated into the labeled proteins. In the case of 2H-labeled GFP, this protonated 
fraction was increased compared to 2H,15N-labeled cAbl. Furthermore, reduction of the 2H 
incorporation was also observed for essential amino acids, albeit less pronounced. As insect 
cells cannot synthesize such amino acids, this again hints at a cellular pool comprising all 
amino acids in their unlabeled form. Hence, the comparable level of deuteration may be 
explained by two reasons: (i) a different size of the amino acid pool due to metabolic 
variations of the insect cell and (ii) the relative amount of amino acids provided to the growth 
medium by supplementation of the cellular extracts. 
In a recent protocol, high deuteration levels of ~76 % were reported using isotope-labeled 
algal extracts (39). However, the protocol also uses 15N-labeled ammonium salt to avoid 
supplementation of labeled glutamine. When glutamine is not present in the growth medium, 
insect cells synthesize glutamine from glutamate and ammonium by activity of glutamine 
synthetase (35). Consequently, deuterated glutamine can be formed using deuterated 
glutamate, which is highly abundant in the commercial algal extracts (Chapter 4). 
 
Conclusions and perspectives 
A mass spectrometric approach was established to study the isotope incorporation of 
isotope-labeled proteins expressed in insect cells. The method enables simultaneous analysis 
of different isotopes such as 2H and 15N at the single amino acid level. It was shown that the 
results obtained by mass spectrometric analysis were in good agreement with the NMR data 
described in Chapter 2.1. The data hints at a significant dilution of the isotope label due to a 
cellular pool of unlabeled amino acids, which caused an overall decrease of the labeling. 
Remarkably, incorporation of 15N was homogenous for all amino acids, whereas the level of 
deuteration was strongly dependent on the amino acid type. The cellular pool of amino acids 
may be further studied in insect cell cultures, which are continuously grown on dropout 
media supplemented with isotope-labeled yeast extract. Isotope labeling for individual amino 
acids may then be determined within the cell in comparison to the medium at several time 
points.  
Substantial back-protonation was predominantly observed for non-essential amino acids, 
most notably for alanine, glutamate, and aspartate. This may be related to the use of 
protonated glucose or glutamine, as their concentrations exceed those of the deuterated amino 
acids provided by supplementation of the cellular extracts. It is hoped that further insights 
into metabolic scrambling and label dilution can be obtained by mass spectrometric analysis, 
which may then be used to guide optimization of the existing labeling protocols (39, 98) and 
increase the level of deuteration. 
In the next step, uniform labeling by 13C will be analyzed using 13C-labeled yeast and algal 
extracts (Chapter 2.1 and Chapter 4). This may be further combined with the use of 
13C-glucose to estimate the metabolic scrambling of the glucose carbon scaffold. It is well 
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known that 13C is scrambled into several non-essential amino acids. However, so far the 
analysis has only been performed on the whole protein using mass spectrometry (13). 
The method can also be applied to investigate isotope incorporation for labeling schemes 
using a single labeled amino acid in an otherwise unlabeled growth medium. In particular, 
metabolic scrambling of glutamine has to be explored using 13C- and possibly 2H-labeled 
glutamine in further experiments. Selectively deuterated glutamine can be obtained by 
enzymatic synthesis as described in Chapter 5.  
Finally, mass spectrometric analysis may be used to identify differences in the label 
incorporation between permanent cultures and cultures infected with the baculovirus. Recent 
metabolic analysis hints at a change of amino acid utilization upon infection (96). As 
expression is driven by very late viral promoters and occurs only after several hours post 
infection, additional exchange steps in labeled growth medium may be performed to 
overcome some of the observed limitations. 
 
Materials and Methods 
Uniform isotope labeling in insect cells 
Detailed protocols are presented in Chapter 2.1. 
 
Purification of isotope-labeled cAbl and trGFPuv 
Detailed protocols are presented in Chapter 2.1 
 
Acid hydrolysis of proteins 
Free amino acids were obtained by acid hydrolysis of 1-10 μg of purified protein using the 
analysis service of the Functional Genomics Center Zurich (FGCZ, Zurich). 
 
Pre-column derivatization of free amino acids 
Detailed protocols are presented in Chapter 2.1 
 
LC-MS/MS analysis of free amino acids 
Following derivatization, 0.5 μg of each sample was dissolved in solvent A (2 % 
acetonitrile, 0.15 % formic acid) and subjected to LC-MS analysis using a dual pressure 
LTQ-Orbitrap Elite mass spectrometer connected to an electrospray ion source (Thermo 
Fisher Scientific) as described recently (102) including minor modifications. Peptide 
separation was performed on an EASY nLC-1000 system (Thermo Fisher Scientific) 
equipped with a RP-HPLC column (75 μm × 13 cm) packed in-house with 1.9 μm ReproSil-
Pur 120 C18–AQ resin (Dr. Maisch GmbH) applying a linear gradient from 95 % solvent A 
and 5 % solvent B (98 % acetonitrile, 0.15 % formic acid) to 50 % solvent B over 15 min at a 
flow rate of 0.25 μl min-1. The data acquisition mode was set to obtain one high resolution 
MS scan in the FT part of the mass spectrometer at a resolution of 240,000 full width at half-
maximum (at m/z 400) followed by MS/MS scans in the linear ion trap of the 10 most intense 
ions using a collision energy of 25 %. Charged state screening was applied to exclude 
unassigned charged ions using a dynamic exclusion duration of 15 s. Ion accumulation times 
were set to 300 ms (MS) and 50 ms (MS/MS), respectively.  
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Organization of the chapter 
The first section (Chapter 3.1) describes the initial design of a thermostabilized mutant of 
the turkey β1-adrenergic receptor (TS-β1AR) for expression and isotope labeling in insect 
cells and its characterization. Thermostabilization was optimized as a combination of 
previously established mutants for solution NMR studies.  
The following section (Chapter 3.2) is a reprint of the original publication Isogai, Deupi, 
Opitz et al. (103), which describes the use of TS-β1AR in combination with 15N-valine 
labeling to study the response of the receptor upon binding of six distinct ligands at high 
resolution. Further, the influence of thermostabilization was investigated by reverting 
mutations towards the wild type sequence based on the fully stabilized receptor. Finally, the 
last section (Chapter 3.3) reports an approach to backbone assignment using high-quality 15N-
edited NOESY spectra obtained on a 2H,15N-labeled TS-β1AR expressed in insect cells, 
which were grown on 2H,15N-labeled yeast extracts as described in Chapter 2.1. 
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3.1 Rational design of a turkey β1-adrenergic receptor mutant for 
NMR studies 
 
Introduction 
G-protein coupled receptors (GPCRs) are a physiologically important class of integral 
membrane proteins, which transduce extracellular signals to the intracellular environment. 
Numerous efforts have been made to study structure and function of GPCRs. However, the 
low stability of wild type receptors often precludes structural studies of their native form. 
Hence, virtually all crystallographic approaches to structure determination of GPCRs rely on 
extensive engineering to obtain stabilized receptors (104). Whereas ligand binding is still 
observed in these studies and used to further stabilize GPCRs for crystallization, active 
signaling of the receptor may be strongly reduced such as for the stabilized β1-adrenergic 
receptor (β1AR) (105, 106). 
Recent technical progress in NMR spectroscopy has allowed to study ligand binding to 
eukaryotic GPCRs (29, 41, 107) and more impressively to determine the structure of the 
chemokine receptor CXCR1 (108). However, so far the contribution of NMR to characterize 
dynamics of eukaryotic receptors has been limited to very selective information obtained by 
labeling of amino acid side-chains (41, 107, 109). This is largely due to the difficulties of 
isotope labeling in eukaryotic expression systems used to obtain an active form of the 
receptor. Moreover, solubilization of GPCRs relies on membrane mimics increasing the 
overall size of these complexes to the practical limit of solution state NMR. 
This chapter describes an approach to thermostabilization of the β1-adrenergic receptor 
(β1AR) for NMR spectroscopic analysis in solution. Rational design of the construct followed 
previous approaches utilized in crystallographic studies (103, 105, 110). Expression of the 
mutant receptor (TS-β1AR) was established in insect cells. Moreover, the stability of the TS-
β1AR was analyzed by a microscale thermal shift assay indicating a melting temperature of 
57 °C, which corresponds to an increase by 31 °C compared to the wild type receptor (104, 
110) and is highly beneficial for NMR studies. 
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Results and Discussion 
Thermostabilization of β1AR for NMR studies 
Rational design of a thermostabilized β1AR (TS-β1AR) for NMR studies was based on 
mutations used in two recent crystallographic studies (Figure 3.1) (105, 110). The stabilized 
turkey β1AR44-m23 mutant contains eight thermostabilizing mutations, namely R68S, 
M90V, C116L, Y227A, A282L, F327A, F338, and C358A (Figure 3.1, orange residues). The 
C116L point mutation was reported to increase the yield of purified receptor, whereas C358A 
removes the C-terminal palmitoylation site to aid in crystallization. All remaining mutations 
were shown to increase the thermostability of the receptor to a different extent (111), which 
eventually increased the melting temperature by 21 °C over the native β1AR. Moreover, none 
of these mutations is directed at amino acids essential to ligand binding (Figure 3.1, purple 
residues) but significantly decreased the affinity for agonists such as isoprenaline (111). In 
contrast, this effect was less pronounced for binding of antagonists, which infers stabilization 
of the receptor in the inactive state (106, 111). β1AR44-m23 is further truncated at both 
termini (Δ3-32 and Δ369-483) and the intracellular loop ICL3 (Δ243-270 and Δ247-278). 
Whereas truncation of the N-terminus prevents proteolysis, truncation of ICL3 leaves the 
loop still flexible and allowed to obtain agonist-bound β1AR structures (112). Incorporation 
of the C-terminal hexahistidine tag allows purification of the receptor by Ni-NTA affinity 
chromatography. 
Based on β1AR44-m23 (105), three additional mutations I129V, D322K, and Y343L 
(Figure 3.1, blue residues) reported for the ultra-stable mutant β1AR-JM3 (110) were added 
by site-directed mutagenesis. The point mutation I129V alone has been shown to increase the 
melting temperature of the receptor by about 2 °C. A more pronounced increase of about 
5 °C has been achieved by the aspartate mutation D322K. Similarly, the point mutation 
Y343L has improved the thermal stability by 5 °C, which has been identified as the key 
stabilizing mutation for engineering of β1AR-JM3 (110). Furthermore, the neutral mutation 
D200E was introduced, which is involved in the formation of a salt bridge to K322 and was 
reported to yield an increase in the melting temperature of β1AR-JM3 in the short-chain 
detergent n-nonyl-β-D-glucopyranoside (NG) by 4.7 °C and by 6.2 °C in n-dodecyl-β-D-
maltopyranoside (DDM) (110). Short-chain detergents are advantageous for solution state 
NMR due to a relatively small size of the solubilized receptor complex. However, β1AR-JM3 
solubilized in NG displayed a melting temperature of 35 °C, which was significantly lower 
compared to a melting temperature of 62 °C obtained for the DDM-solubilized receptor. 
Therefore, use of short-chain detergents is very likely not beneficial for NMR studies in 
solution.  
When combined, the four mutations I129V, D200E, D322K, and Y343L were shown to 
increase the melting temperature of β1AR44-m23 by 10 °C (110), which corresponds to an 
overall increase by 31 °C compared to the wild type sequence. However, these 
thermostabilizing mutations further reduce the binding affinity of TS-β1AR for several 
agonists. In particular, Ki values determined for the agonist isoprenaline increased from about 
17 nM in β1AR44-m23 to 80 nM caused by the point mutations I129V, D322K and Y343L 
(110). This trend was similar for the agonist noradrenaline but less pronounced for the 
antagonists cyanopindolol and alprenolol (110). 
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Figure 3.1 Topology and thermostabilization of β1AR. Residues are color-coded as follows: binding site in 
purple, mutations in β1AR44-m23 (105, 106) in orange and mutations in TS-β1AR in blue. Two distinct 
disulfide bridges are drawn as solid lines, whereas the salt bridge introduced by D322K and the neutral mutation 
D200E is shown as a dashed line. The red lines indicate truncations given by the residue numbers followed by 
the Δ. 
 
Expression of TS-β1AR in insect cells 
The expression of TS-β1AR in Sf9 insect cells was tested by preparation of the membrane 
fraction and subsequent solubilization in 1.5 % n-decyl-β-D-maltopyranoside (DM) without 
further purification. Figure 3.2 shows the separation of this solubilized fraction using a 
denaturing polyacrylamide gel electrophoresis (PAGE). However, identification of TS-β1AR 
was hindered by the high background intensity, which was possibly caused by the high 
amount of DM. Western blot (WB) analysis revealed two prominent bands with an apparent 
molecular weight close to 25 kDa (Figure 3.2, WB) indicating “gel shifting” as compared to 
the expected 35.9 kDa, which is characteristic for membrane proteins and may originate from 
the interaction of the protein with sodium dodecyl sulfate (113). The reasons for the sample 
heterogeneity are currently unclear. The heterogeneity may result from degradation of the 
receptor by proteolysis. Typically, this is counteracted by using protease inhibitors during 
purification but may also be caused by the activity of proteases, which are insensitive to this 
treatment. Furthermore, as the posttranslational modifications sites of the wild type sequence 
have been removed in β1AR44-m23 by the point mutation C358A of the single 
palmitoylation site (105, 106) and truncation of the N-terminus (Δ3-32) to impede canonical 
N-linked glycosylation (106), sample heterogenity cannot be caused by these modifications. 
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However, the heterogeneity was eventually removed following purification by using an 
alprenolol-affinity chromatography step to select for active conformations of the receptor 
(103).  
 
 
Figure 3.2 Expression of TS-β1AR in Sf9 insect cells. Membrane 
fractions were solubilized in 1.5 % n-decyl-β-D-maltopyranoside 
and separated from insoluble material by centrifugation 
(see Materials and Methods). The soluble fraction was separated 
using SDS polyacrylamide gel electrophoresis (PAGE) and 
subsequently analyzed by Western blotting (WB). The first lane 
contains a molecular weight marker. TS-β1AR was detected using an 
antibody specific for the C-terminal hexahistidine-tag. 
 
Thermal shift assay of TS-β1AR 
To further characterize the engineered construct, thermal stability of TS-β1AR expressed 
in insect cells was analyzed by a microscale fluorescent stability assay. This assay utilizes the 
thiol-specific fluorochrome N-[4-(7-diethylamino-4-methyl-3-coumarinyl)phenyl]maleimide 
(CPM) to probe temperature-induced unfolding of GPCRs in the presence of detergents 
(114). CPM contains a thiol-reactive maleimide moiety that covalently binds to free cysteine 
residues. Thermal unfolding exposes hydrophobic cysteine residues to the solvent, which are 
typically buried in the tightly packed inter-helix space of the receptor. Covalent binding to 
these exposed thiol groups forms intensely fluorescent thiol adducts, whereas the unbound 
molecule is essentially nonfluorescent (115).  
Thermal unfolding of TS-β1AR in 1 % n-decyl-β-D-maltopyranoside (DM) indicated a 
melting temperature of 57 °C (Figure 3.3), which is slightly higher than the melting 
temperature of 53 °C reported for β1AR-JM3 (110). However, the determined melting 
temperatures vary considerably with respect to the utilized assay. Thermostability of 
β1AR‑JM3 has been analyzed using prolonged incubation times (30 min) at the desired 
temperatures (110). In contrast, the applied heating rate strongly influences the melting 
temperatures determined by the CPM assay. Furthermore, β1AR-JM3 was shown to be 31 °C 
more thermostable compared to the wild type receptor (110). It is expected that a similar 
increase of the melting temperature can be assumed for TS-β1AR based on the sequence 
homology of both stabilized receptors. 
In addition, thermal stability was studied on a mutant of TS-β1AR, for which the point 
mutation Y343L in the NPxxY motif of TM7 was reverted to the native tyrosine residue of 
the wild type receptor (TS-β1AR-L343Y, Figure 3.3). The residue Y343 has been linked to 
G protein activation (105, 116, 117) and has been identified as a key residue for signal 
transduction in β1AR only recently (103). Remarkably, the less stabilized mutant 
TS‑β1AR‑L343Y solubilized in 1 % DM displayed a melting temperature of 53.5 °C, which 
is still considerably high for the apo receptor. Thermostabilization by Y343L may be related 
to the loss of a single water molecule close to the NPxxY motif as observed for the crystal 
structure of the ultra-stabilized β1AR-JM3 (106, 110). 
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Finally, the increase in the observed melting temperatures of TS-β1AR-L343Y and 
TS-β1AR relative to the wild type receptor agrees well with the trend of thermostabilization 
reported in recent crystallographic studies of β1AR (110, 112). The obtained improvement of 
the thermal stability is the basis for studies of these mutants by NMR. 
 
 
Figure 3.3 Temperature-induced unfolding of mutant receptors. Melting curves are shown for apo forms of 
TS-β1AR and reverse mutant TS-β1AR-L343Y obtained for 1 μg of receptor in 20 mM TRIS (pH 7.5), 0.1 % 
DM, and 350 mM NaCl. Thermal stability was probed by the thiol-specific fluorochrome CPM in a real-time 
PCR cycler using a heating rate of 2 K/min. The melting temperature was determined as the zero crossing of the 
computed first derivative of the melting curve (data provided by Shin Isogai). 
 
Further development 
In this section, a thermostabilized mutant (TS-β1AR) of the β1-adrenergic receptor has 
been derived based on previously utilized approaches for crystallization studies. Melting 
temperatures as high as 57 °C have been obtained. 
The TS-β1AR was used for an extensive NMR analysis described in the following section 
(Chapter 3.2). Labeling with 15N-valine enabled backbone chemical shift analysis of the 
thermostabilized receptor to investigate the allosteric signaling network of the receptor and to 
test for G protein activation. The initial constructs of TS-β1AR were then further used to 
assess the effect of thermostabilization on the biological activity of the receptor by reverting 
the introduced mutations towards the native sequence.  
In the final section (Chapter 3.3), expression of 2H,15N-labeled TS-β1AR in insect cells is 
described for backbone resonance assignments based on 3D 15N-edited NOESY experiments. 
Very high spectral quality enabled the initial assignment of a consecutive stretch of residues, 
which is involved in signal transduction of the receptor upon ligand binding. 
 
Material and Methods 
Cloning of the thermostabilized β1-adrenergic receptor  
A pFastBac vector containing β1AR44-m23 (105) was originally provided by Professor 
Gebhard Schertler (PSI, Villigen, Switzerland). Additional thermostabilizing mutations were 
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introduced by site-directed mutagenesis using the primers given in Table 3.1. The 
mutagenesis protocol was adapted from the commercial QuikChange method (Agilent). 
 
Table 3.1 List of primers used for mutagenesis of the β1-adrenergic receptora 
 Forward and reverse primer 
I129V 5’-AAG CGT GGA GAC CTT GTG CGT CAT C 5’-GTC TCC ACG CTT GCC GTC ACG CAA A 
D200E 5’-GCT GCG AAT TTG TCA CCA ACC GGG CTT 5’-ACA AAT TCG CAG CAG CCC GGG TCC T 
D322K 5’-TGC CGA AAT GGC TCT TCG TTG CCT T 5’-AGC CAT TTC GGC ACC AGA TCT CTG TT 
Y343L 5’-TCA TCC TCT GCC GCA GCC CAG ACT T 5’-CGG CAG AGG ATG ATG GGG TTC ATA G 
a Bases modified with respect to the β1AR44-m23 sequence are indicated in bold 
 
The finale TS-β1AR construct confirmed by Sanger DNA sequencing (MicroSynth AG, 
Switzerland) was 
 
MGAELLSQQWEAGMSLLMAL VVLLIVAGNVLVIAAIGSTQ RLQTLTNLFITSLACADLVV 
GLLVVPFGATLVVRGTWLWG SFLCELWTSLDVLCVTASVE TLCVIAIDRYLAITSPFRYQ 
SLMTRARAKVIICTVWAISA LVSFLPIMMHWWRDEDPQAL KCYQDPGCCEFVTNRAYAIA 
SSIISFYIPLLIMIFVALRV YREAKEQIRKIDRASKRKTS RVMLMREHKALKTLGIIMGV 
FTLCWLPFFLVNIVNVFNRD LVPKWLFVAFNWLGYANSAM NPIILCRSPDFRKAFKRLLA 
FPRKADRRLHHHHHH. 
 
Cell culture and preparation of recombinant baculovirus  
In general, handling and maintenance of Sf9 cell culture was based on established 
protocols (118). Permanent cultures were subcultured in mid-log phase and kept in full SF-4 
medium (Bioconcept) and Insect Xpress medium (Lonza) at 27 °C and shaken at 80 rpm. 
Recombinant Bacmid DNA was generated in DH10Bac E. coli cells using the commercial 
pFastBac vector according to the supplier’s procedure (Life Technologies). Baculovirus was 
generated in adherent cultures as reported by O’Reilly et al. (118). Subsequently, two 
additional amplification rounds in suspension cultures were employed to produce high-titer 
virus stocks for expression. In the first amplification round, 50 ml of Sf9 cell culture 
containing 1x106 cells/ml in serum-free medium were infected with recombinant virus and 
cultured until cell viability decreased to ≤90 %. The supernatant (P1) was collected by 
centrifugation at 1000g and 4 °C for 15 min. For the second amplification round, 100 ml of 
serum-free Sf9 cell culture containing 1x106 cells/ml was infected with P1 and processed 
accordingly to yield a P2 virus stock. The optimal P2 virus amount for expression was 
determined in small-scale cultures of Sf9 cells infected with P2 virus stock at a cell density of 
1.5x106 cells/ml in full SF-4 medium by varying the functional titer from 1 to 10 ml per 1 L 
of cell culture. 
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Expression and initial purification of TS-β1AR 
Expression was analyzed in membrane fractions prepared from small-scale cultures of Sf9 
cells infected with recombinant baculovirus containing TS-β1AR. Membranes were 
solubilized with 1.5 % n-decyl-β-D-maltopyranoside (Anatrace) in 20 mM TRIS (pH 7.8) 
and 400 mM NaCl and insoluble material was removed by ultracentrifugation at 50000g for 
1 h (4 °C). The remaining soluble fraction was seperated by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). TS-β1AR was detected by Western blotting 
using an antibody specific for the C-terminal hexahistidine tag. Complete purification of 
TS-β1AR for NMR analysis is presented in Chapter 3.2.  
 
Thermal shift assay of mutant receptors 
Thermal stability analysis of TS-β1AR and TS-β1AR-L343Y was adapted from the 
recently established CPM-based microscale fluorescent assay (114). Briefly, melting curves 
were determined for 1 µg of purified apo receptor in a total volume of 65 µl in 20 mM TRIS 
(pH 7.5), 0.1 % DM, and 350 mM NaCl. Assays were performed in a real-time PCR cycler 
(Rotor-Gene Q, QIAGEN) using a ramp rate of 2 K/min. The melting temperature was 
determined as the inflection point of the melting curve by computing the first derivative. 
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3.2 Backbone NMR reveals allosteric signal transduction networks 
in the β1-adrenergic receptor 
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Backbone NMR reveals allosteric signal transduction 
networks in the β1-adrenergic receptor
Shin Isogai1, Xavier Deupi2, Christian Opitz1, Franziska M. Heydenreich2, Ching-Ju Tsai2, Florian brueckner2,  
Gebhard F. X. Schertler2,3, Dmitry b. Veprintsev2,3 & Stephan Grzesiek1
G protein-coupled receptors (GPCRs) are physiologically important 
transmembrane signalling proteins that trigger intracellular 
responses upon binding of extracellular ligands. Despite recent 
breakthroughs in GPCR crystallography1–3, the details of ligand-
induced signal transduction are not well understood owing to 
missing dynamical information. In principle, such information can 
be provided by NMR4, but so far only limited data of functional 
relevance on few side-chain sites of eukaryotic GPCRs have been 
obtained5–9. Here we show that receptor motions can be followed 
at virtually any backbone site in a thermostabilized mutant of 
the turkey β1-adrenergic receptor (β1AR)10–12. Labelling with 
[15N]valine in a eukaryotic expression system provides over twenty 
resolved resonances that report on structure and dynamics in six 
ligand complexes and the apo form. The response to the various 
ligands is heterogeneous in the vicinity of the binding pocket, but 
gets transformed into a homogeneous readout at the intracellular 
side of helix 5 (TM5), which correlates linearly with ligand 
efficacy for the G protein pathway. The effect of several pertinent, 
thermostabilizing point mutations was assessed by reverting them to 
the native sequence. Whereas the response to ligands remains largely 
unchanged, binding of the G protein mimetic nanobody NB80 
and G protein activation are only observed when two conserved 
tyrosines (Y227 and Y343) are restored. Binding of NB80 leads to 
very strong spectral changes throughout the receptor, including 
the extracellular ligand entrance pocket. This indicates that even 
the fully thermostabilized receptor undergoes activating motions 
in TM5, but that the fully active state is only reached in presence 
of Y227 and Y343 by stabilization with a G protein-like partner. 
The combined analysis of chemical shift changes from the point 
mutations and ligand responses identifies crucial connections in the 
allosteric activation pathway, and presents a general experimental 
method to delineate signal transmission networks at high resolution 
in GPCRs.
A thermostabilized, detergent-resistant mutant of β1AR10–12 
(TS-β1AR; see Methods) was selectively labelled with [15N]valine and 
produced in insect cells without further chemical modifications. Its 
28 valine residues are homogeneously distributed across the receptor 
(Extended Data Fig. 1) at locations suitable to sense ligand binding 
and receptor activation. Although resonances of main chain atoms 
are considerably more difficult to observe than those of mobile side 
chains of surface residues, they are expected to be better reporters of 
functional, long-range backbone motions. We succeeded to obtain 
well-resolved TROSY (transverse relaxation-optimized spectroscopy) 
spectra of the valine 1H–15N backbone resonances of detergent- 
solubilized TS-β1AR in its apo form and in complexes with six ligands 
(Extended Data Fig. 1) ranging in their efficacy from antagonists to 
agonists (Extended Data Table 1). Despite the absence of deuteration 
and very short T2 relaxation times (~4 ms for 1HN), 26 valine reso-
nances could be observed with sufficient sensitivity and resolution. 
Distinct and reversible chemical shift changes were detected for 
many valines after ligand exchange. 16 valines were assigned unam-
biguously and 5 tentatively using spectra from 18 point mutants, as 
well as further spectral and structural information (Extended Data 
Table 2).
Many valine residues in the vicinity of the ligand binding pocket 
could be assigned, showing chemical shift changes that report on the 
ligand functional groups (Fig. 1). Remarkably, residue V172(4.56) 
(the number in parenthesis corresponds to the Ballesteros–Weinstein 
numbering system13), which is located close to the ligand aromatic 
head group, exhibits an unusual 15N chemical shift of ~105–110 p.p.m. 
(Extended Data Figs 1, 2 and Fig. 1c). This anomaly seems caused by a 
distorted backbone geometry, which is presumably conserved among 
adrenergic receptors and results from a missing hydrogen bond to the 
proline at position 176(4.60) (Extended Data Fig. 2). Instead, the car-
bonyl of V172(4.56) participates in a water-mediated hydrogen bond 
network, which connects the ligand binding site, TM3, TM4, TM5, and 
TM612,14. Seemingly as a result of these interactions, the V172(4.56) 
1H–15N resonances cluster according to the substitution patterns of 
the ligand head group (Fig. 1c): one cluster is observed for the partial 
agonists/antagonists cyanopindolol, alprenolol and carvedilol, which 
have larger head groups with ortho- and/or meta-substitutions; a sec-
ond cluster is observed for the agonists isoprenaline and dobutamine, 
which bear a meta- and para-substituted catechol ring. We attribute 
the distinct chemical shifts for isoprenaline or dobutamine to the loss 
of a coordinated water caused by specific hydrogen bond interactions 
between their catechol moieties and the side chain of S215(5.461) 
(Extended Data Fig. 2d).
Remarkably, the resonance positions of V172(4.56) in complex 
with the antagonist atenolol strongly differ from the already described 
complexes and the apo form: considerable 1HN (>0.4 p.p.m.) and 15N 
(>4 p.p.m.) upfield shifts indicate, respectively, a further weakening 
of the main chain hydrogen bond V172(4.56)HN···I168(4.52)O and a 
stronger kink of the backbone. This rearrangement seems caused by 
the insertion of the para-acetamide group of the ligand head between 
residues S215(5.461) and V172(4.56) (Extended Data Fig. 2d). This 
will lead to a substantial disruption of the TM3–TM4–TM5 inter-
face, thereby precluding receptor activation, in agreement with aten-
olol’s inverse agonist pharmacology. Thus, the amide chemical shifts 
of V172(4.56) constitute a very sensitive readout for the state of this 
water-mediated, inter-helical activation switch.
The 1H–15N chemical shifts of further residues in the vicinity of 
the binding pocket report on additional characteristics of the ligands. 
V314(6.59) and V202(ECL2) are located at the extracellular surface 
of the receptor in a “vestibule” next to the entry/exit pathway of the 
orthosteric binding site15,16. The resonances of these residues are either 
severely broadened or undetectable in the absence of ligands, whereas 
they are observable in the presence of ligands (Fig. 1d and Extended 
Data Fig. 3). A line shape analysis for V314(6.59) (Extended Data Fig. 4) 
1Focal Area Structural Biology and Biophysics, Biozentrum, University of Basel, CH-4056 Basel, Switzerland. 2Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland. 3Department of Biology, 
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indicates that this extracellular part of the receptor undergoes micro- 
to millisecond motions in the apo form, which are quenched by ligand 
binding. This is consistent with results on β2AR, which suggest that 
high-affinity ligands stabilize the conformation of ECL2 and ECL35. 
The ligand-induced shifts of the V314 resonance correlate strongly 
(r2 = 0.95) with the reported ligand affinity17 (Fig. 1d). Interestingly, 
the resonances of V314(6.59) in the apo form and in high-affinity 
ligand complexes are very close. This may indicate that the high- 
affinity ligand complexes mimic the average apo conformation. 
Finally, the 1H–15N chemical shifts of V125(3.36) at the bottom of the 
binding site and of V103(2.65) close to the ligand tail reveal additional 
trends (Fig. 1e): the chemical shifts of V125(3.36) correlate with the 
depth of ligand insertion towards the central part of TM3 (r2 = 0.81), 
whereas those of V103 correlate with the volume of the ligand tail 
(r2 = 0.90).
Compared to inactive β2AR, complexes of activated β2AR with either 
G protein2 or the G protein-mimicking nanobody NB809,18 show large 
movements at the intracellular sides of TM5, TM6 and their interven-
ing loop ICL3, which form the binding site for the G protein. These 
conformational changes are expected to be conserved throughout the 
GPCR family19. Four valine residues could be assigned in this region 
of TS-β1AR: V226(5.57), V230(5.61), V280(6.25), and V298(6.43) 
(Fig. 2). In contrast to the chemical shift changes in the vicinity of the 
ligand binding pocket, which depend strongly on the ligand chemistry, 
the shifts of the TM5 residues observed in this region report on ligand 
efficacy. This effect is most prominent for residue V226(5.57), for which 
the 1H–15N resonances fall on one line from antagonists to agonists 
(Fig. 2a). The chemical shifts for the different ligands correlate very 
strongly (r2 = 0.89) with their reported17 efficacies for Gs signalling 
(Extended Data Table 1). This highly linear effect suggests that the 
receptor filters the diverse input signals from the various ligands to 
a unified and precise structural response on TM5, which can be read 
out by the chemical shifts of V226(5.57). Interestingly, the V226(5.57) 
atenolol peak is situated at a position corresponding to lower efficacy 
than for the apo receptor. This gives direct structural evidence of aten-
olol’s inverse agonist action, which reduces the activation relative to the 
basal level of the apo receptor.
Current high-resolution structures of β1AR do not show significant 
changes between antagonist- and agonist-bound forms (Fig. 2b). The 
decrease of the V226(5.57) 1HN chemical shift by about 0.2 p.p.m. 
from the agonist isoprenaline to the antagonist atenolol indicates a 
lengthening of the V226(5.57)-HN···I222(5.53)-O hydrogen bond by 
about 0.05 Å (ref. 20). This small, but clearly NMR-detectable length 
variation is below the resolution limit of current GPCR structures 
(Supplementary Text 1), but may indicate the start of TM5 bending 
towards the active conformation as observed in the G protein-bound 
form of β2AR (Fig. 2b). Remarkably, this response to agonists occurs 
even in the thermostabilized receptor TS-β1AR. Albeit reduced in 
absolute size compared to V226(5.57), V230(5.61) displays similar 
linear chemical shift changes as a function of ligand efficacy for the 
Figure 1 | Ligand-induced 1H–15N chemical shift changes in the 
vicinity of the ligand binding pocket of β1AR. a, Partial view of the 
β1AR–carvedilol crystal structure (4AMJ) showing valine residues (blue 
spheres) in the vicinity (<8.5 Å) of the ligand (magenta sticks) binding 
site. b, Chemical structures of the β1AR ligands used in this study. Ligand 
affinities derived from whole-cell binding assays on the thermostabilized 
β36-m23 β1AR construct17 are indicated as pKD values. Similar pK values 
were measured for the TS-β1AR construct (Extended Data Table 1). c, Left, 
ligand-induced response of V172(4.56) 1H–15N resonances. The black bar 
represents a scale of 0.1 p.p.m. (1H) and 1 p.p.m. (15N). The labels o, m, p 
indicate ligands with ortho, meta, and para substitutions at the head group, 
respectively. c, Right, partial view of the β1AR–carvedilol structure (4AMJ) 
showing the interaction network connecting V172(4.56) to S215(5.461), 
P219(5.50), I129(3.40), and F299(6.44). d, Left, representation as c, left, for 
the 1H–15N resonances of V314(6.59). Centres of resonances are indicated 
by circles. d, Middle, correlation of a best-fit linear combination of the 
V314(6.59) chemical shifts (−49.3 δ1H + 2.02 δ15N + 133) to the ligand  
affinity pKD (Extended Data Table 1). d, Right, partial view of the 
carvedilol (red, 4AMJ), dobutamine (orange, 2Y01), cyanopindolol  
(green, 2VT4 B), and isoprenaline (blue, 2Y03) complex structures 
showing the ligand-induced movement of V314(6.59). e, Left, 
representation as d, left, for the 1H–15N resonances of V125(3.36) and  
V103(2.65). e, Middle, correlations of best-fit linear combinations of 
chemical shifts for V125(3.36) (−0.402 δ1H + 1.17 δ15N − 132) and 
V103(2.65) (−336 δ1H − 634 δ15N + 7.64·104) to the ligand insertion  
depths and tail volumes (Extended Data Table 1), respectively.  
e, Right, partial view of the carvedilol, dobutamine, cyanopindolol, and 
isoprenaline crystal structures (representation as d, right) showing the 
ligand-induced movement of V125(3.36), D121(3.32), and V103(2.65).
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Gs pathway (Fig. 2c). As this residue is located one helical turn further 
towards the cytoplasm, the detected conformational change is not just 
local, but spans a certain length in TM5.
Compared to V226(5.57) and V230(5.61) in TM5, the chemical 
shift response to ligands is much less pronounced for V298(6.43) and 
in particular V280(6.25) at the intracellular side of TM6 (Fig. 2c). 
This suggests that agonist binding to the TS-β1AR does not induce 
the large conformational change in TM6 observed in the activated 
β2AR–G protein2 or β2AR–NB8018 complexes. However, G protein 
activation upon agonist binding has been reported for other less 
thermostabilized β1AR constructs17, indicating that they can still be 
activated, albeit at low levels. Thus we reverted the mutations most 
likely to interfere with the activation mechanism in TS-β1AR, that is, 
I129(3.40)V in the connector switch15, Y227(5.58)A in TM521,22, and 
Y343(7.53)L in the NPxxY motif of TM714,22 to the native residues. 
These reverse mutants were then tested for G protein activation and 
the NMR response in TM6. A summary of the results is given in 
Extended Data Table 3. The original TS-β1AR, the single mutants 
TS-β1AR(V129I), TS-β1AR(A227Y), and TS-β1AR(L343Y) as well 
as the double mutant TS-β1AR(V129I/A227Y) showed no detecta-
ble G protein activation upon isoprenaline binding (Extended Data 
Fig. 5). However, G protein activation was detectable for the least 
thermostable TS-β1AR(A227Y/L343Y) double mutant (Tm reduced 
by 11 °C relative to TS-β1AR), which recovers the conserved tyrosines 
in TM5 and TM7 that are known to stabilize the active state of rho-
dopsin22. None of the reverse mutants showed major changes in the 
NMR spectra of various ligand complexes compared to the original 
TS-β1AR (Extended Data Fig. 6). In particular, residues V298(6.43) 
and V280(6.25) at the intracellular side of TM6 did not show an 
increased response to agonists. This is in agreement with recent DEER 
(double electron–electron resonance) and 19F-NMR data showing that 
agonists alone do not fully stabilize the active state of TM6 in β2AR9. 
Interestingly, the V129(3.40)I and the V129(3.40)I/A227(5.58)Y 
mutations shifted the 1H–15N resonances of V226(5.57) towards 
a more active (that is, bent) state of TM5 in both the atenolol- and 
isoprenaline-bound forms (Extended Data Fig. 6b), thereby given 
direct experimental evidence for an allosteric activation pathway 
spanning about 13 Å from I129(3.40) on TM3 to V226(5.57) on TM5.
With the exception of rhodopsin23, the stabilization of fully active 
GPCR conformations seems to require binding of an agonist and 
an intracellular partner8,9. Indeed, when both the agonist isoprena-
line and the G protein-mimicking nanobody NB8018 were added to 
TS-β1AR(A227Y/L343Y), very large chemical shift responses for many 
valine residues in TM3–TM6 were observed, whereas no change was 
observed for several valines in TM1, 2, and 7 (Extended Data Fig. 7). 
This very strong response extends even to the extracellular residue 
V314(6.59), providing evidence of a long-distance connection from 
the G protein binding site to the ligand entry site. The strong chemical 
shift changes are reverted when the partial agonist/antagonist cyano-
pindolol is added to the isoprenaline-TS-β1AR(A227Y/L343Y)–NB80 
complex. The spectrum then becomes identical to that of the ‘pure’ 
cyanopindolol–TS-β1AR(A227Y/L343Y) complex (Extended Data 
Fig. 7a), indicating that cyanopindolol replaces isoprenaline and 
causes the release of NB80. In agreement with the G protein activa-
tion data, the isoprenaline-bound original TS-β1AR and the mutants 
TS-β1AR(A227Y) and TS-β1AR(L343Y) did not show binding of NB80 
in the NMR spectra. Moreover, supplementing NB80 to the ultrastable 
TS-β1AR did not change its affinity for isoprenaline (Extended Data 
Fig. 7b), whereas it caused a hundred-fold affinity increase in the case 
of TS-β1AR(A227Y/L343Y) and the truncated native turkey β1AR 
receptor (tβtrunc)17. This increase is identical to data for β2AR18 and 
shows the energetic coupling between the NB80 and agonist binding 
also for β1AR.
In combination, these data prove that agonist binding, even in the 
absence of a G protein mimic, induces initial changes in the conforma-
tional equilibrium of TM5 towards the conformation observed in the 
G protein complex of β2AR. Remarkably, these rearrangements occur 
in all thermostabilized forms of β1AR. However, a full shift of the 
equilibrium towards such an active conformation, including allosteric 
Figure 2 | Correlation of ligand-induced chemical shift changes at the  
TS-β1AR intracellular side with Gs efficacy. a, Left, response of the 
V226(5.57) 1H–15N resonance to various ligands (colour coding as in Fig. 1). 
The centres of resonances are indicated by circles. The 1H–15N resonances 
fall on one line from atenolol (antagonist) over apo to alprenolol (partial 
agonist), carvedilol (antagonist), cyanopindolol (partial agonist), dobutamine 
(full agonist) and isoprenaline (full agonist). a, Right, correlation of a 
best-fit linear combination of the V226(5.57) chemical shifts (−515 δ1H 
−31.7 δ15N +8.41·103) in different ligand complexes to their efficacy for 
the Gs signalling pathway17. b, Left, overlay of TM5 and TM6 backbones of 
thermostabilized β1AR in antagonist- (blue, PDB code 4AMJ) and agonist-
bound (green, PDB code 2Y03) form. The agonist does not induce detectable 
helix movements. b, Right, TM5 and TM6 backbone movements upon 
activation in human β2AR. The overlay of inactive (blue, PDB code 2RH1) 
and G protein-bound β2AR (magenta, PDB code 3SN6) structures shows the 
large bend of TM6 along with the smaller conformational change of TM5 
upon activation. Hydrogen bonds 5.57-HN···5.53-O and 5.61-HN···5.57-O are 
indicated by dashes. According to the behaviour of the 1HN chemical shifts 
of V226(5.57) and V230(5.61) in TS-β1AR, these hydrogen bonds expand 
in an efficacy-dependent manner during agonist binding. c, Response of the 
1H–15N resonances for V226(5.57), V230(5.61), V298(6.43), and V280(6.25) 
to various ligands. For clarity, only the centres of resonances are depicted 
as circles with colour coding as in Fig. 1. The black bar represents a scale 
of 0.1 p.p.m. and 1 p.p.m. for the 1H and 15N chemical shifts, respectively. 
The schematic representation of the receptor indicates the locations of the 
respective valine residues at the cytoplasmic sides of TM5 and TM6 within 
the helical bundle of β1AR.
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changes at the extracellular side, occurs only when G protein or its 
mimetic NB80 is bound. This process requires the presence of both 
Y227(5.58) and Y343(7.53), which significantly reduce the thermal sta-
bility. Different active conformations may be reached for non-G protein 
effectors such as β-arrestin.
The possibility to detect NMR signals at many receptor sites in 
response to ligand binding and point mutations provides an experimen-
tal method to trace allosteric signalling paths. Figure 3 shows examples 
of these pathways, derived from the response to the ligands atenolol and 
isoprenaline and the single point mutations V129(3.40)I, A227(5.58)Y, 
and L343(7.53)Y. Choosing a cutoff of 0.05 p.p.m. for the resulting 
combined 1H, 15N chemical shift change (Fig. 3a, red line), long-
range (>10 Å) connections become evident throughout the receptor 
(Fig. 3b, c). Whereas detected ligand signals radiate broadly to almost 
all helices, the point mutants give evidence of smaller interaction net-
works connecting TM3 to TM4/5, TM5 to TM3/4/6, as well as TM7 
to TM2/3 (Fig. 3b, c). Interestingly, the TM2/TM7 network seems to 
be only weakly connected to the TM3–TM6 network. Together, these 
data provide experimental evidence at high resolution of an extensive 
signal transduction network that connects the ligand binding site to the 
intracellular sides of TM5, TM6, and TM7. Such a network of loosely 
coupled allosteric connections has been postulated previously for β2AR 
on the basis of molecular dynamics simulations24.
In summary, we have shown that highly resolved solution NMR 
backbone spectra can be obtained for a eukaryotic GPCR. The NMR 
observations delineate the allosteric signalling pathways and com-
prehensively connect many previous experimental and theoretical 
observations, which may ultimately allow to understand the dynamic 
mechanisms of GPCRs at the atomic level.
Online Content Methods, along with any additional Extended Data display items and 
Source Data, are available in the online version of the paper; references unique to 
these sections appear only in the online paper.
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β1AR constructs. The TS-β1AR mutant was derived from the turkey β1AR44-m23 
mutant used in crystallographic studies25 by adding three additional thermostabiliz-
ing mutations (I129V, D322K, and Y343L) and a neutral mutation (D200E) from the 
ultra-stable β1AR-JM3 mutant11. As compared to the wild type, TS-β1AR contains 
truncations at the amino and carboxy termini and intracellular loop (ICL3), a total 
of nine thermostabilizing point mutations, three further point mutations as well as a 
C-terminal hexahistidine tag (Extended Data Fig. 1). The final TS-β1AR sequence 
is MGAELLSQQWEAGMSLLMALV VL LI VA GN VL VI AA IG ST QR LQ TL TN 
LF IT SL AC AD LV VG LL VV PF GA TL VV RG TW LW GS FL CE LW TSLDVLCVTASVE 
TLCVIAIDRYLAITSPFRYQSLMTRARAKVIICTVWAISALVSFLPIMMHWWR 
DEDPQALKCYQDPGCCEFVTNRAYAIASSIISFYIPLLIMIFVALRVYREAKEQ 
IRKIDRASKRKTSRVMLMREHKALKTLGIIMGVFTLCWLPFFLVNIVNVFNR 
DLVPKWLFVAFNWLGYANSAMNPIILCRSPDFRKAFKRLLAFPRKADRRLH 
HHHHH.
Additional valine-to-alanine or isoleucine point mutations were introduced 
into TS-β1AR for NMR assignment purposes. All constructs were made using the 
QuikChange site-directed mutagenesis method (Agilent). Baculovirus for insect 
cell expression was generated using the Bac-to-Bac system (Invitrogen).
β1AR expression and purification. All β1AR constructs were expressed in bac-
ulovirus-infected insect cells as described26. Selective labelling by [15N]valine 
was achieved by growing cells on unlabelled serum-free insect cell medium 
(InsectXpress, Lonza) and then exchanging into custom-made serum-free medium 
(SF4, BioConcept) devoid of valine and yeast extract, to which 100 mg l−1 [15N]
valine were supplemented. Virus was added immediately after the medium 
exchange. The culture was harvested at 48 or 72 h post infection.
After cell lysis, the membrane fraction was separated from the lysate via ultra-
centrifugation and subsequently solubilized with 2% n-decyl-β-d-maltopyranoside 
(DM, Anatrace). The solubilized membrane fraction was then purified by nickel 
ion affinity chromatography followed by alprenolol ligand affinity chromatography. 
The active receptor was eluted with buffer (20 mM Tris, 350 mM NaCl, 0.1% DM, 
pH 7.5) containing either atenolol (1 mM) or alprenolol (0.1 mM). Final yields 
of detergent-solubilized receptor were 1.5 mg l−1 of cell culture. The molecular 
weight of the receptor-detergent complex was estimated as ~100 kDa by static 
light scattering.
Thermal shift assays of mutant receptors. Detergent-solubilized, purified 
apo TS-β1AR and reverse-mutation receptors for thermal stability assays were 
obtained from their atenolol-bound form by washing with buffer devoid of 
ligand on a HiTrap SP HP (GE Healthcare) column. Their thermal stability was 
determined by the microscale fluorescent stability assay for binding of the thiol- 
specific fluorochrome N-[4-(7-diethylamino-4-methyl-3-coumarinyl)phenyl]
maleimide (CPM)27 in a Rotor-Gene Q (QIAGEN) real-time PCR cycler using 
1 μg of receptor in 20 mM Tris, 350 mM NaCl, 0.1% DM, pH 7.5 and a heating 
rate of 2 K min−1.
NMR experiments. NMR samples were prepared in Shigemi tubes as 250 μl vol-
umes of typically 100 μM receptor, 1 mM ligand (except for apo form), 20 mM 
TRIS, 100 mM NaCl, 0.1% DM, 5% D2O, pH 7.5. For isoprenaline or dobutamine, 
2 mM of sodium l-ascorbate were supplemented as anti-oxidant. All solution NMR 
measurements were carried out at 304 K on a 800 MHz or a 900 MHz Bruker 
Avance III spectrometer equipped with a cryogenic probe. 2D 1H,15N TROSY 
spectra were recorded with total acquisition periods of 16 ms (15N) and 43 ms 
(1H) with typical total experimental times of 24–48 h. As compared to a standard 
TROSY pulse sequence, the 1H–15N INEPT delays were set to 3 ms to reduce 
magnetization losses from relaxation.
Assignment procedure. To obtain sequence-specific assignment information, we 
initially attempted to detect HNCO and HNCA correlations on samples addition-
ally labelled with 13C at specific backbone sites28. However, due to low sensitivity, 
only very few correlations were observable. Therefore, assignments were obtained 
from a combination of information from TROSY spectra recorded on 18 TS-β1AR 
valine point mutants with different ligands, four HN(CO) correlations and five 
distinct structure-based chemical shift predictions (Extended Data Table 2).
Ligand exchange experiments. Receptor complexes with different ligands were 
generated by sequential exchange according to increasing ligand affinity, that 
is, in the sequence atenolol-isoprenaline-dobutamine-alprenolol or alprenolol- 
carvedilol-cyanopindolol. For exchange, the sample was washed three times with 
buffer devoid of ligand at tenfold dilution in Amicon Ultra 50 kDa cutoff concen-
trators. Subsequently, the sample was washed again twice with buffer containing 
100 μM new ligand, separated by a period of 1 h incubation. Final concentrations of 
the ligands were adjusted to 1 mM. Apo receptor was generated from the atenolol 
complex by six washing steps of tenfold dilution in ligand-free buffer using a 1 h 
incubation period for the last three steps.
NMR NB80 binding experiment. Binding of NB80 to β1AR mutants was assessed 
using TROSY and 1D proton NMR spectra. These spectra were recorded on the 
β1AR mutants (TS-β1AR: 132 μM, TS-β1AR(A227Y): 120 μM, TS-β1AR(L343Y): 
110 μM, and TS-β1AR(A227Y/L343Y): 120 μM) in the presence of saturating 
amounts (1 mM) of the agonist isoprenaline before and immediately after addition 
of an equimolar (relative to the receptor) amount of NB80. For TS-β1AR(A227Y/
L343Y) additional spectra were recorded after a further addition of the partial 
agonist cyanopindolol (1 mM) to the already present isoprenaline and NB80.
Scintillation proximity assay with 3H-dihydroalprenolol. For pharmacological 
binding assays membranes were prepared from SF9 insect cells as described 
previously26. The total protein content of the membranes was estimated by A280 
measurements using an average extinction coefficient of 1.0 per mg ml−1. All 
assays were carried out in 96-well plates at 200 μg ml−1 total protein in membranes 
and 2 mg ml−1 WGA-YSi beads (Perkin-Elmer) in a 100 μl total volume per well. 
Samples were equilibrated at room temperature for at least 16 h. KD values for the 
radioactive ligand [3H]dihydroalprenolol (3H-DHA) were determined by titrating 
3H-DHA from 0.032 to 100 nM. Non-specific binding was determined in presence 
of 1 μM S-propanolol to block the ligand binding site. Competition assays were 
performed in the presence of 20 nM 3H-DHA (hot ligand) and increasing con-
centrations of the competitor (cold ligand). Dilutions of alprenolol, atenolol, 
cyanopindolol, dobutamine and isoprenaline were made with phosphate buffered 
saline (PBS, Biochrom, Germany). Due to the limited solubility of carvedilol in 
water, stock dilutions of carvedilol were prepared in DMSO. The final concentra-
tion of DMSO in the samples was 5%. To test the effect of NB80 binding on 
the affinities (IC50) of isoprenaline for various receptor mutants, the competition 
assays were also carried out in the presence of saturating concentrations of 
NB80 (10 μM). IC50 values were determined by fitting the measured radioactive 
counts per minute CPM(X) at a specific concentration X of the competitor 
to the equation ( ) = −
+
+XCPM CPM CPM
1
CPMX
max min
IC
min
50
  , where CPMmax and 
CPMmin are maximal and minimal counts of the assay, respectively. The fits were 
carried in MATLAB (MathWorks, http://www.mathworks.com) with Monte-
Carlo estimation of errors. Ki values were calculated from the obtained IC50  
values according to the formula =
+
K IC
1 A
K
i
50
D
 where A is the concentration of the 
radioactive ligand and KD is its affinity for the receptor determined in the direct 
binding experiment.
G protein activation assay. G protein activation was measured on purified β1AR 
mutants reconstituted with MSP1E3D129 into POPC/POPG nanodiscs. MSP1E3D1 
was expressed and purified as described29 and cleaved with TEV protease. 1-pal-
mitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, Avanti Polar Lipids) and 
1-palmitoyl-2-oleoyl-sn-glycerol-3-phospho-(1′-rac-glycerol) sodium salt (POPG, 
Avanti Polar Lipids) were solubilized at a ratio of 1:1.5 (w/w) POPG/POPC in ND 
buffer (20 mM HEPES pH 8, 100 mM NaCl, 1 mM EDTA) with 50 mM sodium 
cholate (Sigma-Aldrich) at 4 °C. 133.3 μM MSP1E3D1 was incubated with 8 mM 
solubilized POPC/POPG and 10 μM purified β1AR in ND buffer with a final con-
centration of 24 mM sodium cholate for 1 h at 4 °C. Nanodiscs containing the 
receptor were separated from empty nanodiscs using a cobalt-chelating resin. The 
heterotrimeric G protein was prepared by incubating 10 μM recombinant Gαi1 
and 10 μM native Gβγt in activation buffer (25 mM HEPES pH 7.5, 150 mM NaCl, 
2 mM MgCl2, 1 mM DTT) for 30 min at 4 °C.
G protein activation was detected by the change in tryptophan fluorescence 
caused by the exchange of GDP for GTPγS, associated conformational changes 
in the Gα subunit and its dissociation from the Gβγ subunit of the hetero trimeric 
G protein30. All measurements were carried out on a Varian Cary Eclipse flu-
orescence spectrophotometer (λex = 295 nm, λem = 340 nm, 1.5 nm excitation 
slit, 20 nm emission slit, 2 s averaging time, 15 s cycle time) using final sample 
volumes of 1 ml in 10 × 4 mm cuvettes (Hellma, CH) and magnetic stirrers at 
20 °C. Prior to activation, the fluorescence intensity baseline was recorded with 
100 nM heterotrimeric G protein for approximately 500 s. The activation was 
started by adding 6 nM β1AR and 10 μM GTPγS, and the fluorescence intensity 
was monitored for a further 1 h. For experiments in the presence of an agonist, 
the concentrated receptor stock solution (1.5 μM) was pre-incubated for 30 min at 
4 °C with 40 μM isoprenaline, and the buffer during the measurements contained 
2 μM of isoprenaline to maintain the saturation conditions for the receptor.
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Extended Data Figure 1 | Position of valine residues in the 
thermostabilized mutant TS-β1AR. a, Schematic representation of 
secondary structure and amino acid sequence of TS-β1AR. As compared to 
the wild type, the TS-β1AR has truncations at the N and C termini and the 
intracellular loop (ICL3) as well as nine thermostabilizing point mutations 
(colour coded green) and three additional point mutations (colour 
coded yellow). Valines labelled with 15N are indicated by bold circles for 
assigned (blue) and unassigned (grey) residues. b, Structure of β1AR in 
complex with carvedilol (PDB code 4AMJ). The protein backbone and 
carvedilol are shown in ribbon and red stick representation, respectively. 
The individual valines are depicted as spheres (blue, assigned; grey, not 
assigned) labelled by residue number. c, Full 1H–15N TROSY spectra of 
apo TS-β1AR and all investigated ligand complexes. The ligand chemical 
structures are shown as inserts. Resonances are marked with assignment 
information (black, firm; cyan, tentative).
© 2016 Macmillan Publishers Limited. All rights reserved
Letter reSeArCH
V172 4.56
Lig
F207 5.39
P176 4.60
S215 5.461
S211 5.43
w1
w2
TM3
TM4
TM5
P4.60
V4.56 V4.56 V4.56
S5.43
S5.461
T3.37
I3.40
P5.50
w1
w2
S4.57
Y5.39
carvedilol isoprenaline atenolol
connector switch
16
4
16
5
16
6
16
7
16
8
16
9
17
0
17
1
17
2
17
3
17
4
17
5
17
6
17
7
residue
-150
-100
-50
Ph
i
4.
48
4.
49
4.
50
4.
51
4.
52
4.
53
4.
54
4.
55
4.
56
4.
57
4.
58
4.
59
4.
60
4.
61
-100
-50
0
Ps
i
carvedilol
cyanopindolol
dobutamine
isoprenaline
8.28.48.6
1H
100
110
120
130
15
N
[ppm]
V165
V172
BB
 to
rsi
on
HB
 w
ea
ke
nin
g
TVWAISALVSFLPI
TVWAISALVSFLPI
MVWIVSGLTSFLPI
LVWVVSAAVSFAPI
LLWVVALVVSVGPL
TVWVISAVISFPPL
TVWLIAAVISLPPL
AVWLISAVISFPPL
vWiisalvSf Pi
4.50 4.604.56
tADRB1
hADRB1
hADRB2
hADRB3
hADRA1A
hADRA2A
hADRA2B
hADRA2C
consensus
a b
c
d
Extended Data Figure 2 | Effect of ligand head group substitution on 
hydrogen bond network involving V172(4.56) in β1AR. a, Sequence 
alignment of turkey β1AR and human adrenoreceptors around position 
4.56 in TM4 showing the conserved proline at position 4.60. b, Schematic 
representation of the hydrogen bond network between TM4 and TM5 
involving V172(4.56) in β1AR. The hydrogen bond network (orange  
dotted lines) originates at the carbonyl of V172(4.56) and connects to  
TM5 via two water molecules (w1 and w2, red asterisks). c, Left, phi  
and psi dihedral angles (averages and standard deviations in case of 
multiple chains) in TM4 between residues 4.48 and 4.61 for different 
complexes of β1AR (ligand, PDB code [chain]: carvedilol, 4AMJ [A,B]; 
cyanopindolol, 2VT4 [B,D] and 4BVN [A]; dobutamine, 2Y00 [A,B] and  
2Y01 [A,B]; isoprenaline, 2Y03 [A,B]). V165(4.49) and V172(4.56), for 
which 1H–15N resonances could be observed, are shown on a green and 
red background, respectively. c, Right, average of the 1H–15N resonance 
positions for V165(4.49, green) and V172(4.56, red). The phi and psi 
values of V172(4.56) are distorted from the normal helical angles due to  
the loss of the intra-helical hydrogen bond to P176(4.60). Together with 
the loss of the canonical hydrogen bond, this strongly shifts both the 
1H and 15N chemical shifts of V172(4.56) towards smaller p.p.m. values 
relative to V165(4.49), which has normal, helical phi and psi angles.  
d, Partial views of the crystal structures of the carvedilol complex (PDB 
code 4AMJ), the isoprenaline complex (PDB code 2Y03) and a docking 
model of the atenolol complex based on the cyanopindolol complex 
crystal structure (PDB code 4BVN). In the carvedilol complex, one water 
molecule (w2) forms a hydrogen bond network between the carbonyl 
oxygen of V172(4.56) and the side chains of S211(5.43) and S215(5.461). 
In the isoprenaline complex, the side chains of S211(5.43) and S215(5.461) 
are rotated and form hydrogen bonds to the catechol hydroxyl groups 
of isoprenaline. In this structure, no water molecule is observed at the 
equivalent position of w2. In the atenolol complex, the para-substituted 
acetamide of the ligand head ring (dashed circle) inserts between 
S211(5.43) and S215(5.461) and disturbs the interface between TM3 and 
TM5 near V172(4.56) (solid circle).
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Extended Data Figure 3 | Response to various ligands for all assigned 
valine 1H–15N resonances in TS-β1AR. Colour coding as in Extended 
Data Fig. 1: cyan (atenolol), blue (isoprenaline), orange (dobutamine), 
purple (alprenolol), red (carvedilol), green (cyanopindolol), black (apo 
receptor). For clarity the centres of resonances are marked by circles. 
Firmly (tentatively) assigned residues are marked in black (cyan).
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Extended Data Figure 4 | Evidence for micro- to millisecond dynamics 
at the ligand entry/exit pathway. Left, region of the 1H–15N TROSYs 
showing the V314(6.59) 1H–15N resonance of TS-β1AR in the apo and 
various ligand-bound forms. The resonances of the apo and atenolol-
bound forms are severely broadened in the 15N dimension indicative of 
backbone dynamics in the micro- to millisecond range. The broadening is 
not observed for the other more tightly binding ligands. The resonances 
for the low affinity ligands, atenolol, isoprenaline and dobutamine, and 
for the high affinity ligands, alprenolol, carvedilol and cyanopindolol 
cluster at different positions. Interestingly, the resonance of the apo form 
clusters with the high affinity ligands, indicative of a similar backbone 
conformation. Right, 15N and 1H line widths of the V314(6.59) resonance 
for the apo and ligand-bound forms of TS-β1AR.
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Extended Data Figure 5 | Isoprenaline-induced G protein activation 
by β1AR mutants. Activation was measured by the change in tryptophan 
fluorescence upon exchange of GDP for GTPγS in the Gα subunit of the 
heterotrimeric Gi protein. The figure shows the time courses of tryptophan 
fluorescence after the addition of different mutant forms of TS-β1AR in 
nanodiscs and GTPγS to the heterotrimeric G protein in the presence 
(red) and absence (black) of the agonist isoprenaline. The increase in 
fluorescence intensity at time t = 0 is caused by the additional fluorescence 
of the receptor, the nanodisc scaffold protein and the ligand. For the 
active mutant TS-β1AR(A227Y/L343Y), this initial rise is followed by an 
exponential fluorescence increase due to the activation and dissociation of 
the G protein. The rate of the Gαi activation by TS-β1AR(A227Y/L343Y) 
(half-life ~290 s at 6 nM receptor) is approximately 4 times slower than for 
the activation by rhodopsin (half-life ~400 s at 1 nM receptor) using the 
same assay. This assumes that the Km of Gαi for TS-β1AR(A227Y/L343Y) 
is of the same scale as for rhodopsin (8.6 nM) and therefore significantly  
below the (saturating) concentration of Gαi (100 nM). Each mutant 
was measured three times except for TS-β1AR(A227Y/L343Y) that was 
measured four times. Representative fluorescence curves from single 
experiments are shown.
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Extended Data Figure 6 | Observed NMR effects of the reverse 
mutations of TS-β1AR towards the native β1AR sequence. a, 1H–15N TROSY 
spectra of TS-β1AR and several reverse single and double mutants 
in complex with either atenolol (cyan) or isoprenaline (dark blue). 
Resonances are marked with assignment information (black, definite; 
cyan, tentative). b, Enlarged regions of the 1H–15N correlation spectra 
showing only the resonance positions of V226(5.57) and V280(6.25) for  
all mutants in both ligand-receptor complexes. The black bar represents  
0.1 p.p.m. in 1H and 1 p.p.m. in 15N. For all mutants, the resonances  
for V226(5.57) show efficacy-related chemical shift changes between  
atenolol (diamonds) and isoprenaline (circles). For the A227Y mutants 
TS-β1AR(A227Y) (green), TS-β1AR(V129I/A227Y) (orange) and  
TS-β1AR(A227Y/L343Y) (cyan), the 1H–15N resonances of V226(5.57) 
also exhibit an overall shift due to a ring current effect from the introduced 
Y227(5.58) side chain, which has no structural significance. However, 
the V129I mutants TS-β1AR(V129I) (red) and TS-β1AR(V129I/A227Y) 
(orange) exhibit further 1H–15N shifts towards a more active (that is, bent) 
state of TM5 relative to the mutants that carry the V129(3.40) residue. For 
all mutants, the V280(6.25) resonances fall basically in identical positions 
and show no changes between atenolol and isoprenaline.
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Extended Data Figure 7 | Binding of NB80 to agonist-activated  
TS-β1AR(A227Y/L343Y). a, Sequential addition of isoprenaline (1 mM, 
blue), NB80 (120 μM, red), and cyanopindolol (1 mM, green) to  
TS-β1AR(A227Y/L343Y) (120 μM) followed by 1H–15N TROSY spectra. 
Addition of an equimolar amount of NB80 changes the spectrum 
drastically. Except for few resonances (62, 89, 102, 103, 172, 280 and 326), 
the assignments are not transferable from the isoprenaline complex. The 
addition of cyanopindolol to this mixture apparently replaces isoprenaline 
in the receptor and drives the spectrum to the purely cyanopindolol-
bound form. These results indicate that TS-β1AR(A227Y/L343Y) can be 
activated, but that the fully active state requires stabilization with a  
G protein-like partner at the intracellular site. b, Changes in isoprenaline 
affinity of β1AR induced by NB80 binding. The isoprenaline affinity 
was assayed for TS-β1AR (orange), TS-β1AR(A227Y/L343Y) (green), 
and the truncated native turkey β1AR receptor (tβtrunc, blue)17 by 
radio-ligand competition using 3H-dihydroalprenolol in the presence 
of saturating amounts of NB80 (10 μM, squares) or its absence (circles). 
For TS-β1AR(A227Y/L343Y) and tβtrunc the apparent affinity increases 
by two log units in the presence of NB80, whereas no change occurs for 
TS-β1AR. Data points are shown as mean and standard deviation of three 
independent experiments for each condition. c, Combined 1H and 15N 
chemical shift changes (Δδ = (Δδ1H2/2 + Δδ15N2/50)1/2) between the 
isoprenaline-TS-β1AR(A227Y/L343Y) and the NB80-isoprenaline-TS-
β1AR(A227Y/L343Y) complexes as a function of residue number. Except 
for the few assigned peaks in the NB80-isoprenaline-TS-β1AR(A227Y/
L343Y) complex, chemical shift deviations are calculated as the minimal 
difference from the isoprenaline peak position to the nearest peak position 
in the isoprenaline–NB80 complex. Note that these minimal chemical 
shift deviations present a lower boundary for the deviations that could be 
obtained from a full assignment of the isoprenaline–NB80 complex.  
Peak deviations are colour-coded in red (≥0.2 p.p.m.), orange  
(0.2–0.05 p.p.m.), blue (<0.05 p.p.m.), and grey (ambiguity from peak 
overlap). d, Representation of the chemical shift response to nanobody 
binding given in c on the structure of β1AR. Valines in TM1 and TM7 do 
not show a large chemical shift response. Due to overlap the response for 
V280(6.25) in TM6 is unclear. Valines in TM2 show a strong response 
around the sodium binding region near residue D87(2.50), but valines at 
its extracellular side are not responsive. In general, valine resonances at the 
extracellular sides of TM3–TM6 are severely shifted. This indicates that 
the NB80 binding at the intracellular side has a long-range effect on the 
extracellular side near the ligand binding site.
© 2016 Macmillan Publishers Limited. All rights reserved
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extended Data table 1 | Pharmacological and geometrical properties of the β1Ar ligands used in this study
*Values for binding affinity correspond to the β36-m23 construct, which contains C- and N-terminal deletions and six thermostabilizing mutations10. The pKD = −log KD [M] was obtained from [3H]
CGP12177 whole-cell binding assays in stably expressed CHO cells17.
†pKi values were obtained from the pIC50 values given in column 3 by adding log(1+[lig]/KD) = 0.366 as a correction for the concentration of the [3H]dihydroalprenolol (3H-DHA) ([lig] = 20 nM) and its 
determined dissociation constant (KD = 15.1 ± 7 nM, see Methods). Errors are obtained by error propagation from the errors of the pIC50 values and KD.
‡pIC50 values were determined by the radioligand inhibition assay described in the Methods section using 3H-DHA. Data are given as mean and standard deviation of three independent experiments.
§Values for efficacy towards Gs-mediated signalling as determined by adenylyl cyclase activation of the truncated native turkey β1AR receptor (tβtrunc)17. The efficacies are indicated as the percentage 
of the (maximal) isoprenaline response obtained from 3H-cAMP accumulation assays in CHO cells.
||The insertion depth (Å) of the ligand was taken as the distance between the β-carbon atom of the ligand amino group and the amide nitrogen atom of V125 (V117 for β2AR) in the crystal structures 
of turkey β1AR in complexes with isoprenaline (PDB ID: 2Y03), dobutamine (PDB ID: 2Y00), carvedilol (PDB ID: 4AMJ), and cyanopindolol (PDB ID: 4BVN) as well as of human β2AR in complex with 
alprenolol (PDB ID: 3NYA).
¶The tail volumes (Å3) were calculated by the Molinspiration Property Calculation Service (http://www.molinspiration.com/cgi-bin/properties) for the tail group including the amino moiety.
#The pKi and pIC50 are limited by the KD and concentration of the radioactive tracer ligand as well as by the concentration of the receptor in the competition assay.
⋆Not determined, no crystal structure available.
pharmacology geometry
pKD
 36 -m23*
pKi 
TS- 1AR† 
pIC50
TS- 1AR‡
Gs efficacy 
t trunc§
insertion 
depth||
tail volume¶
cyanopindolol 10.01 ± 0.11 >8.4 ± 0.3# >8.1 ± 0.1# 39 ± 1 7.22 90.11
carvedilol 8.72 ± 0.09 >8.3 ± 0.3# >7.9 ± 0.1# 12 ± 0.4 7.62 163.47
alprenolol 7.35 ± 0.07 7.6 ± 0.3 7.2 ± 0.1 31 ± 2 7.25 73.87
dobutamine 5.49 ± 0.03 5.0 ± 0.3 4.6 ± 0.1 112 ± 7 8.46 170.34
isoprenaline 5.16 ± 0.05 4.9 ± 0.3 4.6 ± 0.2 100 7.92 73.87
atenolol 4.29 ± 0.11 5.0 ± 0.3 4.6 ± 0.2 2.1 ± 1 ND 73.87
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extended Data table 2 | Sequence-specific assignment 1h–15N valine resonances
Ate, atenolol; Alp, alprenolol; Iso, isoprenaline; Dob, dobutamine; Car, carvedilol; Cya, cyanopindolol
HN(CO): information from 2D-filtered HN(CO) of [15N,13C]Gly,Val-, [15N]Leu-labelled receptor
Pred: ShiftX2 15N chemical shift prediction31
HB: expected 1HN shift based on hydrogen bond length analysis
NM: peak shift due to mutation of neighbouring residue
Assignments for V89(2.52), V95(2.57), V103(2.65), V122(3.33), and V165(4.49) are tentative. V51(1.42), V52(1.43), V56(1.47), V60(1.51), V309(6.54), V312(6.57), and V320(ECL) have not been 
assigned.
Assigned 
residue
Position Point 
mutation
Spectra with ligands Further
information
V62 1.53 V62A Ate, Apo, Alp
V90 2.53 V90A Ate, Alp, Car, Cya HN(CO)
V94 2.56 V94A Alp, Car, Cya
V102 2.64 V102A Ate, Apo, Alp, Iso, Dob, Car, Cya
V122 3.33 V122A Alp, Car, Cya
V125 3.36 V125A/I Alp(A), Car(A), Ate(I), Apo(I)
V129 3.40 V129I Ate
V134 3.45 V134A Ate
V160 4.44 V160A Ate
V172 4.56 V172A Ate, Alp Pred
V202 ECL V202A Alp Pred
V226 5.57 V226A Alp, Car, Cya
V230 5.61 V230A Alp
V280 6.25 V280A Alp, Car, Cya
V298 6.43 V298A Ate HN(CO)
V314 6.59 V314A Alp, Car, Cya
V326 7.36 V326A Alp
V89 2.52 - Ate, Apo, Alp, Iso, Dob, Car, Cya HB, NM
V95 2.57 - Ate, Apo, Alp, Iso, Dob, Car, Cya HB, NM, HN(CO)
V103 2.65 - Ate, Apo, Alp, Iso, Dob, Car, Cya HB, NM, HN(CO)
V165 4.49 - Ate, Apo, Alp, Iso, Dob, Car, Cya NM
© 2016 Macmillan Publishers Limited. All rights reserved
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extended Data table 3 | Summary of the NMr response to ligands, G protein activation and NB80 binding data for the original tS-β1Ar 
construct and various reverse mutants towards the native β1Ar sequence
*Determined from the shifts of the 1H–15N resonances in response to binding of atenolol and isoprenaline (see Extended Data Fig. 6B).
†Determined from the Gi activation assay described in Extended Data Fig. 5.
‡Determined from NMR experiments by mixing of isoprenaline-activated TS-β1AR with NB80. The 1H–15N spectra are shown for TS-β1AR(A227Y/L343Y) in Extended Data Fig. 7. The spectra of the 
other TS-β1AR mutants showed no response to addition of NB80 up to equimolar concentrations of ~100 μM for both proteins. Values in parentheses show pIC50 for isoprenaline binding in the 
absence or presence of NB80, respectively (see Extended Data Fig. 7).
§Melting temperature Tm of the apo form receptor determined by the CPM thermal shift assay.
||Native residues are highlighted in bold.
¶Not determined.
© 2016 Macmillan Publishers Limited. All rights reserved
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3.3 A NOE-based approach to backbone resonance assignment of 
the β1‑adrenergic receptor 
  
Introduction 
Sequential assignments of the protein backbone are commonly obtained by triple 
resonance correlation experiments such as the HNCA and the HNCOCA (119, 120). These 
experiments involve magnetization transfer via one-bond and two-bond scalar coupling 
interactions. Whereas this approach is very successful for small- to medium-size proteins and 
has seen various technical improvements such as transverse relaxation optimized 
spectroscopy (TROSY) (121), it is of limited use for larger proteins (>100 kDa). Slow 
molecular motion of these large proteins in solution increases transverse relaxation rates, 
which decrease the efficiency of transfer and frequency labeling steps in triple resonance 
experiments. 
An alternative strategy for sequential assignments may be based on 15N-edited nuclear 
Overhauser enhancement spectroscopy (NOESY) to obtain spatial inter-proton information 
(122, 123) resolved for the backbone amide nitrogen. This approach allows correlating amide 
protons of neighboring residues within 5 Å distance and thus may be applied for sequential 
assignment of the amide backbone. 
This section describes uniform labeling by 15N and deuteration of the TS-β1AR in insect 
cells, which was achieved by growth on 2H,15N-labeled yeast extract. This approach has 
allowed obtaining 15N-edited 3D NOESY spectra of very high quality. An initial assignment 
is reported for a selected stretch of residues in the transmembrane helix 5, which is part of the 
allosteric signaling network of the receptor (103). Finally, the impact of fractional deuteration 
for extended assignment of the TS-β1AR is discussed. 
 
Results and Discussion 
Uniform isotope labeling of β1-adrenergic receptor in insect cells 
TS-β1AR was expressed in Sf9 insect cells using 8 g/L 2H,15N-labeled YE and 1 g/L 15N2-
L-glutamine yielding 1 mg/L of purified receptor. The expression level of 2H,15N-TS-β1AR 
was comparable to unlabeled production of the receptor in commercial medium. Moreover, 
the fraction of active receptor obtained by affinity chromatography (see Materials and 
Methods) was similar for unlabeled TS-β1AR and 2H,15N-TS-β1AR. Therefore, the ability to 
bind ligands and the yield remained unchanged when homemade YE was used for labeled 
expression of TS-β1AR. A detailed analysis of 2H,15N-TS-β1AR by NMR is described in 
Chapter 2.1. 
 
Sequential assignment of backbone amide resonances 
15N-edited 3D NOESY spectra using a TROSY-type pulse sequence (124) were recorded 
on the 110 μM 2H,15N-TS-β1AR solubilized in a n-decyl-β-D-maltopyranoside detergent 
micelle. In total, 243 backbone amide resonances were observed in the diagonal of the 3D 
NOESY, which correspond to 80 % of the expected 303 residues excluding the N-terminus 
and 11 proline residues. Moreover, 474 cross peaks between these amide resonances were 
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obtained. These include 138 HNi-NHj / HNj-NHi mirror image pairs. Moreover, long-range i-2 
and i+2 connectivity was observed for A227 and V230 (Figure 3.4A). 
Figure 3.4A shows sequential strip plots obtained from the 3D experiment for the receptor 
in complex with alprenolol. The assignment process was based on the assigned amide 
resonances for the 15N-valine labeled receptors (Chapter 3.2). A consecutive sequence of six 
residues is depicted including V226 and V230 in the transmembrane (TM) helix 5. 
Figure 3.3B indicates where these residues are located within the receptor. TM5 and TM6 as 
well as their intervening loop ICL3 are colored from orange to red. These structural elements 
of TS-β1AR mediate G protein binding. All assigned residues are contained in TM5, which is 
part of the allosteric activation pathway and displayed a remarkable unified response to 
binding of different ligands (Chapter 3.2). So far, chemical shift changes obtained for the 
1H-15N resonances of V226 alone were used to monitor this response. Therefore, it is 
expected that the assigned sequence of consecutive residues may broaden the available 
information for binding of distinct ligands to TS-β1AR. 
Furthermore, 315 cross peaks were observed in the range from -1 to 5 ppm of the indirect 
1H dimension indicating only partial deuteration. This is e.g. evident in the methyl region of 
the 3D NOESY for the assigned residues F225 to V230 (Figure 3.4A, upper panel). The 
obtained peaks mainly result from intra-residue NOEs. However, F225 clearly shows a strong 
cross peak at 0.84 ppm, which is not expected for a phenylalanine side chain resonance (125). 
Consequently, this cross peak corresponds to an inter-residue NOE from a neighboring 
residue. In particular, the resonance very likely originates from the δ-CH3 methyl group of 
the adjacent I224.  
The observed partial deuteration (Figure 3.4A) can be explained by two reasons: 
(i) incomplete deuteration of the prepared YE and (ii) an unlabeled pool of amino acids as 
well as metabolic scrambling of non-essential amino acids in insect cells. As shown by mass 
spectroscopic analysis of individual amino acids, an average deuteration level of 75 % was 
achieved based on growth of Pichia in D2O using protonated glucose (Chapter 2.1). This 
relates to the biosynthesis of amino acids involving glucose as a precursor. Insect cells share 
some of these metabolic pathways, which result in dilution of the deuterium label for several 
non-essential amino acids such as alanine and glycine (Chapter 1). Further, the initial 
starvation step of the labeling protocol (Chapter 2.1) may not completely deplete the pool of 
unlabeled amino acid in insect cells. Hence, these amino acids are likely to be incorporated 
into TS-β1AR during expression.  
 
 87 
 
Figure 3.4 Sequential backbone assignment of TS-β1AR based on a 15N-edited 3D NOESY-TROSY-HSQC 
experiment recorded on 2H,15N-labeled receptor in complex with alprenolol. A Strip plots showing a consecutive 
stretch of amino acids. Bottom: Amide region indicating the sequential walk used to assign the amide backbone 
resonances (orange dashed line). Top: Selected methyl region containing aliphatic cross peaks. V226 and V230 
have been assigned using site-directed mutagenesis in the selectively labeled receptor (103). 2H,15N-TS-β1AR 
was expressed in Sf9 cells grown on 2H,15N-yeast extract and 15N2-glutamine. The 15N-edited 3D NOESY-
TROSY-HSQC experiment was recorded on 110 μM of labeled receptor for 10 days. B Localization of the 
assigned amino acids in the backbone of ultra-stable β1AR (PDB entry 4BVN). The transmembrane helices 
TM5 and TM6 as well as the intervening loop ICL3 are colored using a gradient from orange to red. A detailed 
view of TM5 is shown for F225 to V230 (dashed box). 
 
Residual protonation of the side chain positions may lower the sensitivity of the 15N-edited 
3D NOESY experiment. However, fractional deuteration is to some extent advantageous to 
derive complementary information for the assignment process (126). Moreover, the specific 
interactions of the receptor with its ligands involve side chain contributions, which have been 
used recently to study dynamics of selectively labeled GPCRs by NMR (41, 107).  
 
Conclusions and perspectives 
Uniform isotope labeling by 15N and fractional deuteration of TS-β1AR was achieved in 
insect cells using labeled yeast extract. This approach enabled high-resolution NMR studies 
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on the labeled receptor. Well-resolved 15N-edited 3D NOESY spectra were obtained and 
thereby a preliminary assignment of a stretch of residues ranging from F225 to V230. Based 
on the obtained 138 pairs of mirror peaks, it is expected that the backbone resonance 
assignment of TS-β1AR can be further advanced. Moreover, labeling by 13C may complement 
the available spectral information and can be achieved by preparation of the respective 
2H,13C-labeled yeast extract. 
Assignments obtained for TS-β1AR may be transferred to constructs for which 
thermostabilizing mutations have been reverted towards the wild type of the receptor and thus 
displayed the ability to bind the Nb80 nanobody (Chapter 3.2). The combination of fractional 
deuteration and selective amino acid labels may also be used to resolve spectral overlap in 2D 
1H,15N-TROSY experiments. A similar analysis as shown for TS-β1AR (103) may be possible 
for the β2-adrenergic receptor, for which so far only analysis of selectively labeled 
[13C-methyl]methionine residues has been carried out (29).  
Fractional deuteration and uniform labeling by 15N and 13C of GPCRs in insect cells may 
further provide a basis for solid-state NMR (ssNMR) studies. Recently, a structure of the 
chemokine receptor CXCR1 expressed in E. coli was determined by ssNMR (108). This 
strategy was based on refolding of the receptor, which is often challenging and may not yield 
an active protein. In contrast, most GPCRs expressed in insect cells were obtained in their 
active form and thus allow to study ligand interaction and possibly signaling of the functional 
receptor (127).  
 
Materials and Methods 
Uniform isotope labeling in insect cells 
Detailed protocols are presented in Chapter 2.1. 
 
TS-β1AR expression and purification 
Detailed protocols are presented in Chapter 3.2. 
 
NMR sample preparation  
The NMR sample was prepared in a Shigemi tube as a volume of 270 μl containing 110 
μM of 2H,15N-TS-β1AR in 20 mM TRIS (pH 7.5), 1 mM of alprenolol, 100 mM NaCl, 0.1 % 
DM, and 5 % D2O. 
 
NMR spectroscopy  
All NMR experiments on 2H,15N-TS-β1AR were recorded on a Bruker Avance III 
900 MHz spectrometer equipped with a triple-resonance cryoprobe at a temperature of 30 °C. 
The 15N-edited 3D NOESY-TROSY experiment was recorded with 200 (1H) x 160 (15N) x 
1024 (1H) complex points, a mixing time of 55 ms, acquisition times of 9.6 ms (1H) x 25.6 ms 
(15N) x 43 (1H) ms, and a total experimental time of 10 days. INEPT transfer times were 
optimized for amide proton T2 values of 2H,15N-TS-β1AR (3 ms). 
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NMR data analysis and assignment  
NMR data were processed with the NMRPipe software package (128). Assignments of 3D 
NOESY spectra were carried out using the program SPARKY (129). 
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4 Combined use of yeast and algal cell extracts 
for uniform isotope labeling of the human 
lipopolysaccharide-binding protein in insect 
cells  
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Introduction 
Recombinant baculovirus-mediated expression in insect cells allows producing a 
multitude of human proteins in sufficient quantities for a variety of structural studies. The 
system is frequently applied for the production of cytosolic proteins. However, cytosolic 
expression is not possible when the protein expressed shows toxicity or undesirable 
interactions within the host cell. Therefore, secreted expression may be the only available 
option in spite of the fact that generally lower amounts of protein are obtained. For complex 
secreted proteins, deterioration of the secretory pathway by the progressing baculovirus 
infection leads to inefficient secretion and a decrease in yield (130). Further engineering of 
the secretory pathway was shown to improve expression yields of secreted proteins in the 
insect cell system (131). 
Recently, its was shown that the secretion pathway in the baculovirus/insect cell system 
led to production of a soluble form of the murine lipopolysaccharide-binding protein (mLBP) 
suitable for crystallization studies (132). The solved structure of mLBP shows different 
glycosylation sites as seen in Figure 4.1. Glycosylation is required to enter the secretory 
pathway which enables secretion of glycoproteins (133). While mLBP was characterized in 
detail by X-ray crystallography, its interaction with the lipopolysaccharide (LPS) remains 
unresolved at atomic resolution. Nuclear magnetic resonance (NMR) may be well suited for 
such interaction studies, but poses the additional challenge of stable isotope labeling of the 
protein. Only recently substantial methodological progress has been made that enables such 
uniform isotope labeling including deuteration in insect cells in an economical manner (39, 
40, 98).  
 
 
Figure 4.1 LBP and glycosylation in insect cells. A Structure of murine LBP (PDB entry 4M4D) determined by 
X-ray crystallography. B A detailed view of the two reported glycosylation sites. Asparagine residues N300 and 
N355 (blue circles) are N-glycosylated during post-translational modification to facilitate secretion of mLBP. 
C Paucimannosidic N-glycan pattern. The paucimannose-type structure is the most abundant N-glycosylation 
pattern obtained in insect cells (134). 
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This chapter describes uniform 15N-labeling of the secreted hLBP by combining 
commercial algal and homemade yeast extracts. While labeling solely based on yeast extract 
reduced the amounts of secreted protein, supplementation of algal extract restored expression 
of hLBP. Also, labeling by algal extract alone resulted in high-level expression of hLBP, but 
still required addition of tryptophan. The amino acid analysis of both extracts indicated that 
the difference in expression level was not related to the amino acid composition, but must be 
rather due to other factors such as differences in the carbohydrate content. Finally, a well-
resolved 1H-15N-TROSY-HSQC of 15N-hLBP was obtained on a sample produced on algal 
and yeast extracts at a 1:1 ratio. 
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Results and Discussion 
Development of a labeling strategy for secreted expression of LBP in insect cells 
Secreted expression of hLBP in Sf9 insect cells was achieved by a recombinant N-terminal 
fusion to the honeybee melittin signal sequence (MKFLVNVALVFMVVYISYIYAD-
hLBP(A26-V481)-GSGSGSHHHHHHHHHH). The secreted protein was purified from the 
medium with immobilized-metal affinity chromatography which enables robust 
quantification of the protein yield under different labeling conditions. Initially, reference 
expression levels were established in commercial SF-4 and Lonza media (Figure 4.2). 
Remarkably, 2.4 mg/L of purified hLBP were obtained in SF-4 (Figure 4.2, condition 1), 
while expression in Lonza yielded only 1.2 mg/L (Figure 4.2, condition 2). This twofold 
reduction in yield can be rationalized by the prior adaptation of the Sf9 cells in SF-4, which is 
solely based on YE (personal communication with suppliers’ scientific support). In contrast, 
Lonza Insect Xpress medium contains two different undisclosed sources of hydrolysates 
(personal communication with suppliers’ scientific support) and SF-4 adapted insect cells 
appear to perform less well in this medium. Thus, all subsequent labeling schemes were 
tested in SF-4 adapted insect cells. 
 
 
Figure 4.2 Expression yield of hLBP Sf9 insect cells under different conditions. Reference expression was 
established in commercial SF-4 medium (1). Additionally, expression in commercial Insect Xpress medium (2) 
following adaptation to SF-4 medium was carried out. Different supplements to SF4 medium depleted in amino 
acids and yeastolate (ΔSF4) were tested as follows: 8 g/L of yeast extract (YE) + 1 g/L Q (3), 8 g/L of algal 
extract (AE) + 1 g/L Q without W (4), and 8 g/L of AE + 1 g/L Q and 20 mg/L W (5). Also, two ratios of AE 
and YE supplemented with 1 g/L of Q were tested using 4 g/L of AE + 4 g/L of YE (6) and 6 g/L of AE + 2 g/L 
of YE (7), respectively. Sf9 cell cultures were handeled as described in Chapter 2.1. 
 
Since a uniform 15N-labeling scheme based on yeast extract was previously successful for 
expression of soluble and membrane protein in insect cells (98), the same scheme was 
employed for expression of hLBP. Hence, an amino acid-depleted, yeast extract-free SF-4 
medium (ΔSF4) was supplemented with 1 g/L of glutamine and 8 g/L of homemade yeast 
extract (YE) and the expression of hLBP was analyzed (Figure 4.2, condition 3). However, 
only 0.9 mg/L of purified hLBP were obtained which amounts to 36 % of the reference 
expression level in full SF-4 medium. This significant reduction had not been observed for 
the previously expressed proteins.  
1 - SF-4
2 - Lonza
3 - ∆SF-4 + YE+Q 
4 - ∆SF-4 + AE+Q,-W 
5 - ∆SF-4 + AE+W,Q
6 - ∆SF-4 + (1:1) AE+YE+Q 
7 - ∆SF-4 + (3:1) AE+YE+Q
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To further analyze the cause for the reduction in protein yield, a commercial algal lysate 
based extract (ISOGRO, Sigma) was used as an alternative source of amino acids in ΔSF4. 
The feasibility of this approach has been demonstrated recently (39). In contrast to YE, algal 
extract (AE) is the result of hydrolysis of algal cells by mineral acids. Expression of hLBP in 
ΔSF4 supplemented with 8 g/L of AE and 1 g/L glutamine yielded 1.2 mg/L of hLBP, which 
is an increase in the expression level by 33 % over YE (Figure 4.2, condition 4). However, 
the amino acids cysteine and tryptophan are lost during conventional acid hydrolysis for the 
preparation of commercial AE, while glutamine and asparagine are converted to glutamic 
acid and aspartic acid, respectively (135). In line with the previously published labeling 
protocol based on AE (39), restoration of the expression yield to 2.6 mg/L of purified hLBP 
was obtained by supplementing 1 g/L glutamine and 20 mg/L of tryptophan to the expression 
medium (Figure 4.2, condition 5). Moreover, supplementation of cysteine was not required 
for recovery of the expression yield as has been shown for the YE based labeling scheme 
(Chapter 2.1). Biosynthesis of cysteine from methionine in insect cells was previously 
reported and may explain this result (36).  
In the next step, the prospect of a labeling strategy based on the combination of both 
extracts was analyzed. Since YE is an autolysis-based extract, it still contains tryptophan at a 
growth-promoting level for the insect cells and thus has the potential to replace the additional 
amino acid supplement needed for AE. Combining the two extracts may indicate whether a 
specific component may be absent in the homemade YE but not in the commercial AE. 
Furthermore, YE may contain an inhibitory factor related to the secretion of hLBP. 
Therefore, ΔSF4 was supplemented with 1 g/L of glutamine and two different ratios of 
AE/YE accounting for a total extract concentration of 8 g/L without addition of tryptophan. 
Supplementing ΔSF4 with 4 g/L of AE and 4 g/L of YE (ratio 1:1) yielded 2.4 mg/L of 
purified hLBP (Figure 4.2, condition 6). When 6 g/L of AE and 2 g/L of YE (ratio 3:1) were 
used, the protein yield was again increased by 25 % to 3 mg/L (Figure 43.2, condition 7).  
Interestingly, AE supplemented with tryptophan and the combined AE/YE were able to 
overcome the low expression yield observed for homemade YE provided that glutamine was 
supplemented for all of the conditions. These preliminary data suggest one or more limiting 
components in the homemade YE as the probable cause for the observed recovery of the 
protein yield upon blending of both extracts. Conversely, an inhibitiory effect of homemade 
YE on hLBP expression was not observed for concentrations up to 4 g/L.  
 
Amino acid composition of algal extract 
To further characterize the commercial AE, the amino acid content was quantified by 
phenylthiohydantoin amino acid analysis (PTH-AAA). The sample preparation and data 
analysis was performed according to the previously established PTH-AAA protocol 
(Chapter 2.1). Unmodified cysteine was not detectable by the method applied. 
Figure 4.3 shows the determined single amino acid content for 8 g/L of AE (ISOGRO) and 
8 g/L of Pichia YE in comparison to 20 % IPL-41 medium. The latter had been established in 
prior experiments (Chapter 2.1) as the amino acid reference which promotes cell viability and 
high protein yields in Sf9 insect cells. In line with the preparation of the extracts by acid 
hydrolysis, asparagine, glutamine and tryptophan are not present in the AE. Furthermore, the 
overall content of amino acids was comparable in both extracts, but differed for individual 
amino acids.  
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Figure 4.3 Amino acid content of different cell extracts and IPL-41. The free amino acid content of the 
commercial algal extract (orange) and the Pichia yeast extract (blue) was quantified by HPLC analysis 
following pre-column derivatization with phenyl isothiocyanate. Levels of cysteine were not determined by this 
method. The amino acid content of the both is compared to 20 % concentrations of amino acids in the IPL-41 
medium (black), which was found to be sufficient to promote protein expression in Sf9 insect cells. In addition, 
the concentrations of amino acids yielded by blending both extracts (green) at 1:1 (w/w) ratio are given. The 
asterisk indicates missing amino acids in the algal extract. 
 
Figure 4.3 also indicates that the content of aspartic acid is 70 % larger in AE than in YE. 
However, the combined content of aspartic acid and asparagine is similar in both extracts. 
This behaviour may be explained by the conversion of asparagine to aspartic acid in AE by 
the harsh acid hydrolysis conditions (32, 136). Moreover, glutamine showed the lowest 
abundance of all amino acids in the YE and was not detectable in AE, which may relate to the 
instability of glutamine in solution. Depending on pH and temperature, glutamine is 
converted to glutamic and pyroglutamic acid to a different extent (137). Hydrolysis of algal 
cells by strong mineralic acids at low pH leads to the conversion of glutamine to glutamate 
(135). Hence, the amount of glutamate determined in the AE contains a fraction of glutamine 
initially present in the algal cells. In contrast, autolysis of Pichia was performed for five days 
at pH 6 and 50 °C. These milder conditions may primarily convert glutamine to pyroglutamic 
acid in the YE (138, 139). However, pyroglutamic acid is not detectable by PTH-AAA 
without additional treatment of the sample (140). Furthermore, comparable levels of 
glutamate were observed for both extracts and thus the conversion of initial glutamine to 
glutamate in the final YE cannot be excluded (Chapter 2.1).  
In addition, compared to AE significantly increased levels of arginine, histidine, leucine 
and lysine were observed for the YE, while the content of glycine was reduced. These 
differences may be attributed to the source organism and the method of preparation. In 
particular, it is expected that the differences in the used enzymatic and chemical hydrolysis 
protocols lead to variations in the amino acid yield. 
The 1:1 mixture of YE and AE was sufficient to supply most of the amino acids in 
concentrations that exceed those of the 20 % IPL-41 medium (Figure 4.3). This observation 
is in line with the achieved expression yields (Figure 4.2) and explains why no further 
supplementation of tryptophan was required for the combined labeling scheme. As has been 
discussed in Chapter 2, the low abundance of methionine is apparently compensated by the 
metabolic capacity of the insect cell (36). 
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Solution state NMR spectroscopy of uniformly 15N-labeled LBP 
To proceed with NMR analysis, 15N-labeled hLBP was expressed in Sf9 insect cells using 
a 1:1 ratio of 15N-labeled AE/YE. The complete labeling procedure was adapted from the 
protocol that was originally developed for homemade YE involving an initial starvation step 
(Chapter 2.1). Thus, ΔSF4 supplemented with 1 g/L of unlabeled glutamine, 4 g/L of 15N-
labeled AE (N-ISOGRO, Sigma) and 4 g/L of 15N-labeled YE was used as described before. 
Following purification, 2.7 mg/L of 15N-labeled hLBP were obtained. Since it was previously 
observed that hLBP concentrations exceeding 8 mg/ml led to irreversible precipitation of the 
protein, only a fraction of 1.5 mg was used to prepare the NMR sample. Figure 4.4 shows the 
resulting 1H-15N TROSY-HSQC recorded for 60 h on the 111 μM 15N-labeled hLBP. In total, 
about 324 of the 473 expected backbone amide resonances were observable. The determined 
amide proton T2 value was 5.1 ms. With an estimated molecular weight of 52.8 kDa and 
additional glycosylation sites, further improvement of the spectral quality requires 
deuteration of the protein. Furthermore, 15N-incorporation of hLBP was analyzed by a 1D 
spin echo difference experiment yielding an estimated 15N-incorporation of 79 %.  
 
 
Figure 4.4 1H,15N-TROSY-HSQC spectrum of 15N-labeled human lipopolysaccharide-binding protein. 
15N-labeled hLBP was expressed in Sf9 cells grown on a combination of 15N-yeast extract and 15N-algal extract 
supplemented with unlabeled glutamine as described in the text. The TROSY-HSQC was recorded in 60 h on a 
111 μM sample of 15N-labeled hLBP. 
 
So far mass spectrometric analysis on hLBP could not be established to quantify the 
incorporation of 15N. However, a theoretical estimation of the labeling efficiency can be 
based on the previously obtained mass spectrometry data for cytosolic proteins (Chapter 2.1). 
When applied for expression of cytosolic proteins in Sf9 cells, the applied labeling scheme 
yielded an overall 15N-incorporation of about 82 % for all non-glutamine residues as 
determined by mass spectrometric analysis. Therefore, the 15N-incorporation of 79 % 
observed for hLBP by NMR is in good agreement with the mass spectrometric analysis of the 
cytosolic proteins cAbl and trGFPuv. Moreover, supplementation of 15N-labeled YE and 15N2-
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glutamine may increase the average 15N-incorporation of hLBP to 90 % as was observed for 
cytosolic proteins.  
 
Conclusions and perspectives 
The limitations of the developed yeastolate-based labeling protocol applied to a secreted 
protein have been investigated. Supplementation of homemade YE resulted in the lowest 
expression level of hLBP. However, robust expression yields were achieved in full SF-4 
medium that contains commercial yeastolates. Unfortunately, the exact concentration in the 
medium and the preparation of those yeastolates is not disclosed.  
In line with the recently reported labeling protocol (39), high yield expression of hLBP 
was obtained by supplementation of AE, tryptophan and glutamine into an amino acid 
depleted medium. Furthermore, the level of 15N-incorporation achieved by combined 
application of AE and YE was similar to the AE-based protocol despite addition of unlabeled 
glutamine. This may be attributed to the additional starvation step used in the YE labeling 
protocol (Chapter 2.1). Therefore, it is expected that the reported incorporation levels of the 
AE-based approach may be improved by this starvation step. 
Comparison of the algal and the yeast extract by amino acid analysis revealed only minor 
differences of the overall amino acid content. The differences for individual amino acids can 
be explained to a large extent by the method of lysate preparation. In particular, the loss of 
tryptophan and the conversion of glutamine and asparagine are direct results of acid 
hydrolysis used for AE. It is hoped that milder conditions for the preparation of algal cell 
lysates can be established to optimize the recovery of these amino acids. This may be 
achieved by straightforward adaptation of the autolysis protocol that was applied to Pichia.  
Remarkably, the observed decrease in expression yield of hLBP in YE based labeling 
medium is not caused by significant differences in the amino acid composition and the 
related metabolism of amino acids in the insect cell. Efficient secretion of hLBP may be 
influenced by several factors related to the YE composition. In particular, YE and AE differ 
significantly in their respective content of mono- and polysaccharides. Commercial protocols 
for the production of AE involve removal of nearly all carbohydrates prior to acid hydrolysis 
of the residual biomass. As compared to AE, autolysates of yeast contain carbohydrates, 
which may link the observed behavior with N-glycosylation of the precursor protein. 
N-glycosylation was identified as a strict requirement to enter the secretory pathway (141). 
However, refined analysis of both extracts to characterize carbohydrates and components 
other than amino acids is required to understand the difference in expression yield of AE 
compared to YE (142, 143). 
Moreover, it has been shown that uniform 15N-labeling of hLBP in insect cells is possible 
by a combination of 15N-labeled cell lysates of algae and yeast providing provides a basis of 
an economic labeling medium for expression of secreted proteins in insect cells. This initial 
labeling scheme can be expanded to uniform 13C and fractional 2H labeling in a 
straightforward manner. Deuteration has the prospect to further increase the spectral quality 
and thus will enable a more detailed characterization of hLBP and its interaction with 
lipopolysaccharide (LPS) by solution and solid state NMR experiments.  
In a similar approach, bacterial and algal extracts had been successfully combined for the 
production of labeled proteins in mammalian cell lines (32). Furthermore, studies in Chinese 
hamster ovarian cells have already shown that supplementation of YE tremendously increases 
 100 
cell proliferation and protein expression (144). The combined use of AE and YE has the 
potential to become an economic labeling strategy for mammalian cells. 
 
Material and Methods 
Isotope labeling and preparation of labeling media  
All custom media and stable isotope labeling schemes based on cellular extracts of yeast 
and algae were prepared as described in Chapter 2.1. 15N-labeled algal cell extract was 
purchased from a commercial supplier (ISOGRO, Sigma-Aldrich). 
 
Cell culture and preparation of recombinant Baculovirus  
In general, handling and maintenance of Sf9 cell culture was based on established 
protocols (118). Permanent cultures were subcultured in mid-log phase and kept in full SF-4 
medium (Bioconcept) and Insect Xpress medium (Lonza) at 27 °C and shaken at 80 rpm. 
Recombinant Bacmid DNA was generated in DH10Bac E. coli cells using the commercial 
pFastBac vector according to the supplier’s procedure (Life Technologies). Baculovirus was 
generated in adherent cultures as reported by O’Reilly et al. (118). Subsequently, high-titer 
virus stocks for expression were produced by two additional amplification rounds in 
suspension cultures. In the first amplification round, 50 ml of Sf9 cell culture containing 
1x106 cells/ml in serum-free medium were infected with recombinant virus and cultured until 
cell viability decreased to ≤90 %. The supernatant (P1) was collected by centrifugation at 
1000g and 4 °C for 15 min. For the second amplification round, 100 ml of serum-free Sf9 
cell culture containing 1x106 cells/ml was infected with P1 and processed accordingly to yield 
a P2 virus stock. 
Functional titration of the P2 virus stock was applied to determine the optimal amount for 
expression. Briefly, small-scale cultures of Sf9 cells were infected in full SF-4 medium at a 
cell density of 1.5x106 cells/ml with P2 virus stock corresponding to functional titers of 1 to 
10 ml per 1 L of cell culture. The yield of purified protein was then quantified for different 
expression times. 
 
Cloning and purification of human lipopolysaccharide binding protein 
Leonildo Delgado is gratefully acknowledged for establishing the expression and 
purification protocol of human lipopolysaccharide binding protein (hLBP). A synthesized 
gene sequence of hLBP was purchased from a commercial supplier (Genscript). Recombinant 
Baculovirus was prepared by insertion of the hLBP gene into the pFastBac vector (Life 
Technologies). Bacmid DNA was produced in DH10Bac E. coli cells according to the 
standard protocol provided by the supplier. Functional virus titer and the optimal expression 
time were determined in small-scale expression tests. hLBP was subsequently expressed in 
SF4-adapted Sf9 insect cells until the cell viability decreased to 80-85 %.  
After expression, medium containing secreted hLBP was seperated from the cells by 
centrifugation at 1000g for 10 min (4°C). The supernatant was filtered through a 0.22 μm 
filter and directly loaded on a strong cation exchange column (SP-Sepharose Fast Flow 
2 × 5 ml, GE Healthcare Life Sciences) equilibrated with 25 mM HEPES (pH 7.5), 100 mM 
NaCl and 5% glycerol (buffer A). Following a washing step with 2 column volumes (CV) of 
Buffer A, hLBP was eluted using a gradient of 25 mM HEPES (pH 7.5), 1 M NaCl and 5 % 
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glycerol (buffer B) from 0-100 % over 20 CV.  Fractions containing hLBP were combined 
and subsequently loaded onto a Ni Sepharose column (HisTrap HP 5 ml, GE Healthcare Life 
Sciences) initially equilibrated with 25 mM HEPES (pH 7.5), 500 mM NaCl and 5% glycerol 
(buffer A). The column was washed with 2 CV of buffer A, followed by gradient from 0-5 % 
in 4 CV of 25 mM HEPES (pH 7.5), 500 mM NaCl, 500 mM imidazole and 5 % glycerol 
(buffer B). Bound hLBP was finally eluted by a gradient of buffer B from 5-100 % in a total 
volume of 4 CV. Fractions containing hLBP were combined and concentrated by 
centrifugation in a 30 kDa MWCO filter (VivaSpin 15, Sartorius). The concentrated 
supernatant was loaded onto a size-exclusion column (Superdex 200 10/300 GL, GE 
Healthcare Life Sciences) equilibrated with 5 mM HEPES (pH 7.5), 500 mM NaCl and 
1 mM EDTA. Fractions containing hLBP were combined and concentrated for further 
analysis (VivaSpin 15, Sartorius). 
The NMR sample of 15N-hLBP was prepared in 5 mM HEPES (pH 7.4), 500 mM NaCl, 
1 mM EDTA, 5 % D2O and 0.01 % NaN3. 
 
NMR spectroscopy and data processing 
NMR experiments were recorded on a Bruker Avance III 900 MHz spectrometer equipped 
with a triple-resonance cryoprobe. All experiments on hLBP were acquired at a temperature 
of 37 °C. Amide proton T2 values were determined from a jump-return spin-echo experiment 
(145). The 2D 1H-15N-TROSY experiment on 15N-hLBP was recorded with 130 (15N) x 1024 
(1H) complex points, acquisition times of 26 ms (15N) x 43 (1H) ms, and a total experimental 
time of 60 h. INEPT transfer times were optimized for amide proton T2 values of hLBP. 
NMR data were processed and analyzed with the NMRPipe software package (128). 
 
Yeast growth and preparation of yeast extract 
Detailed protocols are presented in Chapter 2.1. 
 
Quantitative amino acid analysis by LC/MS 
Detailed protocols are presented in Chapter 2.1. 
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5 Synthesis of isotope-labeled glutamine by a 
two-step enzymatic procedure 
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Introduction 
L-glutamine plays an essential role for labeling media based on yeast and algal cell 
extracts described in Chapter 2.1 and Chapter 3. Insect cells utilize L-glutamine within the 
tricarboxylic acid (TCA) cycle, where it functions as an important nitrogen source for the 
synthesis of non-essential amino acids (35, 146, 147). In particular, L-glutamine is used to 
overcome limitations in L-glutamate, L-aspartate and L-asparagine (30). Consequently, this 
metabolic flexibility leads to significant isotope scrambling for 15N-labeled L-glutamine. 
While addition of L-glutamine to the medium is not strictly required for the growth of insect 
cells (35, 37), supplementation of isotope-labeled L-glutamine ensures sufficient expression 
levels and enables high isotope incorporation in insect cell culture media (Chapter 2.1). 
Unfortunately, all labeled variants of L-glutamine are expensive due to the instability of the 
amino acid. As indicated in Chapter 2.1, the costs of isotope labeling by 15N or 2H,15N are 
dominated by the price of 15N2-L-glutamine, which amounts to about 82 % of the total costs 
of the yeastolate-based labeling medium. 
Over the last decades, the use of deuteration has played a key role in advanced 
biomolecular NMR studies. Indeed, the majority of backbone and side-chain NMR 
experiments greatly benefit from deuteration especially when applied to larger proteins (148, 
149). However, the incorporation of deuterons into proteins produced in the 
baculovirus/insect cell expression system is difficult. The present method (Chapter 2.1) of 
supplementing homemade deuterated yeastolates and protonated L-glutamine in the labeling 
medium has only led to 60‑70 % deuteration. Although the overall level of deuteration is 
expected to improve by supplementation of deuterated L-glutamine, it comes at a prohibitive 
cost that might prevent routine application for many laboratories. 
As an alternative to purchasing isotope-labeled L-glutamine, it is also possible to 
synthesize L-glutamine from 2-oxoglutaric acid by enzymatic reactions in a laboratory 
environment. The first step involves reductive amination of 2-oxoglutaric acid by glutamate 
dehydrogenase to L-glutamic acid, which is then used as the precursor for the synthesis of L-
glutamine. A repetitive batch setup for the synthesis of L-glutamic acid from 2-oxoglutaric 
acid was reported two decades ago (150). The second step, which involves the enzymatic 
conversion of L-glutamic acid to L-glutamine upon condensation with ammonium, is 
catalyzed by a class of enzymes known as glutamate-ammonia ligases (151). This reaction is 
widely established for biochemical assays, but has seen only limited use for preparative scale 
production of L-glutamine so far (32). 
In this chapter, we present a detailed protocol for the enzymatic synthesis of L-glutamine 
which enables isotope labeling by 15N including fractional deuteration in an economic 
manner. Figure 5.1 depicts the overall reaction scheme, which combines the repetitive batch 
synthesis of L-glutamic acid (1) with the subsequent enzymatic conversion to L-glutamine 
(2). Fractional deuteration of L-glutamic acid was achieved by deuteration of the precursor 2-
oxoglutaric acid and analyzed by NMR spectroscopy. Furthermore, recombinant expression 
and purification of glutamate-ammonia ligase has been carried out to obtain a functional form 
of the enzyme thereby reducing the overall costs. 
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Figure 5.1 Enzymatic synthesis of isotope-labeled L-glutamine. In a first step, 2-oxoglutaric acid (1) and NH4Cl 
are converted to L-glutamic acid (2) by glutamate dehydrogenase. This reaction is coupled to the regeneration of 
NADH+H+ by formate dehydrogenase. Subsequently, (2) and NH4Cl are converted to 15N2-L-glutamine (3) by 
glutamate-ammonia ligase. In both reactions, use of 15NH4Cl leads to incorporation of 15N at the amine and 
amide positions. 
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Results and Discussion 
Synthesis of 15N-L-glutamic acid from 2-oxoglutaric acid and NH4Cl in a repetitive batch 
setup 
L-glutamic acid was produced by condensation of 2-oxoglutaric acid with NH4+ by 
glutamate dehydrogenase (GDH) according to the scheme depicted in Figure 5.1. As 
indicated in this scheme, efficient regeneration of NADH was achieved through oxidation of 
formate by formate dehydrogenase (FDH), which was reported previously by Kragl and 
coworkers (150). A detailed protocol of the reaction is outlined in Table 5.1. 
 
 
Figure 5.2 A Polarimetric analysis of L-glutamic acid formation at 589 nm. ORD was directly measured in the 
enzymatic reaction (Tab 5.1) at 25 °C using a light path of 1 dm yielding a specific rotation [𝛂𝛂]𝑫𝑫𝟐𝟐𝟐𝟐 of -1.24 
deg∙dm−1∙ml∙g−1. The dashed line indicates the obtained fit for a single exponential decay function. Degrees of 
rotation (α) were related to the concentration of L-glutamic acid by a calibration curve. B Incorporation of 15N 
determined by ESI-TOF mass spectrometry. L-glutamic acid was derivatized with phenyl isothiocyanat (PTC) 
prior to analysis by LC/MS leading to a monoisotopic mass of 283.06 Da. Likewise a mass of 284.06 Da 
corresponds to the 15N-labeled PTC-L-glutamic acid. 
 
L-glutamic acid is a chiral molecule and displays optical activity. The ability to rotate the 
plane of linearly polarized light is known as optical rotation and in the case of L-glutamic 
acid is strongly governed by the allowed electronic transitions of the carboxylate 
chromophore. Optical rotatory dispersion (ORD) can be measured at wavelengths far 
removed from the resonance frequency of the carboxylate group due to the dispersive nature 
of the phenomenon. To this purpose, samples were taken during course of the reaction and 
optical rotation was determined at 589 nm (Sodium D line), 25 °C and pH 8. A calibration 
curve for L-glutamic acid standards covering the concentration range of the reaction was 
determined by linear regression.  
Figure 5.2A shows the obtained degrees of rotation (α) over the course of the reaction. 
The initial value at the time point t = 0 h was determined in the absence of GDH and FDH, 
indicating the optical activity of NAD+ in the reaction mix. However, this contribution to the 
overall optical activity of the reaction mixture may change over the time course, as 
accumulation of NADH by activity of FDH occurs at the end of the reaction. To determine 
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the rate of product formation, a rapid equilibrium mechanism was assumed (152) and the data 
was fitted to a single exponential decay yielding an apparent rate constant of 0.63 h-1 and an 
amplitude of 0.09 degrees (dashed line, Figure. 5.2A). Using concentrations of 20 U/ml GDH 
and 200 mM 2-oxoglutaric acid (Table 5.1), this corresponds to a catalytic rate of 0.26 mM-1 
U-1 h-1. This rate is in good agreement with the expected value of 0.28 mM-1 U-1 h-1 based on 
the unit definition indicated by the commercial supplier (one unit converts 1.0 μmole of 2-
oxoglutaric acid to L-glutamic acid per min at pH 7.3, 25 °C).  
Furthermore, the time course of the reaction indicates that the equilibrium was reached 
after 6 h to 8 h. However, the determined α values correspond to a final yield of only 88.6 %. 
In a similar approach, the yield of L-glutamic acid was reported to be >95 % within 4 h of 
reaction (150). Both, the slight decrease in the rate of product formation and the yield suggest 
that the reaction conditions were not yet optimal. Interestingly, substrate inhibition of GDH 
by NADH was reported for a concentration ratio of the enzyme and the cofactor at similar 
conditions (152). This may relate to the activity of FDH, which determines the ratio of 
oxidized and reduced NAD(H). Therefore, increasing the initial amount of GDH or 
decreasing the initial amount of FDH may increase the rate and the yield of the reaction. 
Alternatively, simple reduction of the initial formate concentration may improve the reaction 
kinetics. 
 
Table 5.1 Repetetive batch synthesis of 15N-L-glutamic acid from 2-oxoglutaric acid and 15NH4Cl 
Enzymatic synthesis of 15N2-L-glutamic acid 
Solution 1 1. Prepare 100 ml of solution 1 in ultrapure water (Milli-Q) as follows: 
- 2.92 g 2-oxoglutaric acid (200 mM) 
- 1.09 g 15NH4Cl (200 mM) 
- 2.72 g sodium formate (400 mM) 
 2. Adjust solution to pH 8 
3. Filter-sterilize and store at 4 °C 
Enzymatic reaction 1. Prepare reaction mix in 20 ml solution 1 as follows: 
- 1 mM NAD 
- 20 U/ml glutamate dehydrogenase (GDH) 
- 1 U/ml formate dehydrogenase (FDH) 
2. Run reaction at 25 °C in a stirred filtration cell equipped with a 10 kDa MWCO 
filter membrane (e.g. AMICON) 
3. Follow reaction by polarimetric analysis at 589 nm 
4. Upon completion, filter reaction mix through the 10 kDa MWCO and collect 
permeate for crystallization 
5. Keep retentate (typically 1-2 ml) and add 18-19 ml of solution 1 to continue the 
reaction (step 2) 
Crystallization 1. Combine permeates from all repetitive runs 
2. Adjust pH of combined permeate to 3.2 
3. Cool solution to 4 °C and let crystalize overnight 
4. Separate crystals from residual permeate by filtration (glass frit, fine porosity) 
5. Wash crystals with ice-cold Milli-Q water 
6. Dry crystals in desiccator 
7. Perform another crystallization round with the residual permeate (step 4) using 
the obtained L-glutamic acid crystals as seeds 
8. Analyze purity and isotope incorporation by LC/MS 
 
To obtain pure L-glutamic acid, the reaction mix was filtered and the obtained permeate 
was subjected to crystallization as described in Table 5.1. In a first step, 76 % of the 
theoretical yield was obtained. An additional 12 % of crystalline L-glutamic acid was 
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recovered in subsequent crystallization step, amounting for a total yield of 88 %. This is in 
good agreement with the value determined by polarimetric analysis.  
Incorporation of 15N into synthesized L-glutamic acid was analyzed by mass spectrometry 
(Figure 5.1B), revealing a residual unlabeled fraction of 1.02 %, which was calculated as the 
ratio of the unlabeled peak integral over the sum of all observed 15N-labeled species. This 
value is consistent with the 15N-incorporation of 15NH4Cl (99 %). Likewise, mass 
spectrometry analysis showed that no traces of 2-oxoglutaric acid were present following 
crystallization. 
 
Enzymatic conversion of L-glutamate to L-glutamine by glutamate-ammonia ligase  
In the second step of the enzymatic synthesis, 15N-L-glutamic acid was converted to 15N2-
L-glutamine by a commercial glutamate-ammonia ligase (GAL) isolated from E. coli. A 
detailed protocol is presented in Table 5.2. Again, 15NH4Cl was employed as the nitrogen 
source in the reaction mixture. Thus, the condensation of 15NH4+ with L-glutamic acid will 
incorporate 15N into the carboxamide group of L-glutamine. The enzymatic reaction was 
analyzed by thin-layer chromatography (TLC) developed in 20:5:1 isopropanol/water/formic 
acid. Commonly, a silica gel matrix is used to separate L-glutamine and L-glutamic acid 
based on their different adsorption behavior. This difference in adsorption is caused by the 
distinct polarity of the functional groups in the side chains of both amino acids. Compared to 
the carboxamide group of L-glutamine, the more polar carboxylic group is decreasing the 
hydrophobicity of L-glutamic acid (153). Consequently, L-glutamine will interact stronger 
with the silica gel matrix of the TLC plate. A quantitative measure of the interaction and 
hence a way to identify different compounds is given by the retention factor, which is equal 
to the distance migrated by the compound over the distance covered by the solvent following 
complete development. 
 
Table 5.2 Conversion of 15N-glutamic acid and to 15N2-L-glutamine by glutamate-ammonia ligase 
Production of 15N2-L-glutamine by glutamate-ammonia ligasea 
1. Prepare 100 ml of reaction mix in ultrapure water (Milli-Q) as follows: 
- 1 g 15N-L-glutamic acid (67 mM) 
- 0.36 g 15NH4Cl (67 mM) 
- 6.6 g ATP-2Na (120 mM) 
- 1.9 g MgCl2 × 6 H2O (93 mM), for optimal reaction speed 120 mM should be used 
- 6 U/ml of glutamate-ammonia ligase (GAL), 12 U/ml were required to complete the reaction (Figure 5.3) 
- 50 μg/ml gentamycin 
2. Adjust to pH 7.6 and filter-sterilize. 
3. Run reaction at 37 °C for 48 h to 72 h. 
4. Maintain pH at 7.6 by addition of NaOH. 
5. Analyze reaction by thin-layer-chromatography or LC/MS. 
a Optimized reaction conditions are described in the main text 
 
Figure 5.3 shows the developed TLC plates for different reaction conditions including a 
reference for each amino acid. Retention factors of 0.54 and 0.42 were determined for 
commercial standards of L-glutamic acid and L-glutamine, respectively (Lane 1 and 2, Figure 
5.3). Initially, the enzymatic reaction was carried out in batch-mode at pH 7.5 and 37 °C for 
4 days without readjustment of the pH. Analysis of the intensity ratio obtained by TLC 
revealed that only a fraction of about 40 % was converted to L-glutamine under these 
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conditions (Lane 3, Figure 5.3). Further extension of the reaction time to a total length of 
7 days did not increase the yield of L-glutamine. However, a decrease in pH was observed 
during the course of the reaction. In the initial setup, the pH of the reaction mixture decreased 
to 6.5 after 16 h. The pH dependence of the enzyme activity was well described in previous 
studies, showing an optimum at pH 7.5 (154). With decreasing pH the activity significantly 
decreases, having declined to less than 60 % at pH 6.5 (154).  
 
 
Figure 5.3 Enzymatic synthesis of L-glutamine analyzed by 
thin-layer chromatography. Commercial standards of E (1) 
and Q (2) were employed to establish retention factors. 
Initial reaction conditions without readjustment of the pH (3) 
and optimized reaction under continuous pH control (4). 
Complete conversion to L-glutamine upon two-fold increase 
in enzyme concentration and tight pH control (5). 
 
To counteract this decrease and the correlated loss of enzyme activity, the pH of the 
reaction mixture was monitored and readjusted to 7.5 by addition of 5 M NaOH at regular 
time points during the course of the reaction. Without further modification of the reaction 
mixture, it was possible to increase the yield of L-glutamine to about 70 % after 2 days of 
reaction according to the intensity ratio of the TLC spots (Lane 4, Figure 5.3). The reaction 
was thus continued for another 2 days amounting to a total reaction time of 4 days. 
Remarkably, the yield remained unchanged indicating another limiting factor other than pH 
optimum. Therefore, the amount of GAL in the reaction mixture was varied to assess the 
effect of the enzyme concentration. Upon increasing the concentration of GAL by two-fold, 
complete conversion of L-glutamic acid to L-glutamine was achieved within 2 days (Lane 5, 
Figure 5.3). This finding may suggest a relation of the incomplete conversion to product 
inhibition by accumulation of ADP and pyrophosphate. In addition, the initial concentration 
of ATP has a significant impact on the velocity of catalyzed reaction (146). When free ATP 
is present in concentrations exceeding 30 mM, a decrease in the reaction rate was observed. 
The reaction was carried out using 93 mM of MgCl2 (Table 5.1), whereas an equimolar 
concentration of divalent magnesium ions is required to prevent substrate inactivation caused 
by free ATP. Therefore, reaction speed and yield may increase by addition of 120 mM MgCl2 
to account for the concentration of ATP. 
Since the entire amount of L-glutamic acid was converted to L-glutamine in this step of 
the reaction, the overall yield of L-glutamine production is simply limited by the efficiency of 
the first reaction, where 88 % of 2-oxoglutaric acid was converted to L-glutamic acid by 
GDH. Hence, the combined efficiency of the reaction is equal to 88 %. 
 
Fractional deuteration of L-glutamic acid by proton-deuterium exchange 
The described enzymatic synthesis of L-glutamine based on the precursor 2-oxoglutaric 
acid is amenable to partial deuteration. A detailed protocol for the selective deuteration of 
L‑glutamic acid at the Hβ positions is given in Table 5.3. In brief, the precursor 2-oxoglutaric 
acid was incubated at pD 10, 45 °C in 99.8 % D2O for 16 h to form 2-oxoglutaric-3,3’-d2 
acid. A similar approach was applied to achieve deuteration of 2-oxobutyric acid for the 
generation of 13C,2H-(1H-δ1 methyl)-isoleucine for NMR studies (2). 
E
Q
1 2 3 4 5
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Table 5.3 Fractional deuteration of 2-oxoglutaric acid in D2O 
Preparation of 2-oxoglutaric-2,2’-d2 acid 
1. Prepare 10 ml of reaction mix (RM) containing 1 g of 2-
oxoglutaric acid in 99.8 % D2O 
2. Adjust RM to pD 10 by addition of NaOD in D2O 
3. Incubate for 16 h at 45 °C 
4. Lyophilize RM 
5. Add lyophilized powder to Solution 1 (see Table 5.1)  
 
The underlying mechanism based on the keto-enol tautomerism of 2-oxoglutaric acid is 
depicted in Figure 5.4. As shown in this scheme, the acidity of the protons at the C3 position 
allows for the exchange of these protons with the deuterated solvent. In the next step, 
enzymatic conversion of 2-oxoglutaric-3,3’-d2 acid by activity of GDH results in selective 
deuteration of the Hβ positions in L-glutamic acid, which enables production of selectively 
deuterated L-glutamine according to the protocol given in Table 5.2. 
 
 
Figure 5.4 Base-catalyzed proton-deuterium exchange reaction of 2-oxolgutaric acid. The depicted keto-enol 
tautomerism (1) at elevated temperature and pH imposes an equilibrium of both tautomeric forms leading to an 
enolization of 2-oxoglutaric acid. Hence, the initial protonation of the C3 position is lost. The backward reaction 
when carried out in D2O eventually enables deuteration of the C3 position (blue circle) to yield 2-oxoglutaric-
3,3’-d2 acid (2).  
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Analysis of deuterium incorporation into L-glutamic acid by NMR 
Incorporation of deuterium at different positions of L-glutamic acid was analyzed by 1D 
1H NMR spectroscopy based on comparison with the fully protonated amino acid 
(Figure 5.5). A reference spectrum was obtained for protonated L-glutamic acid that displays 
splitting of the proton lines due to homonuclear JHH-couplings (Figure 5.5A). The assignment 
of the Hα (orange), Hβ (green) and Hγ protons (blue) was derived from the 1H chemical shift 
and expected multiplet structure (Figure 5.5B). In the case of L-glutamic-3,3’-d2 acid where 
homemade 2-oxoglutaric-3,3’-d2 acid prepared according to the exchange protocol in Table 
5.3 was employed as a precursor, the resonances of the Hβ protons disappear from the 
spectrum (Figure 5.5C). In addition, the Hα multiplet collapsed into a single line indicating 
efficient deuteration of the Hβ position. This is also evident from the obtained doublet of 
doublets of the Hγ protons, which originates from the 1JHH to the second Hγ proton and the 4JHH 
coupling to the Hα proton, respectively. Furthermore a secondary isotope shift of about 12 
ppb was observed for the Hα proton upon deuteration of the Hβ position. 
To quantify the level of deuteration in the selectively deuterated samples, the residual Hβ 
and Hγ resonances were integrated and the resulting integrals calibrated on the TSP signal. 
Proton-deuterium exchange (PDE) as described in Table 5.3 results in deuteration of the Hβ 
positions, whereas the Hγ positions remain protonated. Following PDE, a residual protonation 
level of about 3.9 % was observed for the Hβ position. This is slightly higher than the 
estimated residual protonation level in the reaction mixture of about 1.2 % based on the 
exchangeable protons of 2‑oxoglutaric acid and may be explained by incomplete exchange. 
Enzymatic conversion of the PDE-based precursor results in L-glutamic-3,3’-d2 acid but 
leaves Hα and Hγ positions protonated. In an effort to further extend the level of deuteration, 
the commercial precursor 2-oxoglutaric-3,3’,4,4’-d4 acid was employed for enzymatic 
synthesis of L-glutamic acid according to Table 5.1. Conversion of this precursor will 
generate L-glutamic-3,3’,4,4’-d4 acid leading to the deuteration of the Hβ and Hγ positions. 
The additional deuteration of the latter is shown 1D 1H NMR spectrum of L-glutamic-
3,3’,4,4’-d4 acid (Figure 5.5D). Obviously, the Hγ proton resonances disappear as a 
consequence of efficient deuteration. Again, the splitting of Hα proton line was absent due to 
substitution of the adjacent Hβ protons by deuterons. The residual protonation levels of the Hβ 
and Hγ positions were found to be 0.8 % and 2.1 %, respectively. These correspond to 
deuteration levels of 99.2 % and 97.9 %, which are in good agreement with the average 
deuteration level of 98 % of 2-oxoglutaric-3,3’,4,4’-d4 indicated by the commercial supplier. 
However, the Hα positions still remain protonated for both precursors, the commercial 2-
oxoglutaric-3,3’,4,4’-d4 acid and the homemade 2-oxoglutaric-3,3’-d2.  
It is well understood that the relaxation of HN and 13Cα is dominated by dipole-dipole 
interactions with the Hα proton (126, 155). Hence, deuteration of the Hα position is expected 
to yield a significant increase in sensitivity for these nuclei in modern backbone and side 
chain NMR experiments. To replace the remaining Hα protons in L-glutamic acid, addition of 
formic-d acid would be required in the initial step of the described protocol. It is expected 
that this leads to the deuteration of NAD+ by FDH to form NAD2H (156). NAD2H would 
subsequently be used by GDH during reductive amination of 2-oxoglutaric acid allowing 
incorporation of deuterium at the Hα position of L-glutamic acid. Hence, the synthesis of 
uniformly deuterated L-glutamic-2,3,3’,4,4’-d5 as well as fractional deuterated 
L‑glutamic‑2,3,3’-d3 acid may be established by this procedure using commercial 
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2‑oxoglutaric-3,3’,4,4’-d4 acid and homemade 2-oxoglutaric-3,3’-d2 acid, respectively. This 
approach has not yet been tested during the current thesis. 
 
 
Figure 5.5 Deuteration of L-glutamic acid analyzed by 1D 1H NMR spectroscopy. A The protonated reference 
indicating the Hα (orange), Hβ (green) and Hγ (blue) resonances. Bottom: Detailed comparison of protonated (B), 
fractional (C) and perdeuterated L-glutamic acid (D). Preparation of fractional and perdeuterated L-glutamic 
acid was performed as described in the main text. 
 
It is expected that deuteration of L-glutamic acid for all the described precursors of 
2‑oxoglutaric acid may be extended to L-glutamine, when deuterated L-glutamic acid is used 
for the synthesis of L-glutamine by activity of glutamate-ammonia ligase according to 
Table 5.2. 
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Recombinant expression and purification of glutamate-ammonia ligase  
To further reduce the cost of the procedure, recombinant glutamate-ammonia ligase 
(GAL) of Mycobacterium tuberculosis was expressed in E. coli. Initial expression trials 
indicated that a fraction of GAL was present in the pellet after cell lysis. Therefore, GAL was 
expressed at 30 °C to reduce aggregation and increase the recovery of soluble protein. The 
soluble form of the protein was obtained by a two-step purification based on Ni2+-NTA 
affinity and gel-filtration chromatography (see Materials and Methods) yielding 30 mg/L of 
purified GAL, which amounts to about 70 % of the total expression level when compared to 
remaining fraction in the pellet by SDS-PAGE analysis. 
GAL, like other bacterial glutamate-ammonia ligases, assembles into a dodecamer in 
solution, which is formed by two hexameric rings, stacked on top of each other 
(Figure 5.6A). Here, each active site includes contributions from two adjacent subunits. This 
dodecameric quaternary structure is required for the activity of the enzyme. Multi-angle light 
scattering coupled to a gel-filtration chromatography (SEC-MALS) was employed to 
determine the mass of GAL at different concentrations. Figure 5.6B shows the obtained 
chromatograms and associated molar mass values. The determined mass of 665.54 ± 3.1 kDa 
indicates a native dodecameric state that was found to be stable within a concentration range 
of 0.25 mg/ml to 1.5 mg/ml. However, the mass of the dodecamer based on the recombinant 
sequence of GAL is expected to be 656.7 kDa. While this observed difference may be 
explained by inaccuracy of the calibration used for the SEC-MALS setup, it could as well be 
related to the described adenylylation (AMPylation) of GAL in E. coli (157).  
 
 
Figure 5.6 A Functional assembly of bacterial glutamine-ammonia ligase (GAL). The dodecameric quartenary 
structure is formed by two hexamers stacked on top of each other, consisting of six identical monomeric 
subunits. Adjacent subunits are alternatingly colored in red and blue. B Multi-angle light scattering 
chromatrograms of recombinat GAL from Mycobacterium tuberculosis expressed in E. coli. Multiple runs were 
performed at different concentrations of GAL as indicated and normalized for the change in the refractive 
index (ΔRI).  
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Adenylylation is relevant to the activity of GAL and leads to inhibition of the enzyme. For 
a dodecamer of GAL, an additional mass of 3.6 kDa is expected corresponding to 12-times 
330 amu of adenosine-5’-monophosphate. Thus, adenylylation of GAL yields a theoretical 
mass of 660.7 kDa and cannot be excluded from the SEC-MALS result. 
 
Activity of glutamate-ammonia ligase 
The activity of GAL was determined by a microtiter plate assay, which was described 
recently by Gawronski and Benson (158). This assay monitors the release of inorganic 
phosphate that follows the hydrolysis of ATP during the forward reaction of GAL. An acidic 
solution of ammonium molybdate is then used to induce formation of an anionic phosphorous 
molybdate complex. Subsequent reduction with ascorbic acid yields molybdenum blue that 
correlates linearly with the amount of released phosphate. Molybdenum blue is quantified by 
absorption measurement at 655 nm.  
Using this assay, the Michaelis-Menten parameters were determined for the conversion of 
L-glutamate to L-glutamine at 37 °C in a reaction mixture containing 100 mM MOPS (pH 
7.5), 50 mM MgCl2, 50 mM NH4Cl and 7.5 mM ATP. First, reference kinetic parameters 
were obtained for commercial GAL extracted from E. coli (EC-GAL, Figure 5.7A). The 
determined KM of 12.71 mM (Table 5.4) corresponds to a significant increase compared to 
typically reported KM values for EC‑GAL ranging from 2.7 to 5 mM (159, 160). This hints on 
a reduction in the affinity for L‑glutamate and may indicate inhibition of the enzyme.  
 
 
Figure 5.7 A Activity of glutamine-ammonia ligase (GAL). Recombinant GAL from Mycobacterium 
tubercolusis (MTb-GAL) was compared to a commercial reference obtained from E. coli (EC-GAL, Sigma) and 
MTb-GAL treated with phosphodiesterase 1 (PDE1) to remove adenylylation (MTb-GAL + PDE1). Reaction 
kinetics were measured in 100 mM MOPS (pH 7.5), 50 mM MgCl2, 50 mM NH4Cl and 7.5 mM ATP by 
varying the concentration of glutamate from 0 to 25 mM. The release of inorganic phosphate per minute 
normalized for the amount of GAL in the reaction was measured as described in the text. Solid lines represent 
individual fits according to the Michaelis-Menten kinetic equation and the corresponding Michaelis-Menten 
parameters are given in Table 5.4. B Adenylylation (AMPylation) of L-tyrosine as seen for Y406 in GAL. 
Adenosine-5-monophosphate forms a phosphodiester bond with the hydroxyl group of the L-tyrosine side chain. 
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One possible explanation for the observed decrease in the substrate affinity of EC-GAL 
may be the pre-incubation of the plate at 37 °C prior to the reaction. This may result in the 
degradation of ATP and thus the formation of ADP, which is complexed by magnesium and 
is reported to inhibit GAL in a competitive mode (159). Given the supplier’s information on 
the activity of EC-GAL under similar conditions (pH 7.1 and 37 °C), a Vmax of about 33 nmol 
Pi/min/U is expected. The obtained Vmax of 6.67 nmol Pi/min/μg corresponds to 24 nmol 
Pi/min/U indicating a reduction in the rate of the reaction by about 37 %. A simultaneous 
decrease in the apparent Vmax and in the apparent affinity for L-glutamate (increase in KM) 
indicates mixed inhibition of EC-GAL. 
The recombinantly expressed GAL from Mycobacterium tuberculosis (MTb-GAL, 
Figure 5.7A) displayed a 4.3-fold higher KM relative to EC-GAL and in addition, a significant 
reduction in the Vmax by a factor of 2.5 (Table 5.4). This apparent decrease of the substrate 
affinity and the maximum reaction rate again indicates mixed inhibition of MTb-GAL (161). 
Interestingly, MTb-GAL has been reported to display reduced affinity for ATP compared to 
native EC-GAL even in the absence of adenylylation (157), which possibly hints on an 
overall difference in the enzymatic activities. 
 
Table 5.4 Michaelis-Menten paramaters of glutamate-ammonia ligase (GAL) for the substrate 
glutamate. Reaction kinetics were obtained in containing 100 mM MOPS (pH 7.5), 50 mM MgCl2, 
50 mM NH4Cl and 7.5 mM ATP by varying the concentration of glutamate from 0 to 25 mM. 
 Vmax [nmol Pi/min/μg] KM [mM] 
EC-GAL 6.67 12.71 
MTb-GAL 2.65 55.05 
MTb-GAL+PDE1 5.36 27.32 
 
Since adenylylation of GAL was not ruled out by the SEC-MALS measurements, GAL 
was treated with phosphodiesterase 1 (PDE1), which is known to remove adenylylation 
(162). Remarkably, incubation of GAL with PDE1 (MTb-GAL + PDE1, Figure 5.7A) 
resulted in a two-fold increase of Vmax from 2.65 to 5.36 nmol Pi/min/μg (Table 5.4). At the 
same time the apparent KM decreased from 55.05 to 27.32 mM. Incubation with PDE1 may 
remove AMP from Y406 (Figure 5.7B), thereby restoring the activity of MTb-GAL. Mass 
spectroscopic analysis is required to verify the adenylylation state but has been impeded so 
far by unsuccessful recovery of the peptide comprising Y406 following tryptic digestion. 
However, adenylylation of MTb-GAL was previously observed for recombinant expression 
in E. coli (157) and may thus explain the improvement of the kinetic parameters after the 
treatment with PDE1.  
 
Cost analysis of enzymatic production of L-glutamine  
An estimate of the cost associated with the enzymatic synthesis of isotope-labeled L-
glutamine is given in Table 5.5 based on the current market prices. Combination of the 
inexpensive precursors 15NH4Cl and 2-oxoglutaric acid with recombinant production of GAL 
enables the synthesis of 1 g 15N2-L-glutamine for a total cost of 59 EUR. 15N2-L-glutamine 
contributes significantly to the costs associated with the described isotope labeling media 
based on labeled yeast and algal extracts (Chapter 2.1 and Chapter 4). As indicated in 
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Table 5.3, this cost will eventually be reduced by more than ten times when 15N2-L-glutamine 
is produced according to the described protocol. It can also be noted, that the additional costs 
related to fractional deuteration of the Hβ positions are negligible.  
Furthermore, deuteration of the Hα position can readily be achieved enabling the synthesis 
of 15N2-L-glutamine-2,3,3’-d3, when formic-d acid is used to regenerate NAD+ in the first step 
of the reaction. This will increase the total costs of the procedure from 63 to 72 EUR. 
Although this labeling scheme is not commercially available, it is of great importance for 
backbone and side chain correlation experiments by NMR of larger proteins (126). Complete 
deuteration of L-glutamine requires the commercial precursor 2-oxoglutaric-3,3’,4,4’-d4 and 
addition of formic-d acid in the initial reaction step, which significantly increases the costs of 
the procedure. However, the enzymatic synthesis of 2H5,15N2-L-glutamine is still more 
economical than the commercially available 2H5,15N2-L-glutamine at a 2.5 times higher price 
(2500 EUR/g, Cambridge Isotope Laboratories).  
 
Table 5.5 Cost estimates for enzymatic synthesis of labeled L-glutamine based on a yield of 88 %a 
  Labeling of L-glutamine (1 g) 
Compound (Amount) 15N 
15N,2H2b 
(Hβ) 
15N,2H4c 
(Hβ and Hγ) 
Synthesis of L-glutamic acid  
GDH 156 Ud 6 6 6 
FDH 8 U 11 11 11 
NAD+ 0.26 g 5 5 5 
Na-formate 1.1 g 0.1 0.1 0.1 
2-oxoglutaric acid 1.14 g 0.5 0.5 910 
15NH4Cl 0.42 g 6 6 6 
D2O 12 ml - 4 - 
Synthesis of L-glutamine  
GAL 300 U (382)e (382)e (382)e 
15NH4Cl 0.36 g 5 5 5 
ATP-2Na 6.6 g 25 25 25 
MgCl2 1.9 g 0.1 0.1 0.1 
Total  59 (441) 63 (445) 968 (1350) 
a All costs are given in Euro using conservative estimates of the market prices 
b Synthesis of 15N2-L-glutamine-3,3’-d2 (Hβ) using the homemade precursor 2-oxoglutaric-3,3’-d2 acid 
c Synthesis of 15N2-L-glutamine-3,3’,4,4’-d4 (Hβ and Hγ) using commercial 2-oxoglutaric-3,3’,4,4’-d4 acid 
d Unit definition according to supplier (see Materials and Methods) 
e Costs account for purchase of commercial GAL and may be omitted by recombinant expression (see main text) 
 
Conclusion and perspective 
A step-by-step protocol for the enzymatic synthesis of isotope-labeled L-glutamine 
starting with 2-oxoglutaric acid has been described. Both, high conversion yield to glutamine 
(>88 %) and high levels of 15N and 2H incorporation were obtained. In particular, 15N 
incorporation in combination with selective deuteration of the Hβ and Hγ positions was 
achieved. While deuteration of the Hβ positions is performed by a base-catalyzed exchange in 
D2O prior to the enzymatic reaction, additional deuteration of the Hγ positions is primarily 
established for the commercially available precursor (2-oxoglutaric-3,3’,4,4’-d4 acid). A 
straightforward expansion of the described protocol may provide the possibility to deuterate 
the Hα position in L-glutamine by addition of formic-d acid in the initial reaction step. 
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Furthermore, a protocol for recombinant production of glutamate-ammonia ligase (GAL) 
in E. coli was described. Additional refinement of expression conditions to increase the yield 
of functional GAL is still required. One possible approach could rely on minimal media that 
are synthetically defined and do not contain glutamine, since presence of glutamine in the 
medium is reported to induce adenylylation of GAL (157). In parallel, treatment of purified 
GAL with PDE1 may be routinely employed to overcome adenylylation. The ability to 
produce sufficient amounts of this enzyme dramatically reduces the costs of the developed 
method. Along these lines, recombinant expression of formate dehydrogenase and glutamate 
dehydrogenase in E. coli were recently reported (163, 164). Hence, all enzymes can be 
obtained in their functional form by recombinant production at low overall costs. This is 
especially relevant for large-scale preparations of isotope-labeled glutamine. It is hoped, that 
this protocol including the homemade production of the required enzymes will be 
implemented in a standard laboratory environment to manufacture isotope-labeled glutamine 
in an economic manner. 
 
Material and Methods 
Repetitive batch synthesis of L-glutamic acid 
Glutamate dehydrogenase from bovine liver and formate dehydrogenase from Candida 
boidinii were purchased from a commercial supplier (Roche). Detailed protocols for the 
synthesis and the crystallization of L-glutamic acid are provided in Table 5.1. 
 
Polarimetric analysis of L-glutamic acid formation 
Optical activity of the reaction was determined at 589 nm (Sodium D line) in a cell of 10 
cm path length using a P-2000 polarimeter (Jasco Analytical Instruments). All measurements 
were carried out in the reaction mixture (see Table 5.1) at 25 °C. 
 
Enzymatic synthesis of L-glutamine by glutamate-ammonia ligase 
Glutamate-ammonia ligase from E. coli was purchased from a commercial supplier 
(Sigma-Aldrich). A detailed protocol of the reaction is given in Table 5.1. 
 
Thin-layer chromatographic analysis of amino acids 
Samples of the reaction mix were applied to aluminum supported silica gel TLC plates 
(Sigma-Aldrich). TLC plates were developed in 20:5:1 isopropanol/water/formic acid. Air-
dried plates were stained with 0.1 % ninhydrin in ethanol and subsequently heated for 10 min 
at 100 °C. 
 
Selective deuteration of 2-oxoglutaric acid 
Preparation of 2-oxoglutaric-3,3’-d2 acid by proton-deuterium exchange is described in 
Table 5.2. The deuterated precursor 2-oxoglutaric-3,3’,4,4’-d4 acid was purchased from 
Cambridge Isotope Laboratories. 
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NMR sample preparation  
A protonated reference and partially deuterated samples of L-glutamic acid were prepared 
in 99.96 % D2O containing 25 mM acetic-d3 acid-d (99 atom % D, Sigma-Aldrich) and 100 
μM 3-(trimethylsilyl)-2,2',3,3'-tetradeuteropropionic acid (TSP-d4) at pD 5.0.  
 
NMR spectroscopy and data processing 
NMR experiments were recorded on a Bruker Avance III 600 MHz spectrometer equipped 
with a broadband inverse (BBI) room temperature probe. All experiments on glutamic acid 
were acquired at a temperature of 30 °C. Fractional deuteration of glutamic acid was 
analyzed by 1D 1H NMR experiments using a single pulse-acquire sequence with acquisition 
times of 3 s. Interscan delays were optimized according to proton T1 times obtained by 
standard inversion recovery experiments. NMR data were processed and analyzed with the 
TopSpin 3.1 software package (Bruker). 
 
Recombinant expression and purification of glutamate-ammonia ligase in E. coli 
A synthesized gene of glutamate-ammonia ligase (glnA1) from Mycobacterium 
tuberculosis (Uniprot entry P9WN39) was purchased from GenScript. The sequence was 
codon-optimized for expression in E. coli and an N-terminal hexahistidine-tag was added to 
yield the final construct MGHHHHHHGS-glnA1(M1-V478) (GAL). Recombinant GAL was 
cloned into the pET-11a vector from Millipore. Shaker flask cultures of E. coli BL21 cells 
transformed with recombinant GAL were grown at 37 °C in LB medium until OD600 0.5. 
Protein expression was induced by addition of 1 mM isopropyl-D-thiogalactopyranoside 
(IPTG) and carried out for 8 h at 30 °C. Cells were harvested by centrifugation at 5000g for 
20 min. The pellet was resuspended in ice-cold 50 mM TRIS-HCl (pH 8), 100 mM NaCl, 20 
mM MgCl2, EDTA-free protease inhibitor cocktail (Complete, Roche) and 20 mM imidazole 
(Buffer A). Cell lysates were prepared by a french pressure cell press. The supernatant was 
separated from the cell debris by centrifugation at 10000g for 20 min at 4 °C and 
subsequently applied to a 5 ml HisTrap FF column (GE Healthcare) equilibrated in Buffer A. 
Unbound sample was removed with an additional 2 column volumes (CV) of Buffer A and 
the resin was washed with 10 CV of 50 mM TRIS-HCl (pH 8), 100 mM NaCl, 20 mM MgCl2 
and 50 mM imidazole. Finally, bound GAL was eluted with 50 mM TRIS-HCl (pH 8), 100 
mM NaCl, 20 mM MgCl2 and 250 mM imidazole. Fractions containing GAL were pooled 
and concentrated in a 30 kDa MWCO centrifugal filter unit (Milipore). Concentrated GAL 
was applied to a HiLoad 16/600 Superdex 200 gel-filtration column (GE Healthcare) 
equilibrated with 20 mM TRIS-HCl (pH 7.5), 100 mM NaCl, and 50 mM MgCl2. 
 
Activity assay and de-adenylylation of glutamate-ammonia ligase 
A microtiter plate setup for activity measurements of glutamate-ammonia ligase (GAL) 
was adapted from a previously described protocol (158). Briefly, substrate kinetics for 
glutamate were obtained in a reaction mixture containing 100 mM MOPS (pH 7.5), 50 mM 
MgCl2, 50 mM NH4Cl and 7.5 mM ATP by varying the concentration of glutamate from 0 to 
25 mM. All measurements were carried out for 5 min at 37 °C and pH 7.5. Non-linear fitting 
to the Michaelis-Menten kinetic equation was determined by a routine written in Matlab 
(MathWorks). 
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Removal of adenylylation was achieved by treatment of GAL with phosphodiesterase 1 
(PDE1) purified from snake venom (Sigma-Aldrich). Sufficient amounts of GAL were 
incubated with 5-10 U of PDE1 per mg of GAL at 37 °C for 2 h. Subsequently, PDE1 was 
removed by either gel-filtration chromatography on a Superdex 200 gel-filtration column (GE 
Healthcare) or centrifugal concentration using a 100 kDa MWCO.  
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Introduction 
Cell-free expression (CFE) has seen routine application for the production of isotope 
labeled proteins in NMR structural studies(101, 165-168). Over the past two decades a 
variety of protocols for selective and combinatorial labeling in the CFE system have been 
established. Figure 6.1 depicts the principle of the continuous-exchange cell-free reaction 
representing the open nature of the system. CFE enables direct addition of labeled amino 
acids based on a wide array of isotope-labeling schemes (169). Furthermore, these labeling 
protocols greatly benefit from diminished metabolic scrambling as compared to cell-based 
expression (101, 165). Conventional uniform labeling requires supplementation of all 20 
canonical amino acids in their isotope-labeled form. Although commercial suppliers offer 
tailor-made amino acid mixtures for CFE systems, the respective costs of these mixtures are 
still high. Therefore, alternative sources of labeled amino acids are desirable. Homemade 
yeast extracts (YE) have been previously applied as an economical source of amino acids for 
isotope labeling in insect cell cultures (Chapter 2.1). 
 
 
Figure 6.1 Continuous-exchange cell-free protein production. The reaction mixture containing the translation 
machinery is derived from an extract of cellular origin such as E. coli. In addition, the T7 RNA polymerase is 
used for transcription of the construct of interest. A dialysis membrane to enable constant exchange of the 
required substrates and efficient regeneration of ATP and GTP separates a feeding solution providing all 
reactants, which are consumed during the reaction. 
 
This chapter describes an initial approach to employ homemade YE as the source of 
labeled amino acids for the E. coli-based CFE system before thorough analysis of the YE 
amino acid content had been established (Chapter 2.1). Sufficient expression levels for 
structural studies were obtained using YE and by additional supplementation of the amino 
acid cysteine. The method was then applied for uniform 2H,15N-labeling of the green 
fluorescent protein GFP providing a well-resolved 1H,15N-HSQC spectrum. Based on the later 
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obtained results of single amino acid analysis (Chapter 2), a further optimization of the 
supplementation scheme is suggested. 
 
Remark on author contribution 
The work of this chapter was carried out together with Dr. Sina Reckel (formerly member 
of the lab of Prof. Sebastian Hiller, now EPFL Lausanne), who performed all cell-free 
reactions and provided all additionally required reactants. 
 
Results and Discussion 
Performance of yeast extract in cell-free protein synthesis  
Typically, all canonical amino acids required for protein synthesis are directly added to the 
cell-free reaction mixture. To test yeast extract (YE) as a source for these amino acids, an 
analytical scale continuous exchange cell-free expression (CECF) setup was used to express 
the green-fluorescent protein (GFP). GFP was chosen as a model system due to high 
productivity and the possibility of direct quantification by the intrinsic fluorescence of the 
protein. 
Samples from overnight CECF runs were taken and the fraction of insoluble protein was 
separated by centrifugation. Afterwards, GFP concentration in the obtained supernatants was 
quantified by the fluorescence at 515 nm following excitation at 485 nm using a microtiter 
plate reader. Figure 6.2 shows the resulting protein yields for different amino acid sources. 
Reference expression was established for the twenty canonical amino acids at concentrations 
of 0.5 mM yielding 216 (± 9) μg/ml of folded GFP (Figure 6.2, 20 aa). When yeast extract 
was used in the CECF reaction at a concentration of 5 mg/ml an average yield of 88 (± 1) 
μg/ml was obtained (Figure 6.2, YE). This corresponds to a significant decrease in the 
expression level by about 59.3 %. Remarkably, the yield of GFP stayed constant with 
increasing concentrations of employed YE. This hints at a complete abscence rather than an 
insufficient concentration of a single compound. 
In addition, algal extract (Figure 6.2, AE), which serves as the commercial source for 16 
out of 20 isotope labeled amino acids, was supplemented to CECF reactions at 5, 10, and 15 
mg/ml. When AE was supplemented at 5 mg/ml only 0.44 (± 0.1) μg/ml of folded GFP was 
obtained, while a maximum yield of 0.93 (± 0.2) μg/ml was achieved for 15 mg/ml AE. The 
average expression level for all AE conditions tested was equal to 0.65 μg/ml corresponding 
to an average reduction of about 129-fold relative to all analyzed YE conditions. Whether 
higher concentrations of AE would further improve the expression level was not tested at this 
point. However, as the overall expression was dramatically lower than the reference level, a 
substantial increase in the AE concentration would be required to recover the yield of GFP. 
Moreover, a correlation was found between the productivity and the employed concentration, 
which may indicate insufficient levels of several amino acids. As discussed in Chapter 4, the 
overall amino acid content of YE and AE was found to be similar, yet both extracts differ in 
their respective composition. Algal cell extracts do not contain tryptophan, cysteine, 
asparagine and glutamine as a result of acid hydrolysis. In contrast, all twenty amino acids 
can be detected in yeast extracts that are produced by autolysis of the yeast cells. Therefore, 
the obtained difference in GFP expression for AE and YE may simply relate to the difference 
in amino acid composition. 
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Figure 6.2	Continuous exchange cell-free production of GFP based on different amino acid sources. Expression 
levels were determined for a reference containing all 20 canonical amino acids (20 aa), yeast extract (YE) and 
algal extract (AE) shown in the inset. The concentration of GFP in the reaction mixture was determined from 
the fluorescence read-out of the soluble fraction, which was calibrated for GFP samples of known concentration 
using linear regression. Numbers below the bars indicate the concentration of the respective extract in mg/ml. 
 
Initial combinatorial trials in insect cells showed that when YE was the only source of 
amino acids in the labeling media, a significant improvement of the expression yield was 
obtained by additional supplementation of the amino acids cysteine, aspartate, asparagine, 
proline and tryptophan. This was obtained by screening for changes in the expression level 
using SDS-PAGE analysis, since a quantitative amino acid analysis of the extracts had not 
been established at this point. Accordingly, it was tested whether addition of these five amino 
acids (CDNPW) to the YE-based CECF reaction shows a similar improvement. Figure 6.3 
shows the expression level of GFP obtained when using the addition of two different batches 
of homemade YE (YE 1 and YE 2) at a concentration of 10 mg/ml in comparison with the 
addition of twenty canonical amino acids 0.5 mM each (20 aa). As before, a reduction of the 
expression level was observed for both YE preparations with 149 (± 17) μg/ml and 
107 (± 4) μg/ml of GFP for YE 1 and YE 2, respectively. This corresponds to a relative 
decrease in expression yield to 55.6 % and 42.9 % when compared to the 20 aa reaction for 
which 255 (± 9) μg/ml of GFP were obtained. Furthermore, the data indicate a difference 
between the two extracts, which may relate to variations in the extract preparation. When 
0.5 mM of CDNPW was supplemented to the YE-based reactions (+), recovery of GFP 
expression to 81.7 % and 68.8 % was observed for YE 1 and YE 2, respectively. This 
indicated that at least one of the added amino acids contributes significantly to the expression 
yield and presents a limiting factor in the prepared YE.  
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Figure 6.3 Performance of yeast extracts for cell-free production of GFP. Expression levels of GFP are shown 
for a reference reaction containing all 20 canonical amino acids (20 aa) and two batches of yeast extract (YE 1 
and YE 2) employed at 10 mg/ml. Reactions based on YE as the sole amino acid source are denoted by the “-“, 
while supplementation (0.5 mM each) of the amino acids C, D, N, P, and W is indicated by the “+”. The 
concentration of GFP in the reaction mixture was quantified as described in the text. 
 
Production of 2H,15N-GFP for NMR studies 
In a next step, labeling of GFP by 15N and 2H was investigated based on this protocol for 
the CECF system. To this purpose 2H,15N-labeled YE was prepared as described in Chapter 
2.3 and used in a CECF reaction supplemented with unlabeled CDNPW. Folded 15N-GFP 
was obtained from the supernatant of the reaction using Ni-NTA affinity chromatography 
followed by a buffer exchange step for NMR spectroscopy. Figure 6.4 shows the obtained 
1H-15N HSQC spectrum recorded for 9 h on the 60 μM sample of 2H,15N-GFP. Although the 
NMR data are of preliminary nature, the spectrum appears well dispersed and homogenous. 
In total, 205 peaks were observed, which correspond to 85 % of all 241 non-proline residues. 
The fact that CDNPW are unlabeled reduces the number of expected residues to 207, which 
agrees well with the observed number of resonances. In line with this expectation, a 
preliminary examination indicated that the readily assignable cysteine (C48, C76) and 
aspartate residues (D19, D102, D197) were missing. Careful analysis of the peak intensities 
may still reveal differences for the CECF and the insect cell derived protein (see Chapter 2.3) 
regarding label dilution.	 A recent report indicates no detectable isotope scrambling of C, P 
and W (101). However, significant scrambling for D and N was observed. Further analysis of 
the isotope incorporation by mass spectroscopy (Chapter 2.2) is required to characterize 
isotopic scrambling as well as label dilution present in YE-based CECF reaction. 
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Figure 6.4 1H-15N HSQC spectrum of 2H,15N-GFP produced in the CECF system using 15N-labeled YE and 
unlabeled CDNPW. The spectrum was recorded in 9 h on a 60 μM sample of 2H,15N-GFP obtained by affinity 
purification as described in the text. 
 
Refinement of the amino acid supplement 
To test whether all or only a subset of the initially supplemented amino acids CDNPW is 
required to restore expression, each amino acid was separately removed from the 
supplementation scheme and the expression level of GFP was quantified. Figure 6.4 shows 
the resulting productivity for different CDNPW-derived combinations of amino acids in 
CECF reactions containing 10 mg/ml of YE. Reference expression levels were again 
established for supplementation of CDNPW and YE (Figure 6.5, condition 1). The overall 
expression yield was slightly increased compared to the previous results, where the identical 
batch of YE was used. Batch to batch variations in the cell-free reactions may explain this 
effect (S. Reckel, personal communication). 
In case of YE alone (Figure 6.5, condition 8), a decrease in expression to about 48.8 % 
relative to the reaction supplemented with CDNPW was observed, which is in good 
agreement with the previous results. Remarkably, comparable expression levels were 
obtained when D, N, W and P where eliminated from the supplement (Figure 6.5, conditions 
2-5), suggesting that none of these amino acids is essential to improve the productivity of YE. 
In line with this observation, supplementation of DNPW was not sufficient to restore the 
yield (Figure 6.5, condition 7) and displayed equally low yields of GFP as YE alone (Figure 
6.5, condition 8). Therefore, supplementation was reduced to C and W recovering the yield of 
GFP (Figure 6.5, condition 6). Both results indicate that C is strictly required to achieve high-
level expression in the YE-based CECF setup. Presumably, supplementation of W is not 
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required as indicated by condition 4 in Figure 6.5. It is thus expected that supplementation of 
C alone in addition to YE is efficient for cell-free protein synthesis. 
However, supplementation of C alone was not tested in these preliminary experiments. As 
discussed in Chapter 2, cysteine is among the low-abundant amino acids in YE prepared by 
autolysis. The recovery of the expression level observed for supplementation by C-containing 
amino acid mixtures corroborates this finding. Although biosynthesis of cysteine is present in 
E. coli (170) the obtained data suggest that the respective pathway is inactive in the cell-free 
extract. A possible explanation for this inactivity may be given by the degradation or loss of 
the involved enzymes, which otherwise display significant aminotransferase and 
transamidation activity (101). Reduced metabolic scrambling of amino acids is indeed 
described for the cell-free system in the literature (101, 165). 
 
 
Figure 6.5	Influence of single amino acids on the productivity of yeast extract in the CECF reaction. Different 
combinations of the amino acids C, D, N, P, and W were added at concentrations of 0.5 mM to cell-free 
reactions supplemented with 10 mg/ml of YE. The expression level of GFP for individual reactions was 
determined as described in the text. 
 
Rational optimization of the supplementation scheme by amino acid analysis  
The experiments described above on amino acid substitution in YE-based CECF reactions 
were carried out before a thorough analysis of the amino acid content had been established. 
Using the later obtained results on the amino acid composition of YE, the limitation by 
individual amino acids can be quantified (Chapter 2). Figure 6.6 shows the amino acid 
content of CECF reactions supplemented with 10 mg/ml of YE (green bars) in comparison to 
concentrations of amino acid typically used for these reactions and the amino acid 
distribution of GFP (blue). Whereas in most cases, the concentration of amino acids exceeded 
those of the reference (0.5 mM, dashed line), concentrations of glutamine, histidine, 
methionine, and tryptophan were significantly lower in the YE-based reaction. However, 
supplementation of Q, H and M was not required to restore expression levels for all tested 
conditions (Figure 6.5). In contrast, supplementation of cysteine was strictly required but the 
respective concentration of C in YE has not been determined by amino acid analysis.  
The limitation in glutamine is possibly compensated by activity of glutamine synthetase, 
which performs the conversion of glutamate to glutamine and was reported to be present in 
the cell-free system derived from E. coli (101) . Moreover, the concentration of histidine in 
the YE-based CECF reaction differed only by a factor of 1.4 and may still support high-level 
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expression of GFP. Despite the 2.5-fold lower concentration of methionine in YE, none of the 
tested supplementation schemes containing cysteine (Figure 6.5, conditions 1-6) displayed a 
significant decrease in overall expression compared to the reference using 20 amino acids 
(Figure 6.3). This indicates that in contrast to cysteine, supplementation of methionine was 
not essential to restore expression. S30 extracts used for CECF reactions are prepared from E. 
coli K-12 strain A19 engineered for methionine prototrophy (171). Therefore, cysteine may 
donate sulfur for biosynthesis of methionine. 
Whereas the amino acid analysis suggests a possible limitation of tryptophan, no decrease 
in the expression level was observed when tryptophan was removed from the 
supplementation scheme (Figure 6.5, condition 4). Remarkably, GFP contains only a single 
tryptophan residue and hence, limitations of individual amino acids are expected to correlate 
with their abundance in the sequence of the expressed protein (Figure 6.6). Indeed, 
supplementation of the YE may be optimized according to the distribution of amino acids in 
the protein. In order to study the effect of glutamine, histidine, and methionine 
supplementation additional experiments are needed, but have not been carried out in this 
thesis due to time constraints.  
 
 
Figure 6.6 Concentrations of single amino acids in CECF reactions supplemented with 10 mg/ml of yeast 
extract (green) and amino acid distribution in GFP (blue). Reference concentrations of 0.5 mM used for cell-free 
protein synthesis based on 20 amino acid are indicated by the dashed line (172). The free amino acid content of 
the yeast extract was quantified by HPLC analysis following pre-column derivatization with phenyl 
isothiocyanate (Chapter 2.1). Levels of cysteine were not determined by this method (indicated by the asterisk). 
 
Preliminary cost analysis 
Given a working concentration of 10 mg/ml, 180 mg of labeled YE are required for a 
typical preparative scale CECF reaction volume of 18 ml (173). The associated costs for 
labeling by 2H and 15N are less than 10 EUR for a single reaction based on the cost analysis in 
Chapter 2.1 (Table 4). As shown in Figure 6.2, the concentration of YE may possibly be 
reduced to 5 mg/ml decreasing the reaction costs twofold. Furthermore, the obtained data 
supports unlabeled supplementation of cysteine for all protocols involving uniform isotope 
labeling and thus incurs practically no additional expense.  
Commercially available cell-free amino acids mixtures contain all 20 amino acids at 
defined concentrations (Sigma, Cambridge Isotope Laboratories). These mixtures are derived 
from algal extracts and thus require addition of the four deficient amino acids C, N, Q, and W 
(Chapter 5) increasing the costs of the product. Based on a conservative estimate of the 
market prices, labeling by 2H and 15N using such commercial mixtures amounts to 
approximately 180 EUR for a typical preparative scale reaction (18 ml). Therefore, reduction 
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of the costs per reaction by 14-fold is possible by use of the YE‑based protocol already 
accounting for the difference in yield. 
 
Conclusions and perspectives 
Originally, the cell-free approach was applied to screen for the required supplement of 
amino acids in YE-based labeling media for insect cells. Consequently, all CECF reactions 
were performed during an early stage in the development of the YE-based approach to 
isotope labeling. Eventually, the preparation of YE was optimized as described in 
Chapter 2.1. Therefore similar experiments employing more recent batches of YE are 
required. Furthermore, it is expected that production yields may only be limited by the 
amount of individual amino acids in the YE (Chapter 2.1). The optimal concentration of YE 
still remains to be determined for the modified protocol that employs supplementation of 
cysteine and tryptophan. Additional refinement based on the amino acid analysis of YE is 
required to obtain an optimal supplementation scheme for robust expression. In particular, 
supplementation of glutamine to the CECF reaction should be explored, which has been 
successfully used to obtain high protein yield in YE-based culture media for insect cells 
(Chapter 2.1). 
An initial protocol for cell-free protein synthesis employing homemade YE as the amino 
acid source has been developed. The associated decrease in productivity has been overcome 
by addition of cysteine and tryptophan, which were required to establish high levels of 
expression. The combined results of different supplementation schemes (Figure 6.5) suggest 
that presumably tryptophan can also be omitted. This approach enables economical 
production of labeled proteins for NMR studies in the commonly applied CECF setup and 
becomes particularly advantageous for the production of proteins that require deuteration. 
Uniform isotope labeling by 2H and 15N has been demonstrated for GFP yielding a well-
resolved 1H-15N HSQC spectrum. The protocol can be extended to 13C labeling by 
straightforward preparation of the respectively labeled YE. Future studies need to address 
isotope scrambling and label dilution, which can readily be accomplished by mass 
spectrometric analysis as described in Chapter 2.2. 
 
Material and Methods 
Preparation of yeast extracts 
Fermentation of Pichia pastoris was carried out as described in Chapter 2.1. Autolysis was 
induced by addition of 2 % (v/v) ethanol to 30 % (w/v) yeast slurries adjusted to pH 8 and 
performed for five days at 50 °C. Subsequently, extracts were filtered through a 10 kDa 
MWCO using a stirred filtration cell (Millipore). The obtained permeate was lyophilized to 
yield a powder of yeast autolysate (yeastolate). 
 
GFP construct for cell-free expression 
The amino acid sequence of the GFP construct (EGFP) used to evaluate the productivity 
of the cell-free reaction was 
 
MSKGEELFTGVVPILVELDG DVNGHKFSVSGEGEGDATYG KLTLKFICTTGKLPVPWPTL  
VTTLTYGVQCFSRYPDHMKR HDFFKSAMPEGYVQERTISF KDDGNYKTRAEVKFEGDTLV  
 131 
NRIELKGIDFKEDGNILGHK LEYNYNSHNVYITADKQKNG IKANFKIRHNIEDGSVQLAD  
HYQQNTPIGDGPVLLPDNHY LSTQSALSKDPNEKRDHMVL LEFVTAAGITHGMDELYKKL  
AAALEHHHHHH. 
An additional C-terminal hexahistidine tag was introduced to enable affinity purification 
of GFP for NMR studies. 
 
Continuous-exchange cell-free synthesis of GFP 
Setup of the E.coli-based cell-free expression system was adapted from the recently 
published protocol (173). Analytical scale reactions were performed in homemade dialysis 
chambers fitted to a 24-well plate format at 30 °C for 16 h. Algal amino acid extracts 
(ISOGRO) were purchased from Sigma-Aldrich.  
 
Quantification of GFP expression 
Productivity of the cell-free reactions was determined by measurements of the intrinsic 
GFP fluorescence using a 96-well format in a microtiter plate reader (BioTek Instruments). 
Fluorescence of the soluble fractions was quantified at 515 nm following excitation at 
485 nm. Soluble fractions containing folded GFP were obtained by centrifugation of the cell-
free reactions at 15000g for 10 min. 
 
Purification of 2H,15N-GFP for NMR spectroscopy 
15N-GFP was obtained from the supernatant of the cell-free reaction by centrifugation at 
15000g for 10 min at room temperature and subsequently applied to a 1 ml HisTrap FF 
column (GE Healthcare) equilibrated in 20 mM sodium phosphate (pH 7.2), 100 mM NaCl, 
and 20 mM imidazole. Unbound sample was removed with an additional 2 column volumes 
(CV) of the equilibration buffer and the resin was washed with 5 CV of 20 mM sodium 
phosphate (pH 7.2), 100 mM NaCl, and 50 mM imidazole. Finally, bound GFP was eluted 
with 20 mM sodium phosphate (pH 7.2), 100 mM NaCl and 250 mM imidazole. Fractions 
containing GFP were pooled and buffer-exchanged using a 10 kDa MWCO centrifugal 
concentration unit (Millipore). The NMR sample was prepared as a volume of 270 μl 
containing 60 μM of 2H,15N-GFP in 20 mM BIS-TRIS (pH 7) and 50 mM NaCl.  
 
Purification of 2H,15N-GFP for NMR spectroscopy and data processing 
The 2D 1H-15N HSQC experiment on 2H,15N-GFP was recorded at 25 °C with 75 (15N) x 
1024 (1H) complex points and acquisition times of 30 ms (15N) and 40 ms (1H) on a Bruker 
Avance III 800 MHz spectrometer equipped with a triple-resonance TCI cryoprobe. NMR 
data were processed with the NMRPipe software package (128). 
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7 Analysis of the proteomic response to 
deuteration in E. coli 
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Introduction 
Deuterium labeling is of major importance for NMR studies of high molecular weight 
proteins (>20 kDa) and protein complexes (2, 149). Efficient incorporation of deuterium is 
possible in the prokaryote E. coli and lower eukaryotic systems such as yeast by growth on 
deuterated media with 100 % D2O as solvent (2). However, higher eukaryotic cells do not 
tolerate such growth conditions. Accordingly, in the last two decades deuterium labeling has 
been performed almost exclusively and with great success in E. coli. Surprisingly, adaptation 
of E. coli to growth in D2O has not been studied systematically and thus remains poorly 
understood. However, the understanding of the cellular processes related to survival of E. coli 
in a highly deuterated environment may help to develop methods for deuterium labeling in 
higher eukaryotic cells. 
Interestingly, despite successful adaptation to growth in D2O, the biomass of E. coli is 
significantly lowered and a reduction in expression yield is generally observed (174, 175). 
Deuterium kinetic isotope effects are known to decrease steady-state enzyme kinetics in 
reactions involving bond cleavage and proton transfer steps (176, 177). Consequently, 
introduction of deuterium may significantly affect enzyme-catalyzed rates and binding 
equilibria. Moreover, deuteration causes changes in the thermal stability of enzymes (178), 
which may alter their lifetimes and genetic regulation of their activities. A recent metabolic 
study by NMR utilizing 13C-labeled glucose revealed differential regulation of the 
tricarboxylic acid cycle (TCA) in deuterated minimal media suggesting energy starvation 
(175). However, a single key factor could not be determined to improve deuterated 
expression in E. coli.  
This chapter describes a proteomic approach to study the response of E. coli to growth in a 
perdeuterated minimal medium. The analysis revealed significant changes for a total of 263 
proteins upon adaptation to the deuterated environment. A functional classification of the 
involved genes related the observed differences to generic stress response, which is similar to 
temperature or osmotic stress. In agreement with previous studies, the data indicate 
regulatory changes in the anaplerotic reactions of the TCA (175) and further suggest elevated 
activity of the electron transport chain as well as oxidative phosphorylation to generate 
energy. Moreover, a substantial decrease in the expression level of 30S and 50S ribosomal 
proteins was observed, which is the possible cause for the decrease of protein expression in 
deuterated minimal media. 
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Results and Discussion 
Adaptation of E. coli to growth in a perdeuterated environment 
Robust expression of uniformly deuterated proteins in E. coli requires one or more 
intermediate adaptation steps in minimal media typically comprising fractions of 30, 50 or 
70 % D2O. Growth in these adaptation cultures is limited to the end of the exponential growth 
phase, effectively restraining the number of cell divisions and thus the likelihood of 
mutations (179). Therefore, short-term adaptation of E. coli to growth in a perdeuterated 
minimal medium was studied on the proteome but not on the genome level.  
First, cultures of the E. coli expression strain BL21(D3) were grown in protonated M9 
minimal medium (light cultures) to the end of the exponential growth phase. These cultures 
were used to obtain the reference expression level in a protonated environment. In the next 
step, cells were adapted to growth in D2O using M9 medium containing 70 % D2O and finally 
grown in perdeuterated M9 medium containing 99.8 % D2O and 2H7-glucose (heavy cultures) 
to emulate the protocol used for uniform deuteration. 
Growth of E. coli on the nutritionally rich lysogeny broth (LB) medium typically results in 
mean generation times of ~0.5 h. When grown on minimal media, the mean generation time 
increased to ~1 h in protonated M9, ~1.5 h in M9 containing 70 % D2O, and ~2.5 h in 
perdeuterated M9, respectively. To obtain uniform adaptation of E. coli to growth in these 
minimal media, cultures were grown for five generations corresponding to the end of the 
exponential growth phase. 
Light and heavy cultures were normalized for their total protein content and subject to 
LC/MS analysis following tryptic digestion to identify changes in the peptide level between 
the two cultures. 
 
Analysis of the proteomics data  
Initially, proteomics data were analyzed using the commercial software package 
Progenesis IQ (Nonlinear Dynamics, version 2.0). This approach yielded robust peak 
detection results for a total of 10748 light peptides, which were subsequently identified using 
Mascot (Matrix Science). However, the corresponding heavy peptides were not correctly 
detected and thus, quantification of these peptides was not possible. Progenesis employs a 
peak-modeling algorithm based on continuous wavelet transformation in combination with 
isotope pattern matching (180), which enables robust peak detection and handling of the 
noisy MS data (181). Whereas highly accurate peak identification was obtained for the 
natural abundance isotopologue pattern of the light peptide, pattern matching is impeded for 
the corresponding heavy peptide by complex convolution patterns of deuterium due to 
incomplete deuteration. More specifically, residual protonation of the solvent (0.2 %) and 
2H7-glucose (<2 %) results in isotopologue distributions comprising protonated isotopomers. 
The abundance of these isotopomers increases with the number of aliphatic proton positions 
for a given peptide and hence is significant for the quantification. 
 
Quantification of the protein level in deuterated E. coli cells  
To overcome the above described quantification problem, an in-house algorithm for exact 
detection of deuterated isotopic envelopes (EDDIE) was used to allow quantification of the 
heavy peptides. EDDIE relies on the prediction of the isotopic pattern based on the 
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incorporation level of deuterium and accounts for a shift in retention time on the reverse 
phase column caused by deuteration of aliphatic hydrogen positions of the amino acids.  
In a first step, peak detection was verified for a total of 10748 light peptides, which were 
combined per protein to obtain protein level intensities (Figure 7.1A). The intensities 
obtained by EDDIE correlated strongly (r2 = 0.99) with the results determined by Progenesis. 
This method was then used for quantification of the related heavy peptides in the 
perdeuterated cultures. To account for the occurrence of protonated isotopologues, 
quantification was performed by summation of the intensities for the five most abundant 
isotopologue peaks of the peptide matching the predicted m/z values. These five peaks 
typically present ~99.5% of the theoretical isotopologue pattern, which was calculated using 
a binomial distribution and a conservative estimate of the residual protonation level of 1.5 % 
based on deuterium labeling of individual medium components (see Materials and Methods). 
Unique peptide intensities were combined for individual proteins to obtain the protein level 
intensities. The correlation between light and heavy protein intensities (r2 = 0.84) determined 
by EDDIE indicated that the majority of the protein expression levels were not altered as a 
response to growth in a deuterated environment (Figure 7.1B). This hints at a specific change 
in the proteome of D2O-adapted cultures. 
 
 
Figure 7.1 A Correlation of logarithmic protein intensities determined by Progenesis IQ and the in-house 
algorithm EDDIE. Light peptides were identified in whole cell lysates of E. coli cultures grown in protonated 
minimal medium (light cultures) following tryptic digestion. Protein level intensities were obtained by 
combining the annotated light peptide intensities as described in Materials and Methods. B Quantification of the 
protein intensities in perdeuterated relative to protonated E. coli cells. The heavy peptide intensities were 
quantified in whole cell lysates of E. coli cultures grown in perdeuterated minimal medium (heavy cultures) by 
EDDIE using the sum of the five most abundant deuterated peaks for a single heavy peptide (see main text) and 
converted to the related heavy protein intensities. 
 
Changes in the protein expression upon growth in D2O 
Protein expression levels were analyzed for three biological replicates of E. coli BL21(D3) 
cells cultured in protonated M9 minimal medium (light cultures) and perdeuterated M9 
medium containing 99.8 % D2O and 2H7-glucose as the sole carbon source (heavy cultures). 
Heavy/light protein ratios were calculated per protein based on quantification of the peptide 
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level by EDDIE to identify the change in the proteome. The obtained ratios were then tested 
for differential expression using moderated t-statistics based on empirical Bayes estimators 
(182) and corrected for multiple comparison using the Benjamini-Hochberg procedure (183). 
This approach estimates the false discovery rate for a change in the abundance of a single 
protein expressed as the q-value (see Materials and Methods).  
Figure 7.2 shows a double logarithmic plot for the calculated heavy/light protein 
abundance ratios and the corresponding q-values. From a total of 1082 detected proteins, 420 
were recognized as confident hits using a q-value cut-off of 0.01. These confident hits were 
further constrained using a 2-fold abundance ratio cut-off identifying 239 proteins 
(Figure 7.2, colored circles), for which a significant difference in the expression level was 
observed. Compared to E. coli cultures grown in protonated minimal medium, in D2O-
adapted cells the expression was lowered for 76 proteins (Figure 7.2, brown circles) and 
increased for 163 proteins (Figure 7.2, blue circles). This indicates that the proteomic 
response to high levels of deuterium is very likely not limited to only a single metabolic or 
regulatory pathway. 
 
 
Figure 7.2 Proteome-wide response of E. coli to growth in a perdeuterated environment. Significant changes in 
the protein abundance (q-value ≤0.01) corresponding to a 2-fold increase or decrease in the expression level are 
shown in blue and brown, respectively. Heavy/light ratios were calculated from protein level intensities 
determined in whole cell lysates of E. coli cultures grown in protonated (light) and perdeuterated (heavy) M9 
minimal medium. Protein level intensities were determined by quantification of the annotated light and 
corresponding heavy peptide intensities using EDDIE as described in the main text. The q-values reflect a 
significant change of the expression level controlled by the false discovery rate (see Materials and Methods). 
 
It should be noted that the difference in protein abundance level could also in part be due 
to the change from a nutritionally rich LB to the M9 minimal medium. More specifically, the 
overall number of generations grown in minimal medium differs for the protonated (five 
generations) and perdeuterated culture (fifteen generations). To identify possible changes in 
the protein abundance level related to adaptation of E. coli to growth on protonated M9 
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medium alone, extended subculturing in this medium is required to obtain the same overall 
number of generations with respect to the perdeuterated culture. This will be verified in 
additional experiments. However, for the present analysis is was assumed that such an effect 
is insignificant as metabolic adaptation of E. coli predominantly occurs within the initial lag 
phase of the culture (184).  
Differential expression data were grouped by their biological function to identify the 
response to D2O adaptation using the functional annotation tool of the DAVID bioinformatics 
resources (http://david.ncifcrf.gov, v6.7) (185). Out of 236 identified, 25 genes were 
uncharacterized according to the functional cluster annotation table of DAVID. This refers to 
proteins, for which comprehensive information on the structure and function is limited and 
for some cases has been predicted by in silico methods alone. Consequently, careful analysis 
of these proteins is required to identify their biological context and their relevance for 
adaptation.  
A comprehensive discussion of all identified proteins is beyond the scope of this thesis 
and thus a limited number of proteins will now be discussed in detail, which may contribute 
to an understanding of the adaptation to growth in high levels of D2O.  
 
Response to abiotic stress 
Among all identified groups, the most notable change in the protein expression in the 
perdeuterated minimal medium was related to a response to abiotic stress (Table 7.1, abiotic 
stress response). Such a response is typically induced by limitation of a substrate, temperature 
or osmotic stress. The expression levels in this functional group were significantly increased 
for all genes but the cold shock protein (cspA).  
Entericidin B (encB) and the osmotically-inducible lipoprotein E (osmE) are directly 
linked to osmotic stress. At high osmolarity conditions, encB was found to induce cell death 
acting as a bacteriolytic lipoprotein (186). Similarly, increased levels of osmE were found in 
cultures grown in a hyperosmotic medium and associated with a modification of the 
supercoiled DNA structure (187). The hyperosmotic behavior of deuterium oxide is well-
known to cause shrinking of living cells (188). A possible explanation is the decrease in the 
zero-point energy of deuterium compared to hydrogen (189), which leads to a slightly 
stronger bond between the deuteron and oxygen in D2O, thereby lowering the self-ionization 
tendency of the molecule. Consequently, the solubility of ions is lowered in D2O (190). This 
may influence the activity of ion channels, which are essential to regulate the cell volume 
(191). Remarkably, the expression level of the morphogene bolA was increased 13-fold, 
which has been described to cause a round morphology (192). A sphere-like cell shape 
effectively offers to smallest surface-area-to-volume-ratio and may function to minimize the 
contact area with the hyperosmotic solvent. Furthermore, overexpression of three lipoproteins 
(ybjP, yceB, and ydcL) was observed, which have not been functionally characterized. As 
these proteins are localized in the outer membrane of E. coli, they may play a role in 
adaptation to osmotic stress. 
Remarkably, the proteomic response to growth in a perdeuterated environment in part 
resembles a protective reaction to temperature stress in E. coli. Incorporation of deuterium 
directly affects the stability of cellular macromolecules and may cause similar structural 
changes as imposed by a high temperature shock. However, genes such as endo IV are further 
indicative for a physiological response to oxidative stress induced by a possible accumulation 
of pro-oxidants (193). Furthermore, increased levels of glutaredoxin-2, thiol peroxidase (tpx), 
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and the manganese-dependent superoxide dismutase (sodA) were observed (Table 7.1, 
electron transport reactions), which function to prevent cell damage by quenching of active 
oxygen species. Pro-oxidants are naturally occurring during aerobic energy generation (193) 
but may accumulate as a consequence of the significant changes in oxidative phosphorylation 
and the electron transport chain. A response to oxidative stress was further supported by 
upregulation of the multidrug resistance protein (mdtE), for which activity was shown to 
increase upon oxygen deprivation (194). The requirement for rigorous aeration to enable 
high-level expression in highly deuterated cultures of E. coli (175) may be rationalized by the 
observed increase of mdtE. 
Interestingly, a substantial 7.7-fold increase in the protein abundance was found for the 
universal stress protein G and was even more pronounced for the related universal stress 
protein F (14.3-fold). These two genes have been reported to show an additive effect in 
response to oxidative stress and promote cellular adhesion (195).  
 
Changes in the stability of cellular macromolecules  
It is expected that incorporation of deuterium and the solvent effect of D2O may alter the 
strength of non-covalent interactions, which are the key-stabilizing elements in secondary 
structures of proteins and nucleic acids (178, 189, 196). Therefore, genes associated with a 
response to abiotic stress were classified for their function in maintaining the structural 
integrity of the cell as well as the assembly and disassembly of cellular macromolecules. The 
resulting list of functional groups contained several chaperones, proteases, DNA repair 
enzymes, and regulatory proteins involved in stress response pathways as well as ribosomal 
proteins (Table 7.1), which necessarily intersect with the previously described functional 
groups.  
Increased levels of the heat shock protein hslJ and the small heat shock protein ibpA were 
observed (197, 198). Heat shock proteins resemble a family of ubiquitous chaperons essential 
to the protein folding machinery and temperature-induced stress response in many cells 
(199). Recent studies in yeast grown in D2O and deuterium-resistant Chlorella mutants linked 
adaptation to growth in a highly deuterated environment to increased levels of the heat shock 
proteins 70 and 60 (200, 201). However, the protein abundance level of dnaK, the E. coli 
homolog of the heat shock protein 70, was only changed by about 1.8-fold, albeit satisfying 
the false discovery rate (q-value ≤0.01). Therefore, dnaK was not considered for the present 
evaluation but is possibly involved in the response to deuteration. Accordingly, an 8-fold 
increase in the protein abundance level was observed for the thiol:disulfide interchange 
protein dsbC. Previously it was shown that dsbC functions as an isomerase to resolve 
erroneously formed disulfides in proteins (202). Overexpression of heat shock chaperones 
suggests that protein misfolding occurred more frequently and hence may require reshuffling 
of non-native disulfide bonds in folding intermediates of cysteine-containing proteins. 
Similarly, genes specifically involved in DNA repair were significantly altered upon 
deuteration. Most notably, upregulation was observed for the endonuclease 4 (endo IV) and 
the uvrABC system protein B (uvrB). Both proteins are involved in the excision repair 
mechanism of damaged double-stranded DNA such as base loss, deamination or oxidation 
(203, 204). This process is known as transcription-coupled DNA-repair and resembles a rate-
limiting step in transcription (205). 
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Regulation of transcription 
Gene functional analysis further indicated differential expression of proteins linked to 
regulation of transcription (Table 7.1, regulation of transcription), which were mainly 
upregulated. The integration host factor subunit beta (ihfB) is known to be involved in the 
maintenance of the DNA architecture, acting globally to ensure correct DNA replication and 
transcription	(206). Interestingly, ihfB was reported to promote bending and supercoiling of 
DNA (207, 208) and is possibly linked to increased levels of osmE. Interestingly, osmotic 
stress has been shown to increase the level of DNA supercoiling in E. coli (209), which is in 
line with the above described hyperosmotic behavior of D2O and the observed response to 
abiotic stress. Moreover, two mRNA chaperones, the DNA-binding protein stpA (210) and 
the cold-shock protein cspA were identified. Interaction of the latter was reported to prevent 
formation of non-native secondary structure (211). Incorporation of deuterium possibly alters 
stability and folding of mRNA caused by a difference in the relative stabilities of hydrogen 
bonds in the molecule (189). Therefore, a change in the expression levels of cspA and stpA 
possibly indicates misfolding of mRNA, which is likely to interfere with transcription as well 
as translation.  
 
Changes in the ribosome biogenesis and translation 
A possible alteration of the translation in E. coli adapted to growth in a perdeuterated 
environment was indicated by a decrease in the abundance of several 30S and 50S ribosomal 
proteins (Table 7.1, translation). This hints at an overall decrease in translation in these 
cultures. However, this decrease may as well be interpreted as a modulation of the 
transcriptional activity to facilitate survival of the D2O-induced stress, which is possibly 
favored over proliferation and growth at these conditions. Moreover, the 30S ribosomal 
protein S4 (rpsD) is not only a structural constituent of the ribosome, it also functions as a 
negative regulator of translational initiation and displays translational repressor activity (212, 
213). The observed decrease in rpsD possibly indicates a difference in the regulation of 
translation upon deuteration. Again, this response may be explained by changes in the 
stability of the different RNA species (mRNA, rRNA, and tRNA) or the ribosome itself 
caused by deuterium incorporation. 
Furthermore, the level of the ribosome-associated inhibitor A (raiA), known to regulate 
transcription, was found to be increased 3-fold. The activity of raiA was described to 
compensate for errors during translation by counteracting miscoding (214), which possibly 
links overexpression of raiA to a change in the pairing of amino acids with cognate tRNA 
typically observed for temperature-induced stress. 
In contrast to the overall reduction in the protein abundance level of ribosomal proteins, a 
concurrent upregulation of the expression was observed for the arginyl-tRNA synthetase 
(argS). Oxidative stress was reported to significantly reduce the translational fidelity by 
impairment of the aminoacyl-tRNA synthetase editing site, eventually inhibiting growth of 
E. coli in the presence of reactive oxygen species (215). Accordingly, high levels of D2O are 
likely to cause mistranslation. This may be explained by (i) impairment of upregulated argS 
or (ii) altered stability of the corresponding aminoacyl-tRNA, and is possibly counteracted by 
increased expression of the related gene.  
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Modification of the energy metabolism 
Adaptation to growth in minimal media containing high fractions of D2O was shown to 
cause distinct changes in the metabolic flux of the TCA (175). To identify such a change on 
the proteome level, genes related to the cellular energy generation were grouped using the 
functional annotation tool of DAVID (Table 7.1, TCA). In general, differential expression 
was observed for several enzymes involved in the aerobic energy metabolism of E. coli. 
Consequently, electron transport and oxidative phosphorylation reactions may vary 
significantly in the perdeuterated environment, which suggests a change in the cellular energy 
demand (Table 7.1, electron transport reactions and oxidative phosphorylation). Most 
notably, an 8-fold increase in the protein level abundance was found for the hydrogenase-1 
large chain. The membrane-bound hydrogenase-1 is involved in the generation of the proton 
motive force in the presence of oxygen and has been reported to appear sensitive to osmotic 
stress (216-218). Hence, upregulation of hydrogenase-1 is in line with the observed response 
to osmotic stress in D2O-adapated cultures. 
Moreover, rearrangement of the TCA was identified in accordance with the changes in the 
respiratory energy generation. In particular, a significant increase in the expression level of 
phosphoenolpyruvate carboxykinase (pckA) and downregulation of pyruvate dehydrogenase 
(aceE) was observed. Whereas pckA catalyzes the synthesis of phosphoenolpyruvate from the 
TCA-cycle intermediate oxaloacetate, the activity of aceE involves decarboxylation of 
pyruvate to yield acetyl-coA. Regulation of these enzymes is required for metabolic flux 
control of the carbon metabolism (219, 220). Together, the identified change in their protein 
abundance levels suggests a decrease in glycolysis and a concurrent activation of 
gluconeogenesis (219).  
Remarkably, expression of isocitrate lyase was upregulated 18-fold, which strongly 
suggests increased activity of the glyoxylate bypass (221). This was further supported by 
significant overexpression of the transcriptional regulator kdgR responsible for regulation of 
the glyoxylate shunt (222). The glyoxylate shunt is an alteration of the TCA used for 
anaplerotic replenishment of oxaloacetate and characteristic for utilization of carbon sources 
other than glucose (221). This metabolic bypass reaction resembles an important step in the 
gluconeogenesis pathway and avoids carbon loss due to two consecutive decarboxylation 
steps in the regular TCA. Rearrangement of the metabolism may indicate a severe decrease in 
the rate of glycolysis, which may trigger alternative pathways such as the glyoxylate shunt to 
fulfill the energy requirement of the cell in a highly deuterated environment. The second 
enzyme essential to this pathway, which resembles an anaplerotic alteration of the TCA, is 
malate synthase (glcB). Indeed, a significant increase was observed in the protein abundance 
level of glcB. However, the corresponding q-value (0.09) was larger than the cut-off (≤0.01) 
applied in the present analysis. 
  
Biosynthesis of tryptophan and differential expression of ABC transporters  
Moreover, a functional group was identified comprising proteins involved in the 
biosynthesis of tryptophan (Table 7.1, tryptophan biosynthesis). The role of tryptophan for 
adaptation to growth in a perdeuterated environment is unclear. Conversely, biosynthesis of 
tryptophan is regulated by nutritional stress and activity of this pathway has been reported to 
increase in minimal media deficient in tryptophan (223). Whereas E. coli cultures grown in 
protonated minimal medium were directly transferred from LB medium, fully D2O-adapated 
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cells were grown on the basis of this minimal medium for two more cultures (70 % and 
99.8 % D2O). Consequently, the protocol used for adaptation of E. coli may have caused the 
observed change in the expression level.  
Differential expression was also observed for proteins belonging to the transport system 
superfamily of ATP-binding cassette transporters (Table 7.1, ABC transporters). However, 
this group has not been considered at this point, as a comprehensive analysis requires further 
information on the role of these transporters for adaptation to growth on minimal medium. 
Again, the length of the overall adaptation time in minimal medium may have affected the 
expression of the related transporters and thus the transport of several nutrients irrespective of 
the perdeuterated environment. This possibility will be investigated in further control 
experiments. 
 
Table 7.1 Selected changes in the protein expression level of E. coli cultures adapted to growth in 
perdeuterated minimal media with q-values ≤0.01. Functional clusters and gene annotations were 
obtained using the DAVID bioinformatics resource.  
UniProt 
accession Gene name 
Heavy/light 
ratio (log2) 
q-value 
(-log10) 
ABC transporters   
P0AG82 Phosphate-binding protein pstS 1.38 3.95 
P30859 Arginine-binding periplasmic protein 1 1.01 3.05 
P0AFK9 Spermidine/putrescine-binding periplasmic protein 1.11 2.3 
P09551 Lysine-arginine-ornithine-binding periplasmic protein 3.87 4.69 
P0AD96 Leu/Ile/Val-binding protein 5.30 5.63 
P30860 Arginine-binding periplasmic protein 2 -1.06 3.33 
P23843 Periplasmic oligopeptide-binding protein -1.01 3.17 
P0AEX9 Maltose-binding periplasmic protein -1.31 3.49 
P02925 D-ribose-binding periplasmic protein 1.22 2.52 
P37902 Glutamate/aspartate periplasmic-binding protein 1.84 4.05 
Abiotic stress    
P0A9X9 Cold shock protein cspA -2.33 4.05 
P0A6C1 Endonuclease 4 3 2.66 
P0ADB7 Entericidin B 4.59 5.63 
P52644 Heat shock protein hslJ 1.25 2.64 
P00946 Mannose-6-phosphate isomerase 2.74 2.15 
P37636 Multidrug resistance protein mdtE 1.27 3.94 
P0ADB1 Osmotically-inducible lipoprotein E 2.25 4.32 
P0AFH8 Osmotically-inducible protein Y 3.37 5.14 
P0C0L2 Peroxiredoxin osmC 3.38 4.3 
P23894 Probable protease htpX 1.56 3.67 
P0ABE2 Protein bolA 3.70 5.55 
P0C054 Small heat shock protein ibpA 1.37 2.85 
P75818 Uncharacterized lipoprotein ybjP 1.25 4.54 
P0AB26 Uncharacterized lipoprotein yceB 2.91 5.34 
P64451 Uncharacterized lipoprotein ydcL 2.13 3.74 
P0A8F8 UvrABC system protein B 2 3.68 
Aerobic energy metabolism   
P0AFG3 2-oxoglutarate dehydrogenase E1 component 1.62 3.76 
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UniProt 
accession Gene name 
Heavy/light 
ratio (log2) 
q-value 
(-log10) 
P25516 Aconitate hydratase 1 2.76 5.34 
P0A9P0 Dihydrolipoyl dehydrogenase -1.23 3.58 
P0AFG6 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex 1.13 3.62 
P0ACD8 Hydrogenase-1 large chain 3.03 5.13 
P08200 Isocitrate dehydrogenase [NADP] 1.16 3.12 
P0A9G6 Isocitrate lyase 4.17 5.34 
P61889 Malate dehydrogenase 1.61 3.75 
P00393 NADH dehydrogenase -2.12 4.84 
P0AFD1 NADH-quinone oxidoreductase subunit E 1.25 2.37 
P31979 NADH-quinone oxidoreductase subunit F 1.07 3.68 
P0AC41 Succinate dehydrogenase flavoprotein subunit 1.40 3.74 
P0AC44 Succinate dehydrogenase hydrophobic membrane anchor subunit 2.26 3.96 
P07014 Succinate dehydrogenase iron-sulfur subunit 2.24 4.29 
P0AGE9 Succinyl-CoA ligase [ADP-forming] subunit alpha 1.66 4.61 
DNA repair    
P0A6C1 Endonuclease 4 3 2.66 
P15032 Exodeoxyribonuclease 8 -3.97 4.85 
P0A7G6 Protein recA -1.21 3.42 
P30958 Transcription-repair-coupling factor -1.17 2.14 
P0A8F8 UvrABC system protein B 2 3.68 
Electron transport reactions   
P0ABJ9 Cytochrome d ubiquinol oxidase subunit 1 -2.7 4.88 
P0A9P0 Dihydrolipoyl dehydrogenase -1.23 3.58 
P0AC59 Glutaredoxin-2 1.20 3.39 
P00393 NADH dehydrogenase -2.12 4.84 
P0AFD1 NADH-quinone oxidoreductase subunit E 1.25 2.37 
P28304 Quinone oxidoreductase 1.25 3.45 
P27306 Soluble pyridine nucleotide transhydrogenase 1.55 2 
P0AC41 Succinate dehydrogenase flavoprotein subunit 1.4 3.74 
P07014 Succinate dehydrogenase iron-sulfur subunit 2.24 4.29 
P46853 Uncharacterized oxidoreductase yhhX 1.14 2.32 
Osmotic stress    
P0ADB1 Osmotically-inducible lipoprotein E 2.25 4.32 
P0AFH8 Osmotically-inducible protein Y 3.37 5.14 
P0C0L2 Peroxiredoxin osmC 2 4.3 
P0ABE2 Protein bolA 3.7 5.55 
Protein folding    
P29131 Cell division protein ftsN 1.06 2.14 
P0AEU7 Chaperone protein skp -1.27 3.74 
P0ABZ6 Chaperone surA 1.29 3.45 
P0ACG1 DNA-binding protein stpA 1.47 3.62 
P0AEX9 Maltose-binding periplasmic protein -1.31 3.49 
P23843 Periplasmic oligopeptide-binding protein -1.01 3.17 
P0AFK0 Protein pmbA 1.5 3.74 
P0AEG6 Thiol:disulfide interchange protein dsbC 3.01 4.38 
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UniProt 
accession Gene name 
Heavy/light 
ratio (log2) 
q-value 
(-log10) 
Oxidative phosphorylation   
P0ABA6 ATP synthase gamma chain 1.22 2.53 
P68699 ATP synthase subunit c -3.45 5.55 
P0ABJ9 Cytochrome d ubiquinol oxidase subunit 1 -2.76 4.88 
P00393 NADH dehydrogenase -2.12 4.84 
P0AFD1 NADH-quinone oxidoreductase subunit E 1.25 2.37 
P31979 NADH-quinone oxidoreductase subunit F 1.07 3.68 
P0AC41 Succinate dehydrogenase flavoprotein subunit 1.4 3.74 
P0AC44 Succinate dehydrogenase hydrophobic membrane anchor subunit 2.26 3.96 
P07014 Succinate dehydrogenase iron-sulfur subunit 2.24 4.29 
Regulation of transcription   
P0A7V8 30S ribosomal protein S4 -1.4 3.74 
P69913 Carbon storage regulator 1.11 2.3 
P0A9X9 Cold shock protein cspA -2.33 4.05 
P0ACG1 DNA-binding protein stpA 1.47 3.62 
P0A6Y1 Integration host factor subunit beta 1.05 3.63 
P0AD49 Ribosome-associated inhibitor A 1.55 3.76 
P0C054 Small heat shock protein ibpA 1.37 2.85 
P76268 Transcriptional regulator kdgR 1.25 3.35 
TCA    
P0AFG3 2-oxoglutarate dehydrogenase E1 component 1.62 3.76 
P25516 Aconitate hydratase 1 2.76 5.34 
P0A9P0 Dihydrolipoyl dehydrogenase -1.23 3.58 
P06959 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex -1.69 4.28 
P0AFG6 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex 1.13 3.62 
P08200 Isocitrate dehydrogenase [NADP] 1.16 3.12 
P61889 Malate dehydrogenase 1.61 3.75 
P22259 Phosphoenolpyruvate carboxykinase [ATP] 1.21 3.99 
P0AFG8 Pyruvate dehydrogenase E1 component -1.97 4.74 
P0AC41 Succinate dehydrogenase flavoprotein subunit 1.4 3.74 
P0AC44 Succinate dehydrogenase hydrophobic membrane anchor subunit 2.26 3.96 
P07014 Succinate dehydrogenase iron-sulfur subunit 2.24 4.29 
P0AGE9 Succinyl-CoA ligase [ADP-forming] subunit alpha 1.66 4.61 
P30178 Uncharacterized oxidoreductase ybiC 1.42 4.09 
Temperature shock   
P0A9X9 Cold shock protein cspA -2.33 4.05 
P52643 D-lactate dehydrogenase -1.78 3.75 
P52644 Heat shock protein hslJ 1.25 2.64 
P0AG82 Phosphate-binding protein pstS 1.38 3.95 
P23894 Probable protease htpX 1.56 3.67 
P0A7G6 Protein recA -1.21 3.42 
P0AD49 Ribosome-associated inhibitor A 1.55 3.76 
P0C054 Small heat shock protein ibpA 1.37 2.85 
P39177 Universal stress protein G 2.94 4.56 
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UniProt 
accession Gene name 
Heavy/light 
ratio (log2) 
q-value 
(-log10) 
Translation    
P0A7S3 30S ribosomal protein S12 -1.51 2.65 
P0A7V3 30S ribosomal protein S3 -1.12 3.68 
P0A7V8 30S ribosomal protein S4 -1.4 3.74 
P0ADY3 50S ribosomal protein L14 -1.11 3.24 
P0A7K6 50S ribosomal protein L19 -1.15 3.45 
P60422 50S ribosomal protein L2 -1.07 3.31 
P0A7L3 50S ribosomal protein L20 -1.62 3.14 
P0A7Q1 50S ribosomal protein L35 -1.31 3.44 
P11875 Arginyl-tRNA synthetase 1.3 3.67 
P0A8N5 Lysyl-tRNA synthetase, heat inducible -1.18 3.17 
P0AD49 Ribosome-associated inhibitor A 1.55 3.76 
P16456 Selenide, water dikinase 1.59 2.81 
P0A8L1 Seryl-tRNA synthetase -1.17 3.67 
Tryptophan biosynthesis   
P00895 Anthranilate synthase component 1 -1.13 2.83 
P07639 3-dehydroquinate synthase 3.74 5.34 
P00888 Phospho-2-dehydro-3-deoxyheptonate aldolase -1.05 2.53 
P00909 Tryptophan biosynthesis protein trpCF 1.04 3.31 
P00904 Anthranilate synthase component II 1.35 3.76 
 
Conclusions and perspectives 
Proteomic analysis of E. coli adapted to growth in perdeuterated minimal medium was 
established to identify changes in the protein expression level. A key challenge for this 
approach is the adaptation procedure, which requires serial passage of E. coli in minimal 
media containing increasing levels of D2O. In the present study, adaptation was achieved by 
growth of E. coli for five generations in the respective minimal medium to obtain uniformly 
adapted cultures. As cells were first grown on nutritionally rich lysogeny broth (LB) medium, 
a possible response may occur to growth on minimal medium and may still be apparent in the 
proteome of perdeuterated cultures. To identify such a response based on the described 
approach, changes in the protein expression level may be analyzed in cultures continuously 
grown on protonated minimal medium alone or using cultures grown on LB medium as a 
reference, alternatively. 
The proteomic response of E. coli was analyzed with respect to the associated biological 
function revealing remarkable differences in the regulation of transcription and translation. 
Most notably, a generic response typically linked to temperature-induced and osmotic stress 
was observed upon deuteration. Among these response genes, chaperons acting on RNA and 
DNA were identified, which suggests an alteration in the stability of nucleic acids caused by 
incorporation of deuterium. Significant differences in the expression of the ribosome-related 
control genes such as raiA and rpsD suggest increased occurrence of misreading events 
during translation. This observation further supports the idea of a deuterium-related change in 
nucleic acid stability. Moreover, several chaperons involved in protein folding displayed 
higher expression levels in a perdeuterated environment. The hydrophobic effect of the 
solvent is possibly enlarged in D2O (196) and may increase the aggregation propensity as 
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well as the number of non-native conformations sampled during protein folding. Adaptation 
to growth in a perdeuterated environment may be further influenced by abiotic factors other 
than the properties of the solvent such as the aeration and the pH of the culture. To identify 
such an influence, tight control of these parameters is required, but only limited in culture 
flasks. Fermenter-controlled growth of E. coli in perdeuterated minimal medium may enable 
to identify a possible proteomic response to changes in the aeration and the pH on the 
adaptation. 
Furthermore, alteration of the cellular energy metabolism was observed in D2O-adapted 
cells, which is in agreement with the recently reported changes in the TCA (175). The 
proteome-wide analysis also revealed changes in the oxidative phosphorylation, which was 
not accessible to the previous metabolic analysis by 13C-NMR. Whereas a significant change 
of the aerobic energy generation was indicated by the differences in the expression of 
proteins in the electron transport chain, enzymes required for gluconeogenesis and the 
glyoxylate pathway were simultaneously upregulated. This metabolic switch is likely caused 
by a kinetic isotope effect, which may affect rate-limiting steps in glycolysis and the TCA. 
The overall energy demand of D2O-adapted cells may increase due to elevated chaperone 
activity and error correction mechanisms related to improper translation. 
Eventually, the approach may guide the development of optimized protocols for 
deuterated expression in E. coli, which are aimed at improving the protein yield by genetic 
modification to increase resistance to D2O and refinement of deuterated minimal media. 
Particularly, supplementation of acetate is likely to overcome deficiencies in the energy 
metabolism solely based on glucose (184). Alternatively, growth on an increased amount of 
glucose may also be possible to improve the protein yield. In addition, genetic modification 
may be performed by long-term adaptation to a perdeuterated minimal medium to select for 
random mutations, which promote growth and expression under this condition. Further, it is 
hoped that proteomic analysis can be employed to identify the limitations of deuterated 
expression in higher eukaryotes. Common to eukaryotic cells is their high degree of internal 
organization in functional compartments such as the nucleus and mitochondria, which are 
bounded by intracellular membranes (38). As inferred from the proteomic response of E. coli, 
osmotic stress in a perdeuterated environment is likely to change the size of these 
compartments and may interfere with their function. The preliminary results obtained for E. 
coli also indicate a central role of anaplerotic reactions to handle the increased demand of 
energy, which was apparent from differential expression of proteins involved in the electron 
transport chain. Interestingly, the existence of a glyoxylate shunt has not been established for 
insect and mammalian cells (224). In theory, the required enzymes malate synthase and 
isocitrate lyase may be transiently introduced during expression using the baculovirus (78). A 
major concern with respect to the observed increase in the level of chaperones is a possible 
cell cycle arrest of higher eukaryotic cells due to significant alteration of DNA and RNA 
stability, which is likely to ultimately inhibit growth in a perdeuterated medium. Hence, like 
for E. coli, stepwise adaptation to high levels of D2O is expected to be required for the higher 
eukaryotic expression systems.  
A possible extension of the described approach may complement the proteomic analysis 
with changes in the transcriptome and even allow for detection of alternative splicing patterns 
and gene fusion (225). Indeed, changes in the mRNA level may not correlate to the observed 
difference in protein expression (226) and thus might reveal additional insights into gene 
regulation. Moreover, stability-related changes in the protein abundance may be identified 
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with this combined approach as deuteration is reported to improve or worsen the stability of 
proteins based on the nature of the weak interaction (189, 196).  
 
Material and Methods 
Growth and adaptation of E. coli  
Cultures of E. coli BL21(D3) cells were grown on a rotary shaker (220 rpm, 50 mm 
throw) at 37 °C in batches of 10 ml in 100 ml Erlenmeyer flasks to provide sufficient 
aeration. Adaptation to growth in D2O was achieved by repeated subculturing. First, cultures 
grown to stationary phase in LB medium were used to inoculate M9 minimal medium at an 
OD600 of 0.1. Subsequently, cells in protonated M9 medium were grown for about 5 h to the 
end of the exponential growth phase and samples were taken for whole-cell lysis. To reduce 
the spillover of unlabeled medium, cells were separated from the supernatant by 
centrifugation at 5000g for 5 min. The pellet was carefully resuspended in M9 medium 
containing 70 % D2O to yield an OD600 of 0.1 and cultures were grown for about 7.5 h to the 
end of the exponential growth phase. Finally, cells adapted to growth in 70 % D2O were 
transferred to 99.8 % D2O M9 medium containing 2 g/L 2H7-glucose (98 %-d7, Sigma-
Aldrich) as the sole carbon source (M9-D). Again, cultures were inoculated to yield an 
OD600 of 0.1 and centrifugation was used to limit dilution of the isotope label. M9-D cultures 
were grown for about 12 h to the end of the exponential growth phase and samples were 
taken for whole-cell lysis. Samples of M9 and M9-D cultures were normalized for the 
determined OD600. 
 
Whole-cell lysis and tryptic digestion of E. coli 
Cell pellets were resuspended in 100 mM ammonium carbonate containing 2 % sodium 
deoxycholate (SDC) and 5 mM TCEP (lysis buffer). The cells were lysed by combined harsh 
vortexing (3 × 30 s) and sonication (3 × 10 s, 0.5 cycle and 100 % amplitude) using a 
VialTweeter (Hielscher). Obtained lysates were heated at 95 °C for 10 min shaken at 
500 rpm, followed by centrifugation at 10.000g for 10 s to remove cell debris. The protein 
concentration in the supernatant was determined using a BCA assay kit (Thermo Fisher 
Scientific). Subsequently, samples were diluted in lysis buffer to yield protein concentration 
of 5 μg/μl and alkylation was performed on 100 μg of total protein in a volume of 20 μl using 
10 mM of freshly prepared iodoacetamide for 30 min at 25 °C in the dark. The excess of 
iodoacetamide was quenched by addition of 12 mM N-acetyl-cysteine. 
For digestion, samples were diluted to yield a final SDC concentration of 1 % using 
100 mM ammonium carbonate. Subsequently, trypsin (Sigma-Aldrich) was added in a 
1:50 enzyme/protein ratio digestion was performed over night at 37 °C. The reaction was 
terminated by addition of 1 % trifluoroacetic acid, followed by centrifugation to remove SDC 
precipitate at 15.000g for 10 min (4 °C). Centrifugation was repeated once more and the 
obtained supernatant was used for solid phase extraction. 
Peptides were desalted on a C18 reversed-phase spin column according to the supplier’s 
manual (Macrospin, Harvard Apparatus). Three biological replicates of cells grown in M9 
and M9-D were normalized by their peptide content and combined for LC/MS analysis. 
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LC-MS/MS analysis 
Each sample was subjected to LC–MS analysis using a dual pressure LTQ-Orbitrap Elite 
mass spectrometer connected to an electrospray ion source (Thermo Fisher Scientific) as 
described recently (102) with a few modifications. In brief, peptide separation was carried out 
using an EASY nLC-1000 system (Thermo Fisher Scientific) equipped with a RP-HPLC 
column (75 μm × 45 cm) packed in-house with C18 resin (ReproSil-Pur C18–AQ, 1.9 μm 
resin; Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) using a linear gradient from 
95 % solvent A (0.15 % formic acid, 2% acetonitrile) and 5 % solvent B (98 % acetonitrile, 
0.15 % formic acid) to 28 % solvent B over 120 min at a flow rate of 0.2 μl/min. The data 
acquisition mode was set to obtain one high resolution MS scan in the FT part of the mass 
spectrometer at a resolution of 240,000 full width at half-maximum (at m/z 400) followed by 
MS/MS scans in the linear ion trap of the 20 most intense ions. The charged state screening 
modus was enabled to exclude unassigned and singly charged ions and the dynamic exclusion 
duration was set to 30 s. The ion accumulation time was set to 300 ms (MS) and 50 ms 
(MS/MS). 
 
Identification and quantification of non-deuterated peptides 
MS raw files were imported into the Progenesis QI LC-MS software (Nonlinear 
Dynamics, Version v.2.0) and analyzed using the default parameter settings. MS/MS data 
were exported directly from Progenesis in mgf format and searched using Mascot (Matrix 
Science, Version 2.4.0) against a concatenated target-decoy E. coli protein database including 
forward and reversed sequences (UniProt, release date 01.01.2015 including 4479 target 
sequences). The search criteria were set as follows: 10 ppm precursor ion mass tolerance, 
0.6 Da fragment ion mass tolerance, and full tryptic specificity required (cleavage after lysine 
or arginine residues); maximum 3 missed cleavages; fixed modification: 
carbamidomethylation (C), variable modification: oxidation (M). The database search results 
were filtered limiting the peptide and protein level false discovery rate (FDR) to 1 %. The 
Mascot peptide identifications were subsequently imported into Progenesis and mapped to 
the detected MS1 peaks to ≤90 %.  
 
Relative quantification of deuterated and non-deuterated proteins 
Peak identification and quantification for deuterated peptides was obtained using an in-
house algorithm for exact detection of deuterated isotopic envelopes (EDDIE) written in 
Python 2.7. Theoretical isotope patterns of deuterated peptides were calculated as binomials 
accounting for residual protonation and matched with the observed m/z values in the MS1 
data. The retention times of the light peptides determined by Progenesis QI were used to 
define a retention time window for the corresponding deuterated peptides. Relative 
quantification was based on the intensities of the monoisotopic mass of the light peptide and 
the five most abundant deuterated isotopomers excluding natural abundance contributions. 
Peptide annotated MS1 peak intensity lists were processed to obtain protein level relative 
abundances using the SafeQuant R package (available on CRAN) (102). Global data 
normalization was achieved by equalizing the total MS1 peak intensities across all LC-MS 
runs and channels. Subsequently, normalized MS1 peak intensities were combined per 
protein and LC-MS/MS run to calculate the protein abundance ratios followed by testing for 
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differential expression using a moderated t-statistic 𝑡𝑡 based on empirical Bayes variance 
estimators (182) according to:  
 
 
𝑡𝑡 =
1
1
𝑛𝑛!
+
1
𝑛𝑛!
𝛽𝛽
𝑠𝑠!
 [1] 
 
where 𝑛𝑛! denotes the number of replicates in the ith group and 𝛽𝛽 represents the least-
square estimator of the log2 fold change in expression for a particular gene. The posterior 
gene-specific (g) standard deviation 𝑠𝑠! is calculated using: 
 
 
𝑠𝑠! =
𝑑𝑑!𝑠𝑠!! + 𝑑𝑑!𝑠𝑠!!
𝑑𝑑! + 𝑑𝑑!
 [2] 
 
where 𝑑𝑑! and 𝑠𝑠!! correspond to the statistical degrees of freedom and variance of the 
experiment, and 𝑑𝑑! and 𝑠𝑠!! are the prior degrees of freedom and variance estimated from a 
chi-square distribution, respectively. The associated probability values (p-values) were 
calculated from the moderated t-statistic 𝑡𝑡 (Equation 1) based on the t-distribution using 
𝑑𝑑! + 𝑑𝑑! degrees of freedom (227). These p-values, which reflect the probability of detecting 
a given mean expression difference across the sample conditions by chance alone were 
corrected for multiple testing to obtain the false discovery rates (q-values) according to the 
Benjamini-Hochberg method (183). The final candidate list of differentially expressed 
proteins was obtained using a 2-fold abundance ratio cut-off and a q‑value cut-off of 0.01 
reflecting a false-discovery rate of ≤1 %. 
 
Functional annotation and classification 
Identification of functionally related gene groups in the final candidate list were obtained 
using the DAVID bioinformatics database (v6.7) (185). Gene functional annotation was 
analyzed using default medium and high classification stringency settings. 
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8 Economic production of isotope-labeled 
proteins in mammalian cells using cellular 
extracts of yeast and algae 
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Introduction 
Recent progress in gene expression and cultivation protocols of mammalian cell lines 
(MCL) has raised their popularity for structural studies of complex proteins (3, 228). 
Recombinant expression in mammalian cells has been prominently applied to produce 
biologically active G protein coupled receptors for crystallographic and NMR studies due to 
the native cellular environment and a comprehensive post-translational modification 
machinery(229). MCL have been improved to match the scalability of insect cell suspension 
cultures and are amenable to growth in synthetically defined serum- and protein-free 
expression media. Furthermore, transient transfection of MCL dispenses with the need for 
laborious generation of recombinant baculovirus, which is generally required for baculovirus-
infected insect cells. 
In theory, similar considerations as discussed for isotope labeling in baculovirus-infected 
insect cells apply to MCL (Chapter 1). Most importantly, the use of complex, chemically 
defined growth media is required due to limitations of the amino acid metabolism in animal 
cells. Customized dropout media are available from commercial suppliers but can as well be 
prepared in-house based on inexpensive reagents (230), albeit at the expense of additional 
labor. Major difficulties of the insect cell system also apply to MCL, namely high costs of 
practically all labeling approaches and the absence of an efficient protocol for uniform 
deuteration. 
Amino acid type selective labeling has been successfully applied to NMR studies of 
isotope-labeled bovine rhodopsin expressed in HEK293 cells (231-234). Labeling by multiple 
combinations of 13C and 15N enabled resonance assignment of all five tryptophan residues by 
solid-state NMR (234). In addition, simultaneous labeling of several amino acids (Gln, Gly, 
Leu, Lys, Ser, Thr, Trp, and Val) was achieved by the use of commercial growth media 
(235). 
Uniform isotope labeling in MCL was pioneered in CHO and Sp2/0 cells by Hansen and 
co-workers more than 20 years ago (32). The described approach enabled labeling by 15N and 
13C based on the combination of bacterial and algal cell extracts. These cells can be grown on 
inexpensive minimal media containing 15NH4Cl and 13C-glucose or 13CO2, respectively. 
However, the extracts were produced by acid hydrolysis and further purification was essential 
to promote growth of the MCL. Moreover, acid hydrolysis results in degradation of amino 
acids such as glutamine and cysteine, which in turn had to be supplied in the mammalian 
growth medium.  
Today, purified algal amino acid mixtures are readily available from commercial suppliers 
at moderate costs. These mixtures have been successfully applied for NMR studies but still 
required additional modifications of the medium, most importantly supplementation of 
arginine, tryptophan and tyrosine (236, 237). Efficient isotope incorporation (>90 %) has 
been relying on at least two subsequent passages of the MCL in labeling medium prior to 
expression of the target protein.  
In general, replacement of all amino acid sources and their respective precursors such as 
carbohydrates in the medium by the individual labeled components is a straightforward 
approach to uniform isotope labeling. Growth media for MCL entirely based on 
supplementing labeled amino acid sources have been commercialized and provide uniform 
15N and 13C,15N labeling at costs of 7700 EUR and 15400 EUR per liter, respectively 
(BioExpress-6000, Cambridge Isotope Laboratories). Although these media are available for 
several years and have been successfully used to produce isotope-labeled bovine rhodopsin in 
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HEK293 cells (235), they have so far not found routine application in part due to high costs 
and the absence of deuterated labeling schemes.  
A recent development to provide an alternative medium for uniform isotope labeling has 
been based on a combination of yeast and algal extracts (238). This approach has enabled 
uniform labeling in HEK293 cells by the use of a modified DMEM/F12 medium formulation. 
However, four full passages in the labeled medium have been required to achieve equally 
high incorporation (~90 %) as reported for previous protocols. Furthermore, labeling has only 
been limited to 15N and application to canonical NMR experimental schemes has not been 
demonstrated.  
This chapter describes the initial application of isotope-labeled yeast extracts for economic 
production of uniformly labeled proteins in mammalian cells. Recombinant expression of the 
mouse angiotensin II receptor type 1a (mAT1) was analyzed in HEK293 cells grown on 
commercially available dropout media supplemented with extracts of yeast and algae as the 
single source of amino acids. The method enabled high-level expression of mAT1 
corresponding to about 60 % of the yield obtained in commercial media by direct exchange to 
extract-based growth media prior to expression. Finally, possible optimizations of the 
protocol by adaptation of HEK293 cells to the extract-based medium are discussed. 
 
Remark on author contribution 
The work of this chapter was carried out together with Dr. Chayne Piscitelli (Paul Scherrer 
Institute, Villigen), who performed cloning and expression of the mouse angiotensin II 
receptor type 1a in HEK293S cells. 
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Results and Discussion 
Initial design of the extract-based growth media  
To establish the amount of amino acids required as a supplement to an amino acid-
depleted medium for HEK293S cells, concentrations of individual amino acids in the widely 
used Dulbeccos’s modified Eagle’s minimal essential medium (DMEM) were used as a 
reference. When compared to the overall content of amino acids in insect cell media such as 
IPL-41 (Chapter 2.1), DMEM provides a significantly lower amount of amino acids 
(Figure 8.1, grey bars). Furthermore, A, D, E, N, and P are not present in DMEM. These 
amino acids are non-essential and thus can be synthesized by mammalian cells. In contrast, 
high levels of glutamine (584 mg/L) are added to DMEM, which is in line with the 
supplementation scheme developed for insect cells grown on yeast extracts (Chapter 2.1). 
Initially, the use of an amino acid-depleted dropout medium derived from the commercial 
protein expression medium (PEM, Thermo Fisher) was considered as this medium was 
successfully employed to obtain high-level expression of the angiotensin II receptor type 1a 
(mAT1). Unfortunately, customized formulations of PEM are costly (450 EUR/L, personal 
communication with Thermo Fisher). Therefore, an inexpensive dropout medium depleted of 
all amino acids (ΔM77, Bioconcept) based on the commercial MAM-PF 77 medium (M77, 
Bioconcept) was chosen as an alternative to PEM. As the amino acid content of M77 is not 
disclosed, their content was determined by amino acid analysis as described in Chapter 2. 
Using the same assumptions as made for dropout media supplemented with yeast extracts 
used in insect cells, the amino acid content of M77 was analyzed at 20 % (w/v) of the initial 
amino acid level (Figure 8.1, brown bars). Remarkably, the analysis indicated that in such a 
medium most amino acids would exceed the concentrations of the DMEM reference. 
Moreover, M77 did not contain alanine and glutamine. The latter is commonly added shortly 
before use due to the instability of the amino acid (138), thereby increasing the shelf life of 
these media. The concentration of cysteine was not determined by this method (see 
Chapter 2.1) and a possible limitation cannot be excluded. However, supplementation of 
cysteine was not required in extract-based growth media for insect cells, which contain an 
overall higher amount of amino acids. 
In a next step, the amount of yeast extract necessary for supplementation to the amino 
acid-depleted ΔM77 was determined. Comparison to DMEM suggested that in most cases 
supplementation of ΔM77 with 8 g/L yeast extract will provide the required concentrations of 
amino acids (Figure 8.1, blue bars). Since the concentrations of isoleucine and tyrosine were 
only slightly lower, an influence on the growth of HEK293S cells was not expected in such a 
medium. Conversely, the concentration of glutamine was significantly lower (~60-fold) in the 
yeast extract and would have required addition of substantially higher amounts of the extract. 
Therefore, ΔM77 supplemented with 8 g/L yeast extract and 1 g/L glutamine was taken as an 
initial medium (ΔM77+YE) for expression of mAT1 in HEK293S cells.  
In order to test for possible growth promoting (142, 143) or inhibitory effects of the yeast 
extract, an alternative supplementation scheme was developed using algal extract (AE) as 
described for insect cells in Chapter 4. Since the amino acid analysis of AE indicated that the 
overall content of amino acids was similar to yeast extract (see Chapter 4), the same 
supplementation scheme (8 g/L AE and 1 g/L glutamine) was used for preparation of 
ΔM77+AE. The algal extract-based medium also required additional supplementation of 
20 mg/L tryptophan (39).  
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Figure 8.1 Amino acid content of media used for growth of HEK293S cells in suspension. The free amino acid 
content of the commercial DMEM (grey) is compared to 20 % concentrations of amino acids in commercial 
MAM-PF 77 (M77, brown) and a customized amino acid-depleted M77 medium (ΔM77) supplemented with 
8 g/L yeast extract (blue). Concentrations of amino acids in DMEM were taken from (239). Free amino acids in 
homemade yeast extract and M77 were quantified by amino acid analysis (see Chapter 2.1). Levels of cysteine 
were not determined by this method (asterisk). 
 
Expression of mAT1 in HEK293S cells using cellular extracts of yeast and algae 
To test the performance of amino acid-depleted ΔM77 supplemented with cellular extracts 
of yeast or algae, a stabilized construct of the mouse angiotensin II receptor type 1a 
(TS-mAT1) was expressed in HEK293S cells grown on different expression media. TS-mAT1 
comprises a C-terminal fusion protein eGFP (see Materials and Methods), which enables to 
analyze the yield and the oligomerization state of the receptor using fluorescence-detection 
size-exclusion chromatography (FSEC). Typically, ~0.3 mg/L of purified TS-mAT1 were 
obtained by expression in the commercial protein expression medium (PEM, Thermo Fisher). 
Expression of TS-mAT1 in ΔM77 requires medium exchange from PEM prior to 
induction, which may affect cell viability and the protein yield. To test for such effects, 
HEK293S cells grown to a cell density of 1.5×106 cells ml-1 in PEM were collected by a mild 
centrifugation step (see Materials and Methods) and again resuspended in fresh PEM. FSEC 
analysis of solubilized TS-mAT1 expressed in these cells (Figure 8.2, PEM) indicated a single 
peak for the monomeric receptor at an elution volume of about 2.55 ml (Figure 8.2, grey 
rectangle). Formation of higher oligomers could also be excluded from this analysis, as the 
corresponding peak was not observed at an elution volume of 1.9 ml. Furthermore, a second 
peak was observed at an elution volume of about 3.3 ml, which most likely corresponds to 
free eGFP. Substantial amounts of eGFP were so far not observed for expression in PEM 
(data not shown) and suggest an alteration of the expression due to the exchange of the 
medium. However, it is expected that free eGFP is removed during purification. The 
expression level obtained by medium exchange in PEM was further used as a reference to 
estimate the amount of TS-mAT1 expressed in HEK293S cells grown on extract-based media. 
In a next step, cultures of HEK293S cells were first grown in PEM and exchanged to 
ΔM77 supplemented with 8 g/L yeast extract (YE) and 1 g/L glutamine. Again, expression 
was analyzed on the solubilized receptor using FSEC (Figure 8.2, ΔM77+YE). The yield of 
monomeric TS-mAT1 was reduced to about 50 % compared to the reference expression level 
in PEM. Interestingly, a clear doublet was shown for the peak possibly corresponding to free 
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eGFP. This observation may be related to growth in ΔM77. Moreover, a decrease in the 
overall fluorescence in the FSEC measurement indicates a reduction of the total yield of 
protein. 
 
 
Figure 8.2 Fluorescence-detection size-exclusion chromatography (FSEC) analysis of a stabilized mouse 
angiotensin II receptor type 1a (TS-mAT1) solubilized in n-dodecyl β-D-maltopyranoside. TS-mAT1 comprises 
a C-terminal fusion to the green fluorescence protein (eGFP) to enable fluoresence detection of the receptor (see 
Materials and Methods). The solubilized receptor was obtained from HEK293S cells grown on the commercial 
protein expression medium (PEM, Thermo Fisher) and the amino acid-depleted MAM-PF 77 medium (ΔM77, 
Bioconcept) supplemented with 8 g/L yeast extract (ΔM77+YE), 8 g/L algal extract (ΔM77+AE), and a 
combination of 4 g/L of each extract (ΔM77+AE/YE). 
 
A similar FSEC profile was obtained for TS-mAT1 expressed HEK293S cells grown in 
ΔM77 supplemented with 8 g/L algal extract (AE), 1 g/L glutamine, and 20 mg/L tryptophan 
(Figure 8.2, ΔM77+AE). Compared to expression in PEM, the yield of monomeric receptor 
was significantly reduced to about 30 %. Again, the overall fluorescence intensity was 
reduced and a clear doublet was observed for the eGFP peak. Since amino acid analysis of 
indicated similar amounts of free amino acids in AE and YE, the reduction may not be simply 
explained by a limitation of single amino acids. AE contains substantial levels of free 
ammonium (39), which is known to be toxic to mammalian cell cultures at high  
concentrations (240). Therefore, decreasing the amount of AE supplemented to ΔM77 may 
improve expression in this medium. Furthermore, as discussed above, supplementation of YE 
to growth media used for CHO cells significantly improved proliferation and protein 
expression (142, 143). A similar growth-promoting effect is likely to be expected in 
HEK293S cultures.  
To analyze the expression level for a combination of both extracts, TS-mAT1 was 
expressed in HEK293S cells grown in ΔM77 supplemented with 1 g/L glutamine and 4 g/L 
YE and AE, respectively. FSEC analysis indicated that the peak of the monomeric receptor 
was reduced to about 60 % relative to expression in PEM (Figure 8.2, ΔM77+AE/YE). 
Accordingly, this corresponds to 2-fold increase in the yield over ΔM77+AE. The 
improvement may be attributed to the growth-promoting property of YE. However, as the 
amount of AE was simultaneously decreased, a possible inhibitory effect of the AE cannot be 
ruled out from the data. Although expression of TS-mAT1 was slightly higher in 
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ΔM77+AE/YE compared to ΔM77+YE, the difference may be explained by a naturally 
occurring variation of the expression level. Interestingly, a similar decrease in the protein 
yield has been reported in a previous protocol using AE and YE (238), which hints at a more 
fundamental limitation related to the use of such extracts. However, robust expression in 
HEK293S and CHO cells has not clearly been demonstrated for this method in part due to 
batch-to-batch variations of the prepared extracts.  
Furthermore, glutamine is a major source of ammonium, which is released to the culture 
medium during growth and is toxic to mammalian cells (240). According to the amino acid 
content of DMEM (Figure 8.1, grey bars), a reduction of the initial concentration of 
glutamine from 1 g/L to 584 mg/L may be possible without affecting cell growth in ΔM77. 
Consequently, the amount of secreted ammonium may be reduced and expression levels may 
be further improved. 
 
Adaptation of HEK293 cells to growth in alternative media 
For all tested supplementation schemes based on ΔM77, expression of TS-mAT1 was 
significantly reduced in HEK293S cells. To investigate whether such a decrease might be 
caused by the medium alone, adaptation of HEK293S cells to growth in commercial 
MAM-PF 77 (M77) was investigated. First, cell growth was monitored for HEK293S cells 
cultured in PEM supplemented with 5 % FCS (Figure 8.3A, PEM+FCS). A cell density of 
1.5×106 cells ml-1 was reached seven days post inoculation, which is in good agreement with 
typically obtained growth rates in PEM+FCS. In contrast, M77 supplemented with 5 % FCS 
did not support growth of HEK293S cells (Figure 8.3A, M77+FCS). Remarkably, a complete 
growth arrest was observed after three days of culturing. The cells appeared shriveled and 
smaller in size compared to the cultures grown in PEM+FCS. This hints on osmotic stress, 
which is typically caused by a change in the osmolarity of the growth medium. M77 is 
optimized for serum-free growth of CHO cells (personal communication with R. Liebetanz, 
Bioconcept). Supplementation of FCS is likely to increase the osmolarity of the medium, 
which may exceed the level tolerated by HEK293S. To test for such an effect of FCS, 
HEK293S cells were grown in M77 without supplementation of FCS. This serum-free 
medium supported growth of the culture up to a final cell density of 0.72×106 cells ml-1 
(Figure 8.3A, M77). A significant reduction in the growth rate was observed after three days 
of culturing. This effect was more pronounced from day five on indicating an apparent 
stationary behavior. Such a reduction of the growth rate at a later stage of the culture may be 
explained by two reasons: (i) a depletion of a single or several nutrients and (ii) accumulation 
of an inhibitory byproduct such as ammonium. A possible limitation of amino acids may be 
identified by amino acid analysis of M77 at this time point. Furthermore, the cell size was 
reduced by about 2-fold compared to cells grown in PEM+FCS. Again, this hints on a 
difference in the osmolarity between M77 and PEM, which should be tested in a next step. 
To further study the effect on the protein yield, expression of TS-mAT1 was induced in 
M77 and PEM+FCS cultures seven days post inoculation (Figure 8.3A, green rectangle). The 
detergent-soluble supernatant obtained from HEK293S cells after 72 h of expression was 
separated by SDS-PAGE and TS-mAT1 was detected by in-gel fluorescence (see Materials 
and Methods). Analysis of the Coomassie-stained gel indicated a significant reduction of the 
overall expression in the supernatant of HEK293S cells grown on M77 compared to cultures 
in PEM+FCS (Figure 8.3B, SDS-PAGE). Furthermore, a strong fluorescent band 
 159 
corresponding to the monomeric TS-mAT1 was detected in the supernatant of detergent-
solubilized HEK293S cells grown on PEM+FCS using in-gel fluorescence (Figure 8.3B, 
iGF). Conversely, fluorescence of eGFP was hardly detectable in the supernatant obtained 
from M77 cultures (Figure 8.3B, M77). Spectrometric quantification of the eGFP 
fluorescence in the two supernatants revealed that the expression of TS-mAT1 was reduced to 
6 % in HEK293S cells grown on M77 as compared to PEM+FCS cultures. 
In summary, the data suggest that M77 is not optimized for growth of HEK293S cells and 
causes a decrease in the protein yield irrespective of supplementation with cellular extracts of 
yeast or algae.  
 
 
Figure 8.3 A Growth of HEK293S cells in different commercial media. Cultures inoculated with 0.15×106 cells 
ml-1 were grown on protein expression medium (PEM, Thermo Fisher) supplemented with 5 % FCS 
(PEM+FCS), MAM-PF 77 (M77, Bioconcept) supplemented with 5 % FCS (M77+FCS), and M77 alone. The 
M77+FCS culture was no longer monitored after day four as growth was arrested as indicated by the asterisk. 
Expression of TS-mAT1 was induced seven days post inoculation (green rectangle). B Analysis of TS-mAT1 
expression in HEK293S cells grown on PEM+FCS and M77. Detergent-soluble supernatants were seperated by 
SDS-PAGE and TS-mAT1 was detected by in-gel fluorescence (iGF) analysis of the C-terminal fusion protein 
eGFP (see Materials and Methods). 
 
Conclusion and perspective 
Recombinant expression of the stabilized mouse angiotensin II receptor type 1a 
(TS-mAT1) was established in HEK293S cells using cellular extracts of yeast or algae 
supplemented to inexpensive dropout media depleted of amino acids. The method was 
adapted from the protocol originally described for production of isotope-labeled proteins in 
insect cells (Chapter 2.1) and thus may enable uniform isotope labeling of TS-mAT1 in an 
economic manner. So far, the highest yield was achieved by the combined use of yeast 
extract (YE) and algal extract (AE) added to ΔM77 corresponding to 60 % of the expression 
obtained in the full medium. However, also supplementation of YE alone resulted in 
comparable expression of TS-mAT1 (~50 %). Surprisingly, amino acid analysis of the YE did 
not indicate significant limitations of individual amino acids, which have been observed for 
extract-based labeling media used for recombinant expression in insect cells (Chapter 2.1). It 
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is expected that the method may be improved by modifying the supplementation scheme 
based on the amino acid analysis of the cellular extracts. 
Furthermore, adaptation of HEK293S cells to growth in the commercial MAM-PF 77 
medium (M77) used as the basis for the extract-based dropout media was studied. As shown 
here, expression of TS-mAT1 was dramatically decreased in this medium. Since adaptation to 
growth in the commercial M77 was so far not successful, different media formulations need 
to be explored. The preparation of a homemade growth medium provides a promising 
alternative to commercially available media. Such homemade media have already been 
described for NMR studies of G protein coupled receptors (239). Amino acid analysis of the 
commercial protein expression medium (PEM) may guide optimization of the amino acid 
content in these homemade media. 
In the next step, isotope-labeled extracts can be employed to produce uniformly labeled 
TS-mAT1 in HEK293S cells. A thorough analysis of the receptor by mass spectrometry is 
required to characterize isotope incorporation (Chapter 2). Mass spectrometric analysis is 
possibly impeded for the fusion construct of TS-mAT1 due to the requirement of detergent 
solubilization. However, isotope incorporation may readily be determined on the green 
fluorescent protein (eGFP) fused to the C-terminus of the receptor, which can be obtained in 
a soluble form by thrombin cleavage of TS-mAT1. This may enable quantification of the 
overall as well as the amino acid resolved isotope incorporation. 
It is also expected that the use of deuterated YE or AE may provide labeling by 2H in 
HEK293S cells and eventually leads to similar incorporation as described for the labeling 
protocol in insect cells (Chapter 2.1). This may be demonstrated by NMR analysis of 
2H,15N-labeled TS-mAT1 expressed in HEK293S cells grown on 2H,15N-labeled YE. As 
shown in Chapter 3.3, deuteration has been essential to obtain high-quality NMR spectra of 
the 2H,15N-labeled β1-adrenergic receptor, which has been solubilized in detergent micelles 
and hence resembles a system of similar complexity. 
Finally, it is hoped that the described approach may be developed into a robust method for 
uniform isotope labeling in mammalian cell lines including CHO cells. In the case of the 
CHO cell line, the use of the commercial MAM-PF 77 medium as a basis for the extract-
based labeling media may be beneficial, since this medium was originally developed for 
recombinant expression in CHO cells.  
  
Material and Methods 
Construct design of the mouse angiotensin II receptor 
A stabilized construct of the mouse angiotensin II receptor type 1a (TS-mAT1) was 
derived from the wild-type receptor sequence (agtr1a) by addition of the single point 
mutation F117W to enhance expression and obtain a putative increase in thermostability. As 
compared to the wild-type receptor, TS-mAT1 further contains a truncation at the C-terminus 
(Δ324). The modified receptor sequence was fused at the C-terminus via a thrombin cleavage 
site to the eGFP reporter gene sequence (241) and the 1D4 epitope tag for purification (242, 
243) to yield the final construct TS-mAT1-eGFP/1D4. This construct was cloned into the 
pACMV-TetO plasmid to enable expression under the control of the CMV promoter based on 
a tetracycline-inducible operator (TetO) sequence (244).  
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Stable transfection and growth of HEK293S cells  
Generation and selection of HEK293S GnTI cells stably transfected with 
TS-mAT1-eGFP/1D4 was carried out as described previously (245). Stable cell lines were 
expanded in 15-cm-diameter culture dishes at 37 °C using 5 % CO2 in DMEM 
(Thermo Fisher) containing 10 % FCS, 10 μg/ml blasticidin, and 1 mg/ml G418. Adherent 
cells were treated with trypsin at a confluency of 80 % and subsequently washed from the 
culture dish using PEM (Thermo Fisher) supplemented with 5 % FCS and 1x GlutaMAX™ 
(Thermo Fisher). Suspension cultures were inoculated at a cell density of 0.15×106 cells ml-1 
and grown at 37 °C in Erlenmeyer flasks shaken at 110 rpm using 5 % CO2. 
 
Quantitative amino acid analysis by LC/MS 
Detailed protocols are presented in Chapter 2.1. 
 
Growth media containing extracts of yeast and algal cells 
Dropout media were based on the commercial MAM-PF 77 medium (Bioconcept) 
depleted of all amino acids (ΔM77). Supplementation of ΔM77 with cellular extracts of 
algae and yeast was adapted from the protocols used in insect cells, which are presented in 
Chapter 4 and Chapter 2.1. For optimal growth of HEK293S cells in ΔM77, pH and 
osmolarity were adjusted to 7.4 and 300 mosmol kg-1, respectively. 
 
Expression of TS-mAT1-eGFP/1D4 in dropout media supplemented with cellular extracts 
HEK293S GnTI stably transfected with TS-mAT1-eGFP/1D4 were seeded in PEM 
supplemented with 5 % FCS and 1x GlutaMAX™ and cultured to a cell density of 
1.5×106 cells ml-1. Subsequently, cells were collected by centrifugation at 300g for 5 min and 
resuspended in 50 ml of ΔM77 supplemented with different cellular extracts. Expression was 
induced by addition of 2 μg/ml tetracycline and 5 mM sodium butyrate. Moreover, 1 μM of 
the antagonist azilsartan was added to improve the yield of the receptor. The cells were 
further incubated for 48 h and 1 ml of culture was removed to test for expression. 
 
Analysis of TS-mAT1-eGFP/1D4 expression 
Cells collected after 48 h of expression were harvested by centrifugation at 3000g for 30 s 
(4 °C) and resuspended in 200 μl of solubilization buffer containing 50 mM HEPES, 300 mM 
NaCl, 20 mM n-dodecyl β-D-maltopyranoside, 2 mM CHS, 100 μM azilsartan and a protease 
inhibitor cocktail (complete, Roche). Solubilization was performed at 4 °C for 1.5 h using 
mild agitation, followed by an ultracentrifugation step at 90000g for 30 min (4 °C) to remove 
insoluble material. For fluorescence-detection size-exclusion chromatography (FSEC) 
analysis, 10 μl of the supernatant was injected onto a Tosoh SuperSW3000 column 
(4.6 x 300 mm) using an Äkta Ettan LC system (GE Healthcare) running at 0.2 mL/min and 
4°C in SEC buffer containing 50 mM HEPES pH 7.0, 300 mM NaCl, 1 mM DDM, 0.1 mM 
CHS, and 10 μM azilsartan. The elution profile of TS-mAT1-eGFP/1D4 was monitored using 
an in-line fluorimeter to detect GFP fluorescence at 520 nm. For in-gel fluorescence analysis, 
10 μl of the supernatant was separated by SDS-PAGE on a 12 % TEA-Tricine SDS PAGE 
gel under reducing conditions. Subsequently, the gel was exposed for 1 min using an 
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Amersham Imager 600 (GE Healthcare) to detect fluorescence of eGFP. The total protein 
was visualized using the InstantBlue™ stain (Sigma-Aldrich).  
 
Adaptation of HEK293S cells to growth in commercial dropout media 
HEK293S GnTI stably transfected with TS-mAT1-eGFP/1D4 were first expanded in 
DMEM as described above and subsequently seeded at a cell density of 0.15×106 cells ml-1 in 
MAM-PF 77 (Bioconcept) supplemented with 1x GlutaMAX™ and either with or without 
5 % FCS. Suspension cultures were grown for seven days at 37 °C in Erlenmeyer flasks 
shaken at 110 rpm using 5 % CO2. 
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